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SUMMARY
1. Aims of study
The initial aims of this study were to monitor the effects of 
adenosine, ATP and a variety of adenosine analogues on local cerebral 
blood flow (LCBF) and local cerebral glucose utilisation (LCGU) using 
the appropriate quantitative autoradiographic techniques. It was 
anticipated that these initial studies would show that adenosine and 
ATP increased LCBF in the rat, as had already been found in this 
laboratory in studies involving baboons (Forrester et al., 1979), and 
that following these experiments further studies would be carried out 
to determine whether there was any coupling of the vascular and 
metabolic effects, whether any particular areas of groups of areas 
were affected, and whether or not the effects could be antagonised by 
specific adenosine receptor antagonists.
When the initial LCBF experiments revealed that two known 
vasodilators ( the adenosine analogues N^-cyclohexyladenosine (CHA) 
and 2-chloroadenosine (2-CADO)) produced decreases rather than 
increases in LCBF the aims of the thesis then changed to trying to 
identify what receptors were involved in mediating these decreases 
and whether the decreases in LCBF could be antagonised using 
classical adenosine receptor antagonists.
2. Methods
A wide variety of techniques were used to monitor the effects of
adenosine and the analogues of adenosine. Cerebral vessels were 
studied both in vitro (using isolated procine basilar arteries) and 
in vivo (using cat pial vessels). Cerebral blood flow in the rat was 
measured using both laser-Doppler Flowmetry and [^4C]-iodoantipyrine 
autoraiography. Local cerebral glucose utilisation/..
14utilisation in the rat was measured using [ C]-2-deoxyglucose 
autoradiography. In the local cerebral blood flow studies the 
agonists were administered via the right internal carotid artery 
at 50pl/min. for either 2 or 15 minutes. In some LCBF 
experiments an antagonist (8-phenyltheophylline) was given intra- 
peritoneally 20 minutes before the effects of the agonists were 
assessed. In the local cerebral glucose utilisation experiments 
the agonists were administered via the right internal carotid 
artery at 33(Jl/min. for 15 minutes.
3. Results
3.1./ Studies involving cerebral vessels both in vitro and in 
vivo (isolated porcine basilar arteries and cat pial vessels, 
respectively) confirmed the vasodilatory properties of adenosine 
and the adenosine analogues (Edvinsson & Fredholm,1983). The order 
of potency in the in vitro study (i.e. NECA > 2-CADO, adenosine > 
L-PIA > CHA) showed that the vasodilation was mediated via an A^ 
adenosine receptor interaction. In vitro and in vivo studies 
involving the adenosine analogues and the adenosine receptor 
antagonist 8-phenyltheophylline, however, suggest that the 
mechanism mediating the vasodilation is not as straightforward as 
a simple receptor interaction.
3.2./ The in vivo and in vitro studies mentioned above show
the vasodilatory properties of adenosine and the adenosine analogues, 
therefore, one. would expect them to increase local cerebral blood 
flow. The effect of adenosine and the adenosine analogues on local 
cerebral blood flow was found to be dependent not only on the analogue 
used but also on the length of time that the analogue was infused 
via the right internal carotid artery* 15 minute infusions of/..
of adenosine, ATP and NECA all showed a tendency to increase 
local cerebral blood flow, whereas 15 minute infusions of the 
analogues CHA and 2-CADO produced significant decreases in local 
cerebral blood flow. A 2 minute infusion of adenosine produced 
significant increases in local cerebral blood flow and a similar 
2 minute infusion of CHA showed a tendency to increase local 
cerebral blood flow.
3.3./ In animals which had received an intraperitoneal 
injection of the adenosine receptor antagonist 8-phenyltheophylline 
(30mg/kg) a 15 minute infusion of the analogue CHA was again 
found to decrease local cerebral blood flow. It seems likely, 
therefore, since 8-phenyltheophylline is an and A2 receptor 
antagonist, that the decreases in flow produced by CHA are not 
mediated via an A^ or A2 receptor interaction. The recently 
identified third (A^ ) adenosine receptor is also known to be 
xanthine-sensitive, therefore it is also unlikely that the decreases 
in flow produced by CHA are mediated via an action on this receptor. 
Intraperitoneal injections of 8-phenyltheophylline (30mg/kg). were 
able to antagonise the increases in local cerebral blood flow 
produced by a 2 minute infusion of CHA. The A2 receptor is known 
to mediate vasodilation (and will, in turn, increase flow) and 
8-phenyltheophylline is an A^/A2 receptor antagonist, it seems likely 
therefore, that the increases in flow produced by a 2 minute 
infusion of CHA are mediated via an A2 receptor interaction.
3.4./ The possibility of experimental artefact being 
responsible for the unexpected decreases in local cerebral blood flow 
being produced by 15 minute infusions of CHA and 2-CADO is unlikely 
for the following reasons. Firstly, it is unlikely that the 
artefact should be evident only in the experiments involving these/..
these two compounds and not in any of the other experimental groups. 
Secondly, studies were carried out involving FAM fixation and 
pathological examination and there was no evidence of thrombic or 
embolic damage to the cerebral tissue. Thirdly, the vascular effects 
of the compounds are not occurring as a secondary response to 
metabolic changes produced by the compounds, since studies carried 
out to measure the local cerebral glucose utilisation using [^C]-2- 
deoxyglucose autoradiography showed that adenosine and the analogues 
had no effect on local cerebral glucose utilisation.
4. Conclusions
The vessel studies carried out in this thesis confirm the 
vasodilatory actions of adenosine and the adenosine analogues, with 
isolated vessel studies indicating that the dilations are mediated, 
at least in part, by the adenosine receptor. The in vivo 
autoradiographic experiments, however, revealed that there was only a 
barely evident vasodilation with 15 minute infusions adenosine and 
ATP, whereas substantial significant dilations occurred with the 2 
minute infusion of adenosine. In contrast 15 minute infusions of CHA 
and 2-CADO produced significant decreases in LCBF. Antagonism 
studies carried out involving the non-specific adenonsine receptor 
antagonist theophylline showed that although the increases in LCBF 
produced by 2 minute infusions of CHA could be blocked by 
theophylline, the decreases in LCBF produced by 15 minute infusions 
of CHA could not. It seems likely, therefore, that the increase 
in LCBF produced by a 2 minute infusion of CHA are mediated via 
an A£ receptor interaction, whereas the decreases/..
decreases produced by a 15 minute CHA infusion are not mediated via 
an interaction with a known adenosine receptor, The exact identity 
of the receptor involved in mediating the decreases in LCBF produced 
by a 15 minute infusion of CHA, however, was not able to be 
identified using the experiments detailed in this thesis. In 
conclusion, therefore, the in vitro experiments detailed in this 
thesis confirmed the vasodilatory actions of adenosine and its 
analogues, however, when these compounds are administered in vitro 
their effects are dependent not only on the particular compound 
but also on the length of the administration of that compound.
Declaration
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SECTION I 
INTRODUCTION
Interest in the field of adenosine research has grown 
considerably over the past 50 or more years, ever since Drury and 
Szent-Gyorgi (1929) first showed the pronounced cardiovascular 
effects of adenylic acid. They showed that the simple extracts of 
tissues produced both bradycardia and hypotension and that the 
primary active agent of those extracts was adenylic acid. They also 
demonstrated, however, that adenosine had even more potent actions 
than the adenylic acid itself. Adenosine is a purine nucleoside and 
the structure of it and the other related compounds used in this 
study are shown in Figures 1.1. and 1.2.
1. PHYSIOLOGY AND PHARMACOLOGY OF ADENOSINE
1 .1 .Pharmacology of purinergic receptors
One of the major advances in our understanding of the actions of 
adenosine and its analogues has been the identification and 
characterisation of specific receptors. The concept of multiple 
receptors for adenosine was developed when it was observed that 
adenosine had different effects on adenylate cyclase activity in 
different tissues. It was known from very early on that adenosine 
was acting at extracellularly located receptors or binding sites, 
even before the development of specific techniques to look at 
binding sites using radioactive ligands. One technique which led 
to the development of this hypothesis showed that adenosine analogues 
bound covalently to molecules that were unable to pass through cell 
membranes, were still as active as adenosine itself (Daly, 1977).
Bumstock first proposed the idea of two groups of receptors in 
1978. The two purinoceptors proposed were the P^ receptor, linked to/
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to the adenylate cyclase system, with an agonist potency order of 
adenosine AMP > ADP >y ATP, and the P^ receptor, not linked to 
adenylate cyclase, with an agonist potency order of ATP ADP >
AMP ^ adenosine.
Studies by Bumstock and Kennedy (1985) using structural 
analogues of ATP have shown that there are, in fact, two sub-types 
of the P^-purinoceptor: ?2X ' a ran^ order of potency of
« ,f) -methyleneATP, fip j -methyleneATP > ATP = 2-methy 1 thioATP; and 
?2y, wi'th a rank order of potency of 2-methyl thioATP »  ATP >
«,/)-methy leneATP, -methyleneATP. The receptor mediates 
contraction of the guinea pig vas deferens, the urinary bladder and 
the rabbit portal vein, whereas the P ^  receptor mediates 
relaxation of the guinea pig taenia coli and the rabbit portal vein 
as well as the endothelium dependent vasodilation of the guinea pig 
aorta and rat femoral artery.
The P^ (adenosine) receptors can be subdivided into two classes
(Figure 1.3.): the A^ (or r /) receptor, a high affinity receptor
which is coupled to adenylate cyclase in an inhibitory manner
(van Calker, Muller & Hamprecht, 1979. ; Londos, Cooper & Wolff,
1980); and the A0 (or R ) receptor, a low affinity receptor which isa.
coupled to adenylate cyclase in a stimulatory manner (Bruns, 1980). 
Both these adenosine receptors are linked to separate GTP-regulated 
N-proteins, the N. unit for the A1 receptor and the N unit for the
3. Jl S
A2 receptor. It is these proteins that promote the activation or 
inhibition of the catalytic unit of the adenylate cyclase. As can be 
seen in Figure 1.3. there is also a third type of adenosine 
binding site, the purine (P) site. The P-site is intracellularly 
located and it mediates the inhibitory actions of high concentrations 
of adenosine on the catalytic site. It was named the P-site because/.
because it was found that adenosine analogues which had an intact 
purine moiety (e.g. 2 1,51-dideoxyadenosine) were particularly 
potent as direct inhibitors of the adenylate cyclase catalytic site. 
The actual physiological significance of the P-site is, as yet, 
unclear.
The A^ and A2 receptors show a different affinity for adenosine 
and its structural analogues, as has been shown by Londos et al.
(1978) and Trost and Stock (1977) for the sub-type, and Bruns 
(1980) for the A2 sub-type. The rank orders of potency for the 
various adenosine analogues are as follows:
A^ receptor
CHA,L—PIA > 2-CADO > Adenosine > NECA 
A  ^receptor
NECA > 2-CADO,Adenosine > L-PIA > CHA 
Both classes of the adenosine receptor have similar affinities for 
methylxanthine compounds such as theophylline and caffeine, and these 
compounds are competitive antagonists at both sites. Conversely, the 
P-site is not inhibited by methylxanthines, but rather by 5 1 -methyl- 
adenosine.
Although it has been thought that the adenosine receptor 
classification is a simple A^/T^ classification, recent evidence has 
suggested that it might not be this straightforward. Work summarised 
by Williams (1984) suggests, that there may be multiple A^ receptor 
sites, but at present these remain poorly understood. Londos et al. 
(1980) suggested that there may be a further sub-division in the 
A^ classification when they showed that the receptors in the liver 
had a higher affinity for NECA than those in the adrenal gland or 
Leydig cells.
The idea of a third (A^ ) adenosine receptor in the brain, 
not linked to adenylate cyclase but associated with calcium 
channels has been put forward by both Chin & DeLorenzo (1985) 
and Ribeiro & Sebastiao (1986). The physiological responses
t1.
of nerve endings where this receptor appears to be present are 
highly calcium dependent, suggesting that the adenosine 
receptor is linked to calcium. Although these investigations have 
been unable to show how adenosine affects the calcium needed for 
transmitter release they suggest two processes that may be involved, 
either together or independently. These two processes are that 
adenosine acts as a calcium channel antagonist to decreases calcium 
entry, or that there is a reduction in the efficacy of calcium for 
promoting the physiological response. Two speculative hypotheses 
have been put forward to explain these findings: the receptor is 
a voltage-dependent calcium channel which changes its conformation 
after binding adenosine; or activation of the A^ receptor induces 
a conformational change in the membrane which results in an 
alteration of the calcium receptor sites (Ribeiro & Sebastiao,1986).
It can be seen, therefore, that the adenosine receptor picture 
is not as clear as a simple A^ /^ L, receptor classification, and 
further work is required, particularly with regard to identifying 
specific A^, A^ (and A^?) receptor antagonists to help clarify the 
overall picture.
1 .2.Synthesis and degradation of adenosine
There is sufficient evidence to suggest that neuronal activity 
results in adenosine release from neurones in the central nervous 
system. Studies have shown that electrical stimulation of cerebral 
slices results in a large outflow of purines (Pull & Mcllwain, 1972). 
This release of adenosine is calcium dependent. Only a small amount 
of the released compounds have been found to be adenine nucleotides, 
with the bulk of the material (50%) being adenosine itself (Kuroda & 
Mcllwain, 1974).
ATP is often co-re leased with a number of other neurotransmitters 
and thereafter it can be hydrolysed by an ecto-nucleotidase enzyme, 
found on the outer surface of the neurones, to adenosine. However, 
it has been suggested that this hydrolysis of the extracellular ATP 
in the synaptic cleft is not the major source of extracellular 
adenosine, since stimulation-evoked release of adenine nucleotides 
in the presence of an inhibitor of the ecto-nucleotidase (e.g.
&,^ —methylene ADP) has no effect on the proportion of adenosine 
release (Pull & Mcllwain, 1977).
The adenosine which is released from the neurone into the synaptic 
cleft is obtained from the metabolic degradation of ATP (see Figs. I. 
4, 5, 6). It is thought that the release of the adenosine is 
calcium-dependent (Kuroda & Mcllwain, 1974), but by a mechanism 
different from that observed with other neurotransmitters.
(Stone, 1981).
It can be seen, therefore, that the levels of synaptic cleft 
adenosine are determined by both the release of adenosine from 
nerve endings and by hydrolysis of released ATP by ectoenzymes to 
form adenosine (1, 2 and 3 in Fig.1.7). Once in the synaptic cleft 
the adenosine can be either taken back up into the presynaptic
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nerve ending via a specific nucleoside transport system (4 in 
Fig.1.7) or deaminated by adenosine deaminase to form inosine (5 
in Fig.I.7). The sites of action of the remaining adenosine are 
adenosine receptors linked to adenylate cyclase (A^,A2)-, other 
receptors linked to adenylate cyclase (e.g. P-site), calcium channels 
and other receptors. The adenosine metabolite, inosine, may also 
act on other receptor systems. Although Fig. 1.7 shows these 
sites of action as being post-synaptic they may also be located 
pre-synaptically.
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1.3.Physiological actions of adenosine
Adenosine has effects on a wide variety of physiological systems. 
Adenosine has been shown to be a potent vasodilator in a number of 
vascular beds and it is thought that this may mediate postischaemic 
hyperaemia of coronary blood vessels (Berne,1980), since after it was 
conclusively demonstrated that an inadequate oxygen supply led to the 
production and release of adenosine by the heart, it was then shown ' 
that an increased metabolic activity in the heart produced an enhanced 
production and release of adenosine. These studies were carried out in 
a variety of preparations including cultured myocytes and 
unanaesthetised dogs and the results obtained suggested that the release 
of the adenosine was coupled to the balance of the myocardial oxygen 
supply and need, and that the alteration in the coronary circulation 
necessary to keep this balance was mediated in some way by adenosine 
(Berne, 1985). Adenosine is also a potent, fast-acting bronchoconstrictor 
(Cushley, Tattersfield & Holgate, 1983), and it is thought that blockade 
of adenosine receptors by methylxanthines may explain their anti­
asthmatic effects.
Adenosine inhibits platelet aggregation (Bom, 1964) and it is thought 
that the build up of adenosine after cardiac ischaemia could therefore 
influence blood clotting. The effect of the inhibition of platelet 
aggregation can be associated with an increase in cyclic AMP and is mediated 
via adenosine receptors (Haslam &Cusack,1981). Adenosine has been 
shown to inhibit noradrenaline-stimulated cyclic AMP accumulation in 
isolated rat adipocytes (Fain,1973). Lipolysis is partially inhibited 
by adenosine, only if submaximal concentrations of noradrenaline 
are used (Schwabe, Ebert & Erbler,1973).
The best characterised physiological action of adenosine is that 
of inhibition of transmitter release. The inhibition is actually a/..
a heterologous regulation of release, unlike the -autoinhibition 
of noradrenaline or the -inhibition of dopamine release, in which 
the neurotransmitter inhibits its own release via a negative 
feedback mechanism.
Adenosine, in fact, has been shown to inhibit neurotransmitter 
release and therefore synaptic transmission at a variety of synapses 
where adenosine is not the transmitter. Although the best examples of 
adenosine inhibition of neurotransmitter release are to be found in 
the peripheral nervous system, it has also been shown in the central 
nervous system, where evidence suggests that the release or 
turnover rate of many neurotransmitters is reduced by adenosine. 
Included in this list of neurotransmitters are acetylcholine 
(Pedata et al,1983), serotonin (Fredholm, Jonzon & Lindgren,1983), 
dopamine (Hams, Wardeh & Mulder, 1979), ^-aminobutyric acid 
Hollins & Stone,1980) and glutamate (Dolphin & Archer,1983).
In the central nervous system adenosine has inhibitory actions 
on neuronal firing (Phillis & Wu,1981). Although some direct 
postsynaptic actions can be seen, the major effects reflect a 
presynaptic blockade of excitatory transmitter release. These effects 
of adenosine are once again blocked by xanthine compounds.
Administration of adenosine and some of its analogues illicit a 
wide variety of behavioural effects including sedation, analgesia 
(Crawley, Patel & Marangos, 1981), hypnosis (Marley & Nestico,1972) 
and an anticonvulsant action (Maitre et al.,1974). Since adenosine 
has such marked effects on blood pressure it is difficult to 
establish whether the effects of peripherally administered adenosine 
are mediated by the central nervous system or as a consequence of 
its action on the cardiovascular system. Recent work by Patel,
Marangos & Boulenger (1984), however, suggests that at least the 
sedative effects of adenosine are centrally mediated. They found/^
found that when they administered the adenosine receptor antagonist 
8-£-sulfophenyltheophylline (which does not cross the blood-brain
g
barrier) intravenously along with N -eye1ohexy1adenosine (CHA), it 
was able to block most of the cardiovascular actions of CHA. Under 
these conditions, however, the sedative action of CHA was 
unaffected.
2. PROPOSED ROLE FOR ADENOSINE IN THE REGULATION OF CEREBRAL 
BLOOD FLOW
Several factors have been proposed as possible mediators involved 
in the mechanism by which the brain regulates its own: blood flow. 
Included in this list of factors are hydrogen ions (Kontos, Raper & 
Patterson,1977), carbon dioxide (Severinghaus & Lassen,1967), 
oxygen (Courtice,1941), lactate (Siesjo & Zwetnow,1970), potassium 
ions (Kuschinsky et al.,1972) and a more recent addition, adenosine, 
which was proposed as a coronary blood flow regulator by Berne (1963).
In order for a substance to be considered as a mediator in 
cerebral blood flow regulation it must meet certain criteria (Winn, 
Rubio & Berne,1981): (i)it must be a potent dilator of cerebral 
resistance vessels; (ii)the brain must be capable of producing the 
mediator during periods of altered cerebral blood flow and 
metabolism; (iii) the perivascular concentrations must be sufficient 
to produce the vasodilation observed with the metabolic stimulation;
(iv)the time course and magnitude of the increase in substance must 
parallel the metabolically induced rise in cerebral blood flow; and
(v)potentiators of the substance should increase cerebral blood flow 
while inhibitors should cause decreases in cerebral blood flow.
Adenosine is a likely candidate for the regulation of cerebral/..
cerebral blood flow for a variety of reasons. Adenosine has been shown
to dilate pial vessels both in the cat (Wahl & Kuschinsky,1976) and the
dog (Berne, Rubio & Curnish,1974). It can be seen, therefore, that
topical application of adenosine causes a significant increase in pial
vessel calibre, however, intracarotid infusions of adenosine in the
dog have no effect on CBF (Berne et al.,1974). Following intravenous
or intracarotid infusions of radioactively labelled adenosine little
redioactivity is found in the brain tissue or the cerebrospinal
fluid (CSF) (Rubio, Berne & Winn, 1978) and similarly, following
14convexity-cisternal infusions of [ C]-adenosine very little 
radioactivity is found in the venous blood (Winn et al., 1980c). It 
appears, therefore, that a relative blood-brain barrier and CSF-blood 
barrier exists for adenosine (Berne et al.,1974; Cornford & Oldendorf, 
1975) and unlike blood, CSF does not contain the enzymes which 
metabolise adenosine and its degradative products (Winn et al.,1980c).
As a consequence of these findings the changes in brain reflect cerebral 
rather than systemic events and, therefore, adenosine is a local 
metabolite and an ideal candidate for the regulation of cerebral blood 
flow.
Winn et al. (1979) demonstrated that adenosine levels were rapidly 
increased 2.5-fold during profound ischaemia. The adenosine levels were 
measured five seconds after decreasing the mean arterial blood pressure 
from normal levels of more than lOOmrriHg down to OmmHg. Kontos et al. 
(1978) also showed that during similar periods of short-lasting 
ischaemia and hypotension pial vessel dilation occurred. It can be see, 
therefore, that the time course of these increases in adenosine 
levels in response to ischaemia occur with sufficient rapidity to 
account for the vascular changes observed. During sustained hypotension 
in rats brain adenosine levels were increased even if the blood/ # #
blood pressure remained within the normal autoregulatory range 
(Winn et al.,1981). With sustained hypoxia and the use of a rapid 
brain sampling technique Rubio et al.(1975) showed increased levels 
of adenosine in the brain. Work carried out by Rehncrona et al.
(1978), however, using a slow-freezing method, failed to support this 
relationship between adenosine levels and PO^*
With the onset of hypoxia CBF was increased 2-fold within 30 
seconds (Astrup et al.,1978) and during similar periods of hypoxia 
adenosine levels increased 6-fold (Winn, Rubio & Berne,1981). It 
appears, therefore, that adenosine is a relatively sensitive index 
of cerebral hypoxia and the changes in cerebrovascular resistance 
and brain adenosine levels are temporally related during hypoxia.
Previous work has shown that bicuculline-induced seizures in rats 
increased adenosine concentrations in the brain 6-fold (Winn et al., 
1980b) and cerebral blood flow 8- to 9-fold (Meldrum & Nilsson,1976) 
and that these responses occur in parallel.
On examination of the data it can be seen that the concentration 
of adenosine in the brain is increased in conditions of both 
increased oxygen demand (seizure) and decreased oxygen delivery 
(hypotension and ischaemia) thus suggesting that adenosine may well 
be involved in cerebral blood flow regulation. Further direct support 
for the adenosine hypothesis has been obtained using both adenosine 
potentiators (Heistad & Marcus, 1980) and inhibitors (Kontos & Wei, 
1981). Both adenosine and ATP have previously been shown to produce 
increases in cerebral blood flow in baboons (Forrester et al.,1979). 
Adenosine and its analogues have also been shown to dilate feline 
cerebral vessels in vitro (Edvinsson & Fredholm,1983).
It can be seen, therefore, from these data that adenosine meets 
many of the criteria of a metabolic regulator of cerebral blood flow:/.
flow: it is a potent dilator of cerebral blood vessels, particularly 
the smaller ones which play a role in cerebrovascular resistance (CVR) 
the brain produces adenosine under conditions where CVR is decreased; 
the increases in cerebral adenosine levels are temporally related to 
the increases in CBF and cerebral metabolism; the concentrations in 
brain tissue by rapid-freezing techniques are apparently within the 
vasoactive range. All of the data are consistent, therefore, with the 
hypothesis that adenosine is an important metabolic factor in the 
regulation of cerebral blood flow.
3. REASONS FOR STUDY
The studies detailed in this thesis were carried out to monitor 
the effects of adenosine and a variety of adenosine analogues on the 
cerebrovasculature using a variety of in vitro and in vivo techniques. 
Adenosine and the adenosine analogues had previously been shown to 
dilate feline cerebral arteries in vitro via an A2 adenosine receptor 
interaction (Edvinsson & Fredholm,1983), and the isolated vessel 
experiments detailed in this study were carried out to confirm these 
results in another species, namely the pig, and try to determine 
whether the effects could be blocked using known A^/A^ receptor 
blockers. The pial vessel experiments were designed to monitor the 
effects of adenosine and the adenosine analogues on vessel calibre 
in situ, where the innervation, absent in vitro, is present, to 
determine whether the effects are in any way different.
The effects of adenosine on cerebral blood flow have been well
documented. When adenosine was administered via the internal carotid
—8 —7artery of dogs at 10 and 10 moles/min. there were significant 
increases of 15% and 40%, respectively, in CBF of the whole brain/..
brain as measured by xenon clearance (Kozniewska, Trzebski &
Zielinski,1975). Similarly, intracarotid infusions of adenosine at
“ 7 “ 6
10 moles/min. and 10 moles/min. in baboons have been seen to
produce significant increases of 20% and 80%, respectively, in CBF 
of the whole brain as measured using xenon clearance (Forrester et al 
1979). Intracarotid infusions of adenosine have also been shown to 
produce significant increases in CBF in the cerebrum, brain stem 
and cerebellum of dogs, as measured using microspheres (Heistad et al
1981). These studies confirmed the expected effects of known vaso­
dilators on CBF i.e. they increase CBF. Other studies, however, have 
shown that adenosine does not always produce the expected increase in
CBF. When adenosine was injected into the hypothalamus of rabbits at
-4 -3concentrations of 10 M and 10 M there were the expected increases
in blood flow as measured by Xenon clearance (Livemore & Mitchell,
—61983), however, when adenosine was injected at 10 M in the same 
study there was a significant 25% decrease in hypothalamic blood 
flow. This observed vasoconstriction was unaffceted by adrenergic 
blockade with phenoxybenzamine and propranolol, or by the 
inhibition of neuronal activity using barbiturate, which suggests 
that the vasoconstriction is not dependent on adrenergic mechanisms 
or on reduced neuronal metabolism, but is a result of a direct action 
of adenosine on adenosine receptors on blood vessels. No changes 
were found in CBF in young (6 month) rats following infusions of 
adenosine (Hoffman, Albrecht & Miletich,1984). Similarly no changes 
in CBF were found in dogs following intravertebra1 infusions of 
adenosine (Boarini et al.,1984). In both of these studies CBF was 
measured using radioactive microspheres. It was because of these 
discrepancies in the results from species to species that it was 
decided to test the effects of adenosine and a variety of adenosine/# b
adenosine analogues on local cerebral blood flow in the rat as 
14measured by [ C]-iodoantipyrine autoradiography. When these initial 
autoradiographic experiments showed that two of the adenosine analogues 
produced decreases in LCBF further studies were carried.out to 
determine whether these effects could be blocked by known adenosine 
receptor antagonists, thus uncovering the receptor mechanisms 
mediating the effects.
SECTION II
MATERIALS AND METHODS
1. IN VITRO STUDIES USING PORCINE BASILAR ARTERIES
1 .1 .Preparation of porcine basilar arteries for in vitro studies 
Specimens of basilar artery were obtained from adult pigs
immediately after slaughter and stored in the bathing medium (see 
'Compounds under examination and solutions used1) at 4° until use.
The vessels were stored for up to four days before use and the 
responsiveness of the vessels was not altered within this time span. 
However, on average, the vessels were used within one or two days 
of obtaining them. The vessels were trimmed to a length of 4mm. 
and the segments were suspended between two L-shaped metal hooks 
in an organ bath containing 20ml. of the bathing medium, which was 
being continuously gassed with 5% carbon dioxide (C02) in oxygen 
(0 2) in both the stock solution and the bath, to produce a resulting 
pH of between 7.35 and 7.45. The temperature of the bathing medium 
was kept constant at 37°C.
1 .2 .Experimental procedure
Isometric contractions of the circular smooth muscle were measured.
The optimal passive load on the vessels of 37.28 milliNewtons (mN)
was chosen as the tension which produced the largest contractile 
_6
response to 3x10 M PGF2K After application of this load the vessels
were allowed to stabilise for one hour. The vessels were sensitised
with 30mM KCL for ten minutes which produced a contractile response.
The vessels were washed for one minute (three changes of the
bathing medium) and left for thirty minutes with further one minute
washes at fifteen and thirty minutes. At this point the PGF^
“6(3x10 M) was added to the bath to elicit a contriction of the vessels.
_6
The optimal FGF20C concentration of 3x10 M was determined by means of 
a concentration-response curve from which.the concentration producing/...
producing the maximum constriction of the vessels was determined.
Once the PGF2 effect had stabilised concentration-response curves
were obtained for each of the compounds being studied by their
cumulative administration to the bath. In the experiments carried
out to study the antagonistic effects of 8-phenyltheophylline, the
8-phenyltheophylline was administered when the PGF^ effect was
at its peak. The cumulative concentration-response curves were
begun twenty minutes after the administration of the 8-phenyltheophylline.
—8 —7The concentrations of 8-phenyltheophylline chosen (10 M and 10 M) 
were those which were found to have minimal effects on relaxed and 
PGF.^-constricted vessels (see Figures m.l and HC.2).
2. ANIMAL PREPARATION
2 .1 .Preparation of animals for autoradiographic experiments
The experiments were carried out using male Sprague-Dawley rats 
weighing between 250g and 500g. Anaesthesia was induced using a 
mixture of 70% nitrous oxide (N20) and 30% oxygen (02), containing 
5% halothane. Anaesthesia was maintained by means of a face mask, 
using 2% halothane in the same N20:02 mixture. A tracheostomy was 
performed and anaesthesia with 0.5% halothane in the same N20:02 
mixture was delivered by mechanical ventilation. Small incisions, 
approximately 1.5cm long, were made in the groin on both sides of 
the animal to expose the femoral vessels. Polythene catheters (15cm 
long, external diameter 0.96mm) filled with heparinised saline 
(10 IU/ml) were inserted into both femoral arteries and veins, thus 
allowing the continuous measurement of arterial blood pressure, 
the withdrawal of arterial blood samples and the administration of 
drugs and radioactive tracers. Prior to commencement of the neck surgery 
required to expose the external carotid artery, the halothane/...
halothane level was raised from 0.5% to 1.0% in order to ensure 
a sufficient depth of anaesthesia. An incision was made in the 
neck adjacent to the tracheal cannula to expose both the right 
common and external carotid arteries. A heparinised catheter 
(35cm long, external diameter 0.63mm) was inserted into the 
external carotid artery and advanced until it lay at the bifurcation 
with the internal carotid artery, thus allowing any substances 
injected into the catheter to mix with the blood flowing up the 
common carotid artery and pass into the internal carotid artery.
On completion of the neck surgery the halothane level was gradually 
decreased from 1.0% to 0.5% over a period of approximately thirty 
minutes, and it was under this level of anaesthesia that the 
autoradiographic experiments were carried out. Arterial blood 
pressure, Pco2 Po2 pH, bicarbonate (HC03-) concentration, base
r t
excess and core body temperature were monitored throughout the 
course of the experiments.
2 .2 .Preparation of animals for the laser-Doppler experiments 
The animals were prepared in the same way as for the 
autoradiographic experiments until the external carotid artery 
had been cannulated. At this point, with the halothane level in 
the N 20:02 anaesthetic mixture remaining at 1.0%, the animal was 
placed face down and an incision made in the scalp. A 5mm diameter 
hole was drilled in the skull and the dura removed to expose the 
cortical surface of the brain. During the actual experiments 
the laser beam was positioned over the hole to allow the appropriate 
measurements to be made. After the hole had been drilled the 
halothane level was gradually decreased from 1.0% to 0.5% over the 
next thirty minutes and it was at this level of anaesthesia that 
the experiments were carried out. The same blood parameters were/...
were monitored in these experiments as in the autoradiographic 
experients (see 2 .1 . above).
2.3. Preparation of animals for the pial vessel study
The study was carried out using male and female cats weighing 
2.5kg to. 4.0kg. Anaesthesia was induced using saffan (18ml/kg) 
administered via one of the forepaw veins. Saffan is a short-lasting 
steroid anaesthetic, 1ml of which contains 9mg of alphaxalone and 3mg 
of alphadalone acetate. After induction of anaesthesia the trachea 
was intubated using a cuffed rubber endotracheal tube, the cuff of 
which was inflated to give maximum contact between the tube and the 
tracheal wall. The cats were then mechanically ventilated using a 
gaseous mixture of 70% nitrous oxide (N20) and 30% oxygen (02).
The rate and volume of the mechanical ventilator were constantly 
adjusted to maintain the arterial Pco2 around 30mmHg. Two femoral 
arteries and one femoral vein were cannulated to allow the continuous 
measurement of arterial blood pressure, the removal of arterial blood 
samples for analysis and the intravenous administration of anaesthetics. 
After these cannulations the anaesthesia was maintained using intrave­
nous doses of 1% K-chloralose which was prepared by dissolving lg
o
of powder in 100ml of deionised water heated to 60 C and filtering 
off any undissolved powder. The ac-chloralose was kept in a water 
bath at 50 °C throughout the experiment to prevent precipitation 
and was given to the animal when necessary to control the depth of 
anaesthesia. The cat received oc-chloralose when either the blood 
pressure or respiratory trace suggested that the animal was not fully 
anaesthetised, or when a twitch reflex was found on stimulation of the 
animal's eye. Having completed the initial surgery the animals were 
ventilated/.....
ventilated with oxygen enriched air.
The head of the animal was then placed in a stereotactic 
frame and a longitudinal incision was made in the centre of the 
scalp. The edges of the incision were sewn on to a metal ring 
(6cm in diameter) to create a circular pool over a skull. The 
left temporal muscle was retracted and a craniotomy, measuring 
approximately 2cm by 1.5cm, was carried out over the left parietal 
region using a dental drill, the tip of which was cooled by a jet 
of saline. Any bleeding from the vessels in the bone was arrested 
by the application of bone wax to the area, taking care not to 
put any on to the brain surface, and the exposed brain surface 
was covered by surgical patties soaked in saline. The pool 
created in the scalp by the metal ring was filled with paraffin 
oil, the temperature of which was kept at around 37°C by passing 
heated water from the water bath through a jacket surrounding the 
oil inlet tube. The oil was continuously renewed by having a 
system whereby fresh oil was passed in via the inlet tube while 
the overflow was collected by suction via the outlet tube.
When the pool was filled with oil the patties were removed and 
the area was illuminated with a cold light source (Schott, Mainz,F.R. 
With the aid of a stereomicroscope (Bausch & Lamb) the dura was 
cut and reflected to reveal the cortical surface. The preparation 
was left undisturbed for approximately thirty minutes before any 
measurement of pial vessel diameter was made.
Arterial blood pressure was monitored continuously throughout
the course of the experiments by a pressure transducer connected
to one of the femoral artery cannulae. Airway carbon dioxide (C02)
percentage was also measured throughout the experiments using a 
capnograph (Godart). The end tidal percentage C02was displayed on
a chart recorder (Devices). The animal's temperature was monitored/.
monitored via a rectal probe (Palmer) and maintained at 37°C by 
means of a feedback mechanism which connected the rectal probe 
to a heating blanket. Arterial blood smaples (1 - 2ml) were 
taken at regular intervals and used to measure the following:
Pco2 Po2 pH, base excess and bicarbonate (HC03-) concentration.
r r
If a highly negative base excess was found (i.e. HC03- concen­
tration too low) it was corrected by giving the cat an intravenous 
injection of 8.4% bicarbonate solution. The required volume of HC03- 
was calculated using the following equation:-
Volume of HC03- (ml) = 0.3 x animal weight (kg) x base excess
2
= 0.15 x animal weight (kg) x base excess 
where 0.3 is the empirical correction factor.
3. DETERMINATION OF LOCAL CEREBRAL BLOOD FLOW (LCBF)
14USING [ C] - IODOANTIPYRINE (IAP) AUTORADIOGRAPHY
3.1.Theory
The radioactive tracer used in the determination of LCBF is 
14[ C] - iodoantipyrine (IAP), which is freely diffusible 
across the blood-brain barrier in the wall of the cerebral vessels. 
The blood-brain partition coefficient is 0.8. Since the tracer is 
a freely diffusible molecule the equation devised by Kety (1960) 
which relates the accumulation of radioactive tracers in the 
tissue to blood flow can be applied. The equation is as follows:- 
C i  (T) = A k  j y  CA . e ~K (T_t) dT
where Ci = tracer concentration in the tissue at time T, and A  
= the blood brain partition co-efficient (0.8). The integral 
is the area under the curve described by the function arterial 
tracer concentration (C^ ) against time from onset of tracer/*••
tracer circulation. The constant K incorporates the tissue blood 
flow per unit of weight and another constant m , which indicates 
the extent of blood - tissue tracer equilibrium attained in 
a single passage of the tracer through the circulation:-
K n,|A
Since IAP is a freely diffusible tracer , m is taken as being 
unity, therefore the equation becomes:-
K= lA
which indicates that K is equal to the flow per unit weight 
times the partition co-efficient. It can be seen from these 
equations that since we can calculate the tissue tracer concen­
tration at time T(Ci), can monitor the arterial tracer concen­
trations through the course of the experiment ca )
know the blood-brain partition co-efficient (A) , we can derive 
the value of the only unknown quantity, the flow (F) per unit 
weight e.g. ml of blood per lOOg of brain tissue.
In order to be able to resolve differences in regional blood 
flow the arterial tracer concentrations must not be allowed to 
reach constant levels, since under these conditions the accumulation 
of radioisotope in the various brain regions is dependent not on 
the flow through the region, but only on the blood -brain partition 
co-efficient.
If the tracer is infused at a constant rate for a long enough 
period and equilibrium is attained, one merely gets a picture of 
the partition co-efficient. This problem has been overcome by 
administering the radioisotope at a logarithmically increased rate 
over a period of thirty seconds.
3.2.Determination of local cerebral blood flow (LCBF)
LCBF was measured using the quantitative autoradiographic 
14technique with [ C]-iodoantipyrine (IAP) as the radioactive tracer 
(Sakurada et al.,1978). The IAP (50pCi in 1.5ml of saline) was 
infused intravenously at a logarithmically increased rate over thirty 
seconds using a Harvard infusion pump. During this time arterial 
blood was allowed to drip freely from a catheter in one of the 
femoral arteries and eighteen samples of blood were collected on pre­
weighed filter paper discs. The discs were weighed after the experiment, 
thus allowing the calculation of the weight of each sample. The 
course of the experiment was recorded on an audio cassette recorder, 
thus allowing the time of each sample and the decapitation by 
guillotine of the animal at approximately thirty seconds to be 
measured precisely by a deci-minute timer. Following the 
decapitation the brain was dissected out and frozen in isopentane at 
-42°C within about two to three minutes. The filter paper discs were 
placed in scintillation vials and 0.4ml of hydrogen peroxide and 
0 .1ml of water were added to bleach the blood and extract the 
radioisotope. 10ml of liquid scintillant was then added, the vials 
tightly capped and liquid scintillation analysis carried out.
Brain sections (20pm thick) were cut on a cryostat at -22°C and 
three out of e v e ry thirteen sections were mounted on glass 
coverslips and dried on a hot plate. Autoradiograms were prepared 
from these sections together with a set of calibrated plastic 
standards (44-1175 nCi/g.) by placing them in a light tight cassette 
in contact with X-ray film (Kodak GRS) for ten to fourteen days.
The resulting images on the X-ray films were analysed using a 
computer based densitometer (Quantimet 720, Cambridge Instruments,
U.K.) with reference to the precalibrated standards. Five optical/..
optical density readings were measured for each of the thirty
seven regions of the brain being studied and the mean optical
density obtained. Using this data and making comparisons with
the optical density of the precalibrated standards and the arterial 
14C levels, the cerebral blood flow of each region was calculated 
using the equation derived by Kety (1960) and developed for this 
technique by Sakurada et al (1978).
4. MEASUREMENT OF CEREBRAL BLOOD FLOW USING LASER-DOPPLER FLOWMETRY
4.1.Theory
The flowmeter used in the experiments (Periflux Pf2,
Perimed KB, Stockholm, Sweden) measures total microvascular blood 
cell flow through the measured volume i.e., the region of the brain 
surface that the laser beam covers. The measurement comprises all 
the vessels crossing this area, irrespective of the direction of 
blood cell movement. The flowmeter reacts only to the movement 
of discrete bodies, such as blood cells, and not to the flow of 
homogenous liquids like blood plasma or lymph. It responds to all 
movement relative to the probe head, therefore the probe head was 
held in position by means of a clamp.
The flowmeter emits a beam of low power laser light which is 
led by an optical fibre to the probe head. When the probe head is 
positioned over the brain surface the light enters the tissue and 
there it becomes repeatedly rdzfected, refracted and gradually 
absorbed. This multiple scattering of the beam produces a volume 
of almost isotopic illumination in front of the probe head. All 
blood vessels crossing through this volume are struck by light, 
partly reflecting it, whereupon the light undergoes a Doppler 
shift. The light in this volume is therefore a mixture of unshifted/.
unshifted and Doppler.shifted light, the magnitude and frequency 
distribution of the latter being related to the number of red 
blood cells passing through this volume, and to their velocity.
Part of the light is back scattered from the brain surface 
and detected by efferent optical fibres which convey the back 
scattered fraction to photodetectors which convert it into 
electrical signals. Therefore, the greater the blood flow 
the greater the electrical signal there will be. These electrial 
signals from the flowmeter are transmitted to and displayed on 
a chart recorder (Linseis). The recording is a measure of blood 
cell flux i.e., the blood cell flow through the microvasculature 
from the arterial to the venous side. The measurements made are 
only relative and no numerical value can be put on them in terms 
of ml/lOOg/minute.
4.2.Experimental procedure
The probe head was positioned over the hole in the skull and
lowered until a stable baseline flowrate was achieved on the chart
recorder. The drug under study was then infused at a rate of 50pi/
minute via the internal carotid artery for the fifteen and a half
-10minutes of the experiment to give an infusion rate of 10 moles/ 
minute. In the control animals 0.9% saline was infused at the 
same rate, 50pl/minutes, for the same length of time, fifteen and 
a half minutes. The changes in the flow rate were recorded on the 
chart recorder and for both saline control and CHA-treated animals 
the percentage changes relative to the baseline were calculated at 
five, ten and fifteen and fifteen and a half minutes. Each animal 
acted as its own control i.e., they received the saline infusion 
first and after a recovery period of approximately twenty minutes/..
minutes, during which time the baseline returned to its pre-saline 
level, they received the drug infusion. Mean arterial blood 
pressure, Pco2, Po2, pH, core body temperature, bicarbonate 
(HCO3-) concentration and base excess were monitored throughout 
the experiments.
5. MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILISATION (LCGU)
14
USING [ C] -2- DEOXYGLUCOSE (2-DG)
5.1.Theory
Many problems arise when it comes to measuring the functional 
activity of the central nervous- system, since the various sub-units 
which integrate to produce the functional networks of the brain 
are not only anatomically discrete, but also have diverse physiolog­
ical roles. Another problem is the fact that the brain is continuous­
ly reacting to any input which it receives.
It is known that there is close relationship between brain 
activity and its consumption of energy substrate. Under non-path- 
ological conditions the brain receives all its energy requirements 
from the oxidative catabolism of glucose (Sokoloff, 1960). For 
this reason one might assume that either the rate of oxygen or 
glucose utilisation might be a useful method for measuring the 
functional activity of the brain. However, one encounters many 
problems when trying to measure such parameters directly. Oxygen 
electrodes can be used to measure the levels of oxygen or the 
extent of oxygen turnover, but with this method one encounters the 
problems of the insult to the brain caused by the electrodes.
Another possible method would be to measure the turnover of oxygen 
radioisotopes. However, since oxygen radioisotopes have both a/...
a short half-life and are also rapidly cleared from cerebral tissue,
this leads to further problems. Similar problems are also encount-
14ered when trying to use the glucose radioisotope, [ C]-glucose.
However, these problems can be overcome by using the radioactive
14glucose analogue, [ C]-2-deoxyglucose (2DG).
14The theoretical model for the [ C]-2-deoxyglucose method of 
functional activity is shown in Figure II.3. The model shows that 
both 2-DG and glucose enter a common precursor pool in the brain 
via a common carrier in the blood-brain barrier. Once in this 
pool they both compete for either the carrier, which would trans­
port them back to the plasma, or for the enzyme which would convert 
them to their respective hexose-6-phosphates. This phosphorylation
is. far from equilibrium and since, unlike the glucose-6-phosphate,
14the [ C]-2-deoxyglucose-6-phosphate takes no part in any of the known 
metabolic pathways it is trapped within the cell.
The operational equation used to measure glucose utilisation 
is shown in Figure 11.4. The equation shows that in order to cal­
culate the amount of glucose utilised by a specific brain region 
the amount of radioactively labelled products formed during the
experimental period must be calculated. The amount of labelled pro-
14duct which is in the form of [ C]-2-2deoxyglucose is subtracted from 
the total amount of labelled products and the remainder is divided 
by the lumped constant. The lumped constant is the value which ex­
presses the differences in kinetics and distribution of deoxyglucose
14and glucose multiplied by the plasma integral for [ C] -2-deoxyglucose 
and glucose during the experimental period, which is corrected for 
the lag time of equilibration.
The rate constants and lumped constant used in the operational 
equation were obtained from Sokoloff et al. (1977) and for the albino/...
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Fig.III.4. OPERATIONAL EQUATION OF THE 2-DEOXYGLUCOSE TECHNIQUE
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5.2.Determination of local cerebral glucose utilisation (LCGU)
LCGU was measured using the quantitative autoradiographic 
14technique with [ C]-2-deoxyglucose (2-DG) as the radioactive
tracer (Sokoloff et al.(1977).
The measurement was initiated by the intravenous injection of 
14
a bolus of [ C]-2-DG (50|jCi in 0.7ml of saline). During the
following forty five minutes fourteen samples of arterial blood were
obtained at pre-determined times (0, 15, 30, 45 seconds, 1, 2, 3, 5,
7.5, 10, 15, 25, 35, and 45 minutes). These arterial samples were
then centrifuged and approximately 23pl of plasma were taken for the 
14determination of [ C] concentration in the plasma, with another 10|Jl 
being used to measure the plasma glucose levels by means of a semi­
automated glucose oxidase assay (Beckman, USA). Forty five minutes
14after the administration of the [ C]-2-DG the rat was killed by
decapitation. Following the decapitation the brain was dissected 
out and frozen in isopentane at -42°C. within two to three-minutes. 
The frozen brain was coated in an embedding matrix and coronal set- 
ions 20 pm thick were cut on a cryostat at -22 °C. Three sections 
out of every thirteen were mounted on glass covers lips and rapidly 
dried on a hot-plate.
Autoradiograms were prepared from these sections, together with 
a set of calibrated standards (44 - 1175 nCi/g) by placing them in 
a light-tight cassette in contact with X-ray film (Kodak GRS) for/...
albino rat, they are:-
= 0.189 min ^
= 0.052 min ^
for up to thirty days. The length of exposure time was determined
by the value of the plasma integral, as obtained from the raw
blood data. The resulting images on the X-ray films were analysed
using a computer based densitometer (Quantimet 720, Cambridge
Instruments, U.K) with reference to the pre-calibrated standards.
Five optical density readings were measured in both hemispheres
for each of the thirty seven brain regions under examination,
and the mean optical density for both hemispheres obtained.
14Using this data (i.e.,the [ C] concentration in each brain region),
14the history of [ C] and the glucose levels in the arterial plasma 
during the experimental period, the appropriate rate constants for 
the rat and the operational equation devised by Sokoloff et al.
(1977) (see 5.1. above), the rate of glucose utilisation in each 
brain region was calculated.
6. MEASUREMENT OF CHANGES IN CAT PIAL ARTERIOLAR DIAMETER BY THE 
IMAGE SPLITTING TECHNIQUE
6 .1 .Equipment
Changes in pial arteriolar calibre were measured by the television 
image splitting technique of Baez (1966) as modified by Wahl et al. 
(1973). Individual pial vessels on the surface of the brain were 
viewed through a stereomicroscope (Bausch & Lomb) at either x40 
or x70 magnification. A video camera (Sony) was incorporated into 
one eyepiece of the stereomicroscope, and the magnified image trans­
mitted on to a video monitor (Shibaben).
The image-splitting component of the set up consisted of a prism 
within the same eyepiece of the stereomicroscope as the video camera. 
This prism was able to be rotated by means of a screw adjacent to 
the eyepiece,and the more the screw was turned, the more the prism/ •. •
prism would rotate and, therefore, the greater the resulting split 
of the image.
The diameter of a vessel was measured in the following way.
The prism was rotated so that the image of the vessel was split 
on the video screen to give two images of the vessel lying 
parallel to each other with their edges touching. After applic­
ation of the test compound, if the images are found to have over­
lapped, the vessels will have dilated and, conversely, if the images 
are found to have moved apart the vessels will have constricted.
The screw which rotates the prism was connected to a potent­
iometer which was in turn linked to a Servoscribe pen recorder.
At the start of each experiment the Servoscribe recorder had been 
calibrated with monofilament fibres of known diameter. The 
diameter of the pial vessel observed on the video screen could 
then be calculated directly from the servoscribe recorder. Pial 
arterioles in the range 25|jm - 250pm were studied.
6.2.Application of solutions
Glass micropipettes were pulled, sharpened to produce a tip 
size of approximately 10pm and filled with the various test 
solutions on the morning of each experiment. The pipettes were 
filled by capillarity and sealed with mineral oil to reduce any 
C02diffusion which might have occurred.
The micropipettes were moved into position over the vessel to 
be studied by means of a micromanipulator (Leitz). The manipul­
ator consisted of a moveable arm mounted on a stable, weighted 
base and connected by a length of clear tubing to a glass syringe.
The glass syringe, the tubing and the arm were all filled with 
mineral oil. The micropipette, filled with a test solution, was 
attached to the arm of the micromanipulator and by turning a knob/...
knob on the edge of the glass syringe the movement of the mineral 
oil through the system injects a small quantity of the test 
solution (approximate 5pl).
The tip of the micropipette was carefully placed in the 
vicinity of the arteriole being measured and the calibre of that 
vessel was then calculated. The test solution was then injected 
and the calibre of the vessel was re-measured. The effect of the 
drug was calculated as a percentage change in the vessel calibre 
from the pre-injection value.
All the test solutions were dissolved in mock cerebrospinal 
fluid (CSF) and before any of these solutions were injected the 
effects‘of both the mock CSF and a lOmM K+ solution were tested.
The CSF was tested to ensure that the vehicle in which the com­
pounds were dissolved had no effect of its own, and the lOmM K+ 
was administered to test the reactivity of the vessels.
7. PATHOLOGICAL EXAMINATION OF THE RAT BRAIN FOR THE PRESENCE OF
AIR EMBOLI AND THROMBI
The rats were prepared in the same way as for the autoradio­
graphic experiments (see 2.1.) On completion of the surgery 
each animal received a fifteen and a half minute infusion of 
0.9% saline. This was carried out to parallel those experimental 
conditions used in the autoradiographic experiments for the 
determination of local cerebral blood flow (LCBF). After the 
saline infusion, the animals were left for four hours before 
fixation was carried out using a mixture of formaldehyde/acetic acid/ 
methanol (FAM). The FAM fixation was carried out in the 
following way. The rat's chest was opened to expose the heart/...
heart. A small incision was made in the left ventricle and a 
catheter was placed into the heart via this incision. 0.9% 
saline was infused into the heart through this catheter and 
when a swelling of the right atrium was observed a small 
incision was made in it to allow the blood to be washed out by 
the infused saline. When all the blood had been washed out the 
saline infusion was stopped and an infusion of the FAM mixture 
begun. The FAM infusion was stopped when the animal had gone 
completely rigid, indicating the fixation of all the tissues.
The animal was then decapitated and the brain was sent for patholog­
ical examination to look for any damage which may be apparent.
8 . COMPOUNDS UNDER EXAMINATION AND SOLUTIONS USED
The following compounds were used in the course of the studies: 
Theophylline,5 1- (N-ethyl)carboxamidoadenosine (NECA), 2-chloroaden- 
osine (2-CADO), adenosine, adenosine triphosphate (ATP) and
g
prostaglandin F2k (PG F^) (all Sigma, St.Louis, USA), N -cyclohex- 
yladenosine (CHA) (Calbiochem, California, USA), L-phenylisopropyl- 
adenosine (L-PIA) (Boehringer-Mannheim, Ingelheim, F.R.G.) and 
8-phenyltheophy1line (a gift from Dr. Thorwart, Hoechst AG Werk 
Albert, Wiesbaden, F.R.G.).
In all the rat in vivo experiments the compounds were dissolved 
in 0.9% saline and infused via the internal carotid artery cannula 
at either 50pi/minute (LCBF studies) or 33pl/minute (LCGU studies) 
at the concentration necessary to produce the infusion rates of 
moles/minute shown in the text. jn the autoradiographic experiments 
the solutions were infused for 15 minutes prior to commencement of 
the experiment and for the 30 seconds (LCBF) or 45 minutes (LCGU) of 
the experiment. In the Laser-Doppler experiments' the solutions were/.
were infused for 15 mins and 30 seconds, thus corresponding with 
the time course of the autoradiographic determination of 
cerebral blood flow.
In the antagonist studies either saline (5ml/kg) or 
theophylline (30mg/kg) was administered intra-peritoneally 
20 minutes prior to the start of the internal carotid infusion.
In all the cat in vivo experiments the compounds were 
dissolved in mock cerebrospinal fluid (CSF) the constituents of which 
were: -
NaCl, 143.9mM; KC1, 3mM; NaHC03, 12.1mM; and CaCl2, 2.5mM.
In the isolated vessel work the compounds were dissolved in 
distilled water. The bathing medium for the vessels consisted 
of the following
NaCl, 148mM; KC1, 5.4mM; CaCl2,2.2mM; NaHC03, 12mM; and glucose,
12mM.
9. ANALYSIS OF DATA
9.1.Analysis of isolated vessel data
From the dose response curves the relative potencies of the 
various agonists used can be calculated. The order of potency is 
determined by the ^D2 value i.e. the greater the ^D2 va2ue
more potent the agonist is. The D^ 2 values can be calculated by both 
analysis of the dose-response curves and analysis of the data according 
to Hill (Bowman & Rand, 1982).
From the dose-response curves we can determine the concentration 
of agonist producing half maximal response (EC5Q), and the pD2 
value is equal to negative the log of the EC^q value.
The Hill analysis involves the use of the following equation/....
/equation.
r = Ka [D]n
1 + Ka[D]n
  equation (1)
E
where r = Emax ; E = response produced by agonist 
concentration [D] ; Emax = maximum response produced by agonist ; 
Ka = a constant ; [D] = agonist concentration ; and n = molecular 
ratio of drug per adsorptive site (receptor).
From equation (1) we devise: -
,nr = Ka [;D]  equation (2)
1-r
Equation (2) in the logarithmic form gives:-
log (1-r) = n.log[D] + log Ka  equation (3)
If we then plot log (1-r) against log [D] (i.e. Hill plot) we get 
a straight line with gradient ,n. This gradient, n, is a direct 
measure for the Hill co-efficient.
As stated above:-
E
r = Emax   equation (1)
and E [D]
Emax [D] + Kp
  equation (4)
Therefore r = [D]
[D] + Kp
  equation (5)
=> r [D] + r.Kp = [D]   equation (6)
=> r.Kp = [D] - r[D] — —  equation (7)
> kd ^  -rJ  equation (8)
Using equation (8) the KD values for a particular drug can be 
calculated at each concentration of agonist used ([D]), and the 
corresponding ^D2 values were also calculated2-
D. •log Kp  equation (9)
The Dp 2 values are calculated as mean D^., value ± standard
P
error of mean for each agonist used.
The antagonist results were analysed using the Schild plot 
(Arunlakshana & Schild, 1959) to calculate the A 2 value. The A2 
value is calculated in the following way. The log of (dose ratio -1) 
is plotted against the log of the antagonist concentration. The dose 
ratio is the concentration ratio of agonist giving equal responses in 
the presence of a particular -concentration of antagonist and in the 
absence of the antagonist. This line intercepts the X-axis at 
(- pA2 ,0 ), therefore the ^A2 is calculated by taking the negative of 
the X-intercept.
The linear portion of each concentration-response curve in the 
absence and presence of 8-phenyl theophylline is analysed using linear 
regression analysis and tested to see if there is a significant parallel 
shift in the linear part of the curve in the presence of 8-phenyltheo­
phylline.
Student's t-tests are carried out to compare the response obtained 
in the absence of antagonist with that in the presence of antagonist.
9.2./.
9.2.Analysis of pial vessel data
In this study the control values are those obtained with the mock 
CSF, and each drug response is compared to the control by means of a 
Student's t-test, incorporating the Bonferroni correction factor where 
appropriate, and significance is looked for at the 5% level.
The Bonferroni correction takes into account the fact that multiple 
comparisons are being made e.g. if we are comparing four drug treated 
groups to control (i.e. four comparisons) and looking for significance 
at the 5% level (i.e. P < 0.05), we must look for significance at the 
5/4% (1.25%) level for a result to be considered significant i.e. 
PC0.0125.
In the antagonist studies involving the pial vessels the effect 
of the drug alone and the effect of the drug in the presence of the 
antagonist are compared by means of a Student's t-test, incorporating 
the Bonferroni correction factor where appropriate.
9.3.Agonist autoradiographic studies
In these autoradiographic studies the drug treated groups are 
compared to control by means of a Student's t-test, incorporating 
the Bonferroni correction factor.
9.4.Antagonist autoradiographic studies
In the antagonist studies the data are analysed by means of a 
one way analysis of variance with Newman-Keuls multiple range test.
SECTION III 
RESULTS
1. ISOLATED PORCINE VESSELS
1 .1 .Effects of adenosine, some adenosine analogues and
8-phenyltheophylline on isolated porcine basilar arteries
Pig basilar arteries were relaxed in a concentration-dependent
6manner by adenosine, 2-chloroadenosine (2-CADO), N -cyclohexyl- 
adenosine (CHA), L-phenylisopropyladenosine (L-PIA) and 5'-(N-ethyl) 
carboxamidoadenosine (NECA) (Fig.III.1). The relative potencies of 
adenosine and these adenosine analogues were calculated in two ways. 
Firstly, the ^d2 values were calculated by analysis of each dose 
response curve (Table III.l) and secondly by analysis of the data 
according to Hill (Table III.2) (see Section II. Materials and Methods) 
The rank order of potency of the compounds was:
NECA > 2 -CADO, Adenosine > L-PIA > CHA
The effects of 8-phenyltheophylline were tested in both relaxed
and PGF^-constricted vessels and, as shown in Figs.III.2 and III.3
it can be seen that the 8-phenyltheophylline constricts the resting
vessels and dilates the pre-constricted vessels. The concentrations
of 8-phenyltheophylline chosen for use in further experiments were
-8 -7those which had minimal effects, namely 10 and 10 M. At these
concentrations the 8-phenyltheophylline had no significant effect on
the concentration response curves to adenosine, 2-CADO, CHA and L-PIA. 
-7-However, 10 M 8-phenyltheophylline did produce a significant parallel
shift to the right of the NECA concentration response curve (Fig.III.4)
indicating a competitive antagonism. Construction of a Schild plot
(see Section II Materials and Methods) for NECA in the presence of 
—8 —7-10 M and 10 M 8-phenyltheophylline gave a graphically calculated/...
FigOIEl. CONCENTRATION RESPONSE CURVES TO APENOSINF 
AND SOME ADENOSINE ANALOGUES
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This figure shows the effects of adenosineC—•♦••••Xn=8) ,NECA(—- * ^ ) ( n  = 13), 
CHA(—©— )(n=8),2-C A D O (— )(n=9)and L-PIA(•-■•—-)(n= 7). All values are 
expressed as mean ± standard error of mean.
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FigJE.2 EFFECTS OF 8-PHENYLTHEOPHYLLINE ON
RELAXED PORCINE BASILAR ARTERIES
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This figure shows the effects of various concentrations 
of 8-phenyltheophylline on isolated porcine basilar arteries
(n=9) All values are expressed as mean ± standard error of mean.
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Fig.H.3 EFFECTS OF 8-PHENYLTHEOPHYLLINE ON PQRC!N£_
BASILAR ARTERIES PRE-CONSTRICTED WITH PGF2Q<
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This figure shows the effec ts  of various concentrations  
of 8-phenyltheophylline on pre-constricted porcine basilar 
arteries (n=9).All values are expressed as mean + standard  
error of mean
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Fig. SI .4. EFFECTS OFNECA ALONE AND IN THR PRESENCE
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This figure shows the effects of NECA ■•)(n =  13)
and NECA+10“ 'M  8-phenyltheophylline (•■.....••) (n«5)
on pre-constricted porcine basilar arteries.
sfc indicates a significant parallel shift in the curve in 
the presence of 8-phenyltheophylline (P<0.05) 
as determined by linear regression analysis.
All values are expressed as mean standard error 
of mean.
calculated ^A2 value for the antagonist of ?.? (Fig.III.5).
-8 -?With 10 M 8-phenyltheophy1line for adenosine and 10 M
8-phenyltheophy1line for 2-CADO, CHA and NECA, the vessels constricted
-9
rather than dilated, in the agonist concentration range of 10 M 
to 10“%  (Figs III.6 , III.?, III.8 and III.4). This effect was 
absent with L-PIA in the presence of either concentration of 
antagonist.
1.2.Discussion
The study confirms the vasodilatory properties of adenosine 
(Berne et al., 1974) and its analogues,(Hardebo & Edvinsson, 1979)
In comparison to adenosine, NECA is more potent, 2-CADO almost 
equipotent, while L-PIA and CHA are less potent. The relative 
order of potency is in keeping with that of the A 2 adenosine receptor 
sub-type.
When a group of compounds are all acting on a single receptor to
produce the same effects the -concentration response curves are normally
in parallel. This is, in fact, the case for adenosine, 2-CADO, L-PIA
and CHA. However, the concentration-response curve for NECA is not in
parallel with those of the other four compounds and although NECA is
the most potent analogue of adenosine (i.e. highest d 2 value) it
P
has one of the lowest relative Emax values. These observations,
coupled with the fact that the Hill co-efficients for NECA and L-PIA
are less than one (Table III.2), suggest that the dil^tatory effect of
these compounds are possible being produced by more than a simple A^
receptor interaction.
The affinity of 8-phenyl theophylline to A 2 receptors (Ki^lOO M)
M
is about two to three orders of magnitude lower than that of NECA/...
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This figure shows the effects of adenosine ( •——•)(h = 8 ) and adenosine + 10”®M 
8-phenyltheophylline (•■.....••)( n = 8) on pre-constricted porcine basilar arteries.
*• indicates a significant difference between the response to 
agonist alone and the response to agonist + 8-phenyltheophylline 
at the same concentration (P< 0.05) as deiermined by a 
Student's t-test. All values are expressed as meant 
standard error of mean.
FigJH.7. EFFECTS OF 2-CADO.ALONE AND IN THE PRESENCE OF 8-PHENYLTHEOPHYLLINE
■ON PORCINE BASILAR ARTERIES PRE-CONSTRICTED WITH PGF2cx
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This figure shows the effects of 2-CADO(■ *)(n 9) and 2-CADO +
10-7 M 8-phenyitheophylline (.........•) (n 7) on pre-constricted porcine basilar arteries
^-indicates a significant difference between the response to agonist alone and the 
response to agonist - 8-phenyltheophylline at the same concentration (P<0.05) 
as determined by a Students t-test 
All values are expressed as mean ' standard error of mean
Fig.H.8 EFFECTS OF CHA ALONE AND IN THE PRESENCE OF
8-PHENYLTHEOPHYLLINE ON PORCINE BASILAR ARTERIES
PRE-CONSTRICTED WITH PG R^
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This figure shows the effects of CHAfr «)(n = 8 ) and CHA 
+10"7M 8-phenyltheophylline(*- -0(n=7) on pre-constricted porcine
basilar arteries. 5{c indicates a significant difference between the
response to agonist alone and the response to agonist + 1CT7M 
8-phenyltheophylline at the same concentration(P<0.05) as determined by 
a Students t-test. All values are expressed as mean ± standard error of mean
NECA (Schwabe, Ukena & Lohse, 1985). This low affinity has also
been demonstrated in studies with isolated arteries (Edvinsson &
Fredholm, 1983) showing a D2 value of approximately 6.5. On
P
the basis of this information it would perhaps be thought that
_8
8-phenyltheophylline at the concentrations used (10 M to 10 M),
would not be able to block the NECA response. However, since
10 M 8-pheny ltheophy lime did antagonise the NECA response, this
can be seen as adding further support to the idea that the action
of NECA is not completely due to an A2 receptor interaction, but
may involve another receptor which 8-phenyltheophylline can block
(e.g. the A^ adenosine receptor). The concentrations of
—8 —g
8-phenyltheophy1line used (10 M and 10 M) were not able to 
antagonise the actions of the other adenosine agonists, but higher 
antagonist concentrations could not be tested since as stated 
earlier, they possessed their own intrinsic action.
Other facets of the results suggest that there may be more than 
one adenosine receptor site involved. If one examines the concentration- 
response curves to the various agonists in the presence of 8-phenyl­
theophylline there appears to be a trend in the ability of the
agonists to produce further constriction at concentrations between 
-9 -610 M to 10 M. Of the four agonist curves which are parallel
adenosine and 2-CADO show a large further constriction, whereas
CHA and L-PIA show little or no further constriction. The magnitude
of these effects parallels the relative potency of the four agonists.
The NECA curve exhibits a very slight further constriction (5%) within
-9 -6the concentration of 10 M to 10 M NECA. These results may suggest 
that although 8-phenyltheophylline acts on both A^ and A2 receptor 
sub-types it could have a greater affinity at the A2 receptor thus 
uncovering the vasoconstrictive A^ effects, or secondly, that the/...
the 8-phenyltheophylline is blocking the and A2 receptors and, in 
the low dose range, the agonists are acting on another receptor to 
produce a vasoconstriction.
Another explanation for the complexity of the picture could be 
that there are further subdivisions in the A^/A2 receptor 
classification, since it has already been shown by Londos et al.(1980) 
that the A2 receptors in the liver had a very high affinity for NECA, 
an affinity much higher than those in the adrenal or Leydig cells.
On examination of the data the results for NECA seem to be apart 
from those of the other compounds: (i)8-phenyltheophylline, at the 
concentrations studied, antagonised the action of NECA; (ii) the 
vasoconstrictive effect apparent in the presence of 8-phenyltheophy­
lline is markedly less for NECA than for the other agonists; (iii)the 
NECA concentration-response curve has a different gradient than those 
of the other agonists; and (iv) the slope of the Hill plot was 
different from that of the other agonists (with the exception of 
L-PIA). This may support the idea of an atypical adenosine receptor 
at which NECA has a greater affinity than the other adenosine agonists.
A possible third adenosine receptor has been identified in rat fat 
cells (Garcia, Sainz & Tomer, 1985) and also centrally (Chin & 
DeLorenzo, 1985, 1986). Recent work by Lee & Reddington (1986) 
also speculates on the existence of a previously undescribed non-A^ 
receptor site.
The agonist data in this study suggests that adenosine and its 
analogues produce their dilatatory effects via an action on the A 2 
receptor, as has previously been described (Edvinsson & Fredholm, 1983). 
However the results with 8-phenyltheophylline antagonism, along with|...
with the different gradient of the NECA concentration-response 
carve suggest that the mechanism of action of adenosine and its 
analogues on pig cerebral arteries is not via a single sub-type 
of adenosine receptor, but a more complicated picture, with the 
possible involvement of other receptor sub-types.
1.3. Summary of isolated vessel results
Compounds 
(in order 
of potency)
NECA
2-CADO
Adenosine
L-PIA
CHA
Vasodilatation (D) 
or
Constriction (C)
Antagonised by Constriction
D
D
D
D
D
-9
8-phenyltheophylline produced by 10 M 
(8-PT)
Yes
No
No
No
No
—6-10 M agonist
in the presence
of 8-PT________
Yes
Yes
Yes
No
Yes
2. IN VIVO FELINE VESSELS
2 .1 .Effects of adenosine and some adenosine analogues and 
antagonists on cat pial vessels in vivo
Since all of the compounds tested in this study were dissolved
in mock cerebrospinal fluid (CSF), the response obtained to the
mock CSF alone (1.5% dilatation) was taken as.the control response
and the effects of all the compounds were compared to this value.
Injections of a lOmM K + solution were administered to test
the responsiveness of the vessels and were found to produce a
mean dilatation of 36% (vessel calibre range 46-194pm; mean vessel
calibre ± standard deviation =98 ± 40pm). This response was
significantly different from control (see Table III.3 and Fig.III.9).
Two adenosine antagonists, theophylline and 8-phenyltheophylline,
—9at concentrations of 10 M and 10 M, were tested to determine their 
effects on vessel calibre. Neither of the compounds produced any 
significant changes in vessel calibre (see TableIII.3 and Fig.III.9)
-9
10 M 8-phenyltheophylline was chosen as the antagonist concentration
to be used in further antagonism studies.
-9 -? -5Adenosine, at concentrations of 10 M, 10 M and 10 m  produced
a ?% constriction (vessel calibre range 58-123pm; mean vessel
calibre ± standard deviation = 92 ± 26|jm), a 13% dilatation
(vessel calibre range 34-161|jm; mean vessel calibre ± standard
deviation = 88 ± 40pm) and a 22% dilatation (vessel calibre range
40-223pm; mean vessel calibre ± standard deviation = 123 ± 56pm),
-5respectively. The responses obtained to both 10 M and 10 M
adenosine were significantly different from the mock CSF control
-9and both, m  turn, were significantly antagonised by 10 M 8-pheny- 
ltheophylline (see Table III.4 and Fig.III.10).,
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gJII.9 EFFECTS OF MOCK CEREBROSPINAL FLUID (CSF) 10mMK+
THEOPHYLLINE (Theo) AND 8-PHENYLTHEOPHYLLINE (8-PT)
ON CAT PIAL VESSEL DIAMETER
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6 -9N -cyclohexyladenosme (CHA), at concentrations of 10 M,
-? -5
10 M and 10 M produced dilations of 10% (vessel calibre range
66-248pm; mean vessel calibre ± standard deviation = 139 ± 6?pm),
8% (vessel calibre range 46-251pm; mean vessel calibre ± standard
deviation = 110 £ 63pm) and 21% (vessel calibre range 68-189pm;
mean vessel calibre ± standard deviation = 12? ± 42pm), respective-
-? -5ly. The responses obtained to both 10 M and 10 M CHA were
significantly different from that of the mock CSF control and both,
-9in turn, were significantly antagonised by 10 M 8-pheny ltheophy 1 line 
(see Table III.5 and Fig III.11).
5 1 - (N-ethyl) carboxamidoadenosine (NECA), also at concentrations
-9 -? -5of 10 M, 10 M and 10 M produced dilatations of 9% (vessel calibre
range 48-182pm; mean vessel calibre ± standard deviation = 111 ± 42pm), 
15% (vessel calibre range 63-l?9pm; mean vessel calibre ± standard 
deviation = 119 ± 43pm) and 18% (vessel calibre range 5? -192pm; 
mean vessel calibre ± standard deviation = 114 ± 51pm), respective­
ly. The responses obtained* to all three concentrations of NECA
were significantly different from that of the mock CSF control and 
-? -5both the 10 M and 10 M, in turn, were significantly antagonised 
-9by 10 M 8-phenyltheophy 1line (see Table III.6 and Fig.III. 12).
The response obtained to each compound was not dependent on 
either the resting vessel calibre or the mean arterial blood 
pressure of the cat at the time of application of compound.
2.2.Discussion ,
The results obtained in this study show that in pial vessels
which are responsive (as seen by the action of lOmM K+) adenosine,
CHA and NECA all produce increases in vessel calibre, with the 
—9exception of 10 M adenosine which produces a 7% constriction. The/..
Fig. I L 11 EFFECTS OF N6-CYCLOHEXYLAPENOSINE (CHA) 
QR-CAT PIAL VESSEL DIAMETER IN THE ABSENCE
AND PRESENCE OF 8-PHENYLTHEOPHYLLINE
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-5The change in vessel calibre produced by 10 M adenosine (i.e. a
P22% dilatation at a C02 of approximately 30mmHg) compares favour­
ably with values obtained in previous studies using cat pial vessels:
P . Pa 14% dilatation at a C02 of 25mmHg and a 29% dilatation at a C02
of 34mmHg (Gregory, Boisvert & Harper, 1980) and a 24% dilatation
p
at a C02 of approximately 31mmHg)Wahl & Kuschinsky, 1976).
The results also confirm the vasodilatory properties of 
adenosine and its analogues which have been shown in isolated cerebral 
vessel preparations (Edvinsson & Fredholm 1983). Since the vaso­
dilatory effects of adenosine and both the adenosine analogues CHA 
and NECA can be blocked by the A ^/A 2 adenosine receptor antagonist, 
8-phenyltheophylline, and also since the A 2 receptor mediates 
vasodilatation (Edvinsson & Fredholm, 1983), it seems likely that 
the effects of all three compounds are mediated via an A2 receptor 
interaction. However, as was found in the isolated vessel study
(Results Section 1), adenosine and NECA are seen to constrict the
-9vessels in the presence of 10 M 8-phenyltheophylline )see Tables 
III.4^and 111.6) and this may suggest the involvement of other 
mechanisms as well.
2.3. Summary of cat pial vessel results
Compound
-910 M Adenosine
-7
10 M Adenosine 
-510 M Adenosine
Vasodilatation (D) Antagonised by Effect in 
or 8-phenyltheophylline presence of
Constriction (C) (8-PT)___________   8-PT:D or C
C
D
D
No
Yes
Yes
C
C
C
10"9M CHA 
10"7M CHA 
10~5M CHA
D
D
D
No
Yes
Yes
D
C
D
10_9M NECA 
10~7M NECA 
10"5M NECA
D
D
D
NO
Yes
Yes
3.LASER-D0PPLER FLOWMETRY
63.1.Effect of the adenosine analogue N -cyclohexyladenosine (CHA) 
on cerebral blood flow (CBF) as measured in the rat by laser- 
Doppler flowmetry
The percentage changes in CBF produced by infusions of saline 
were taken as the control values and the changes produced by CHA 
infusion were compared to those controls at each time point (see 
Table III.7 and Fig.III.13). Within 5 minutes CHA had decreased 
CBF by 10% (saline, 4% increase); after 10 minutes CHA had decreased 
CBF by 19% (saline, 7% increase); after 15 minutes CHA had decreased 
CBF by 20% (saline, 11% increase); and after 15.5 minutes CHA had 
decreased CBF by 18% (saline 11% increase). The changes produced 
by CHA were significant at 5, 10, 15 and 15.5 minutes.
Various physiological parameters were monitored before both the 
saline and CHA infusions (see Table -111.8) but there was found to be 
no difference between the two groups for each of the parameters 
studied.
3.2.Discussion
The results show that the adenosine analogue, CHA, produces a
decrease in CBF and that this effect is monophasic i.e. at no time
is there any apparent increase in CBF. One must now explain,
however, how CHA, which has already been shown to be a vasodilatator
in earlier studies, is decreasing flow. One possible explanation
could be that at the low concentration-of CHA being used 
-10
(10 moles/min.) in order to prevent any hypotensive effect, the
CHA is acting either on a different adenosine receptor or on a/..
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a completely different receptor type,, rather than the receptor 
which is known to mediate vasodilatation. The results obtained 
in this study, however, do not allow us to identify the mechanism 
mediating this vasoconstrictive action of CHA.
It is more likely that the laser-Doppler technique is 
measuring red cell velocity, however, a decrease in velocity is 
probably due to an increase in resistance to the flow i.e. a 
vasoconstriction, which would in turn decrease flow. The rises 
in flow caused by saline may be due to a haemodilution effect 
which the flowmeter picks up as an increase in flow.
One factor which can not be used to explain the decreases in 
CBF produced by CHA is any change in the mean arterial blood pressure 
(MABP) since as Fig.III.14 shows there is no significant alteration 
in the MABP during the CHA infusion.
Since the maximum effect of the CHA is seen after 15 minutes
of the infusion it was decided to monitor the effects of this
14compound and other adenosine‘related compounds using [ C]-iodo- 
antipyrine autoradiography to measure local cerebral blood flow 
(LCBF) after a 15 minute infusion of the compounds. The purpose 
of this is to determine whether the effects of the compounds on 
LCBF in 35 discrete brain regions are the same as the effect of 
CHA on cortical blood velocity/flow as measured in this study.
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Fig. m . 14 CHANGES IN MEAN ARTERIAL BLOOD PRESSURE (MABP) 
WITH RESPECT TO CHANGES IN CEREBRAL BLOOD FLOW 
(CBF) DURING INFUSION OF CHA
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144. [ C]-IODOANTIPYRINE AUTORADIOGRAPHY
4.1.Effects of a 15 minute infusion of adenosine, ATP and some
adenosine analogues on local cerebral blood flow (LCBF) in
14the rat as measured by [ C]-iodoantipyrine (TAP) autoradiography 
The following physiological parameters were monitored throughout 
the course of all the experiments: PCC^; PC^; mean arterial blood 
pressure; core body temperature; bicarbonate(HCO^ ) concentration; 
base excess and pH. No significant changes in any of these 
parameters were found in any of these experiments reported in this
section (see Tables III.15, III.16 and III.17).
-7 -7Adenosine and ATP, at concentrations of 10 moles/min and 3x10
moles/min, did not produce any significant change in LCBF either
ipsilateral or contralateral to the side of infusion (see Tables
III.9 and III.10). Both adenosine and ATP, however, showed a
tendency to increase LCBF in a number of the 34 brain regions studied
e.g. the visual and parietal‘cortices, the lateral geniculate and
the globus pallidus.
5 1 - (N-ethyl) carboxamidoadenosine (NECA) at a concentration of 
-11
10 moles/min, did not produce any significant change in LCBF 
either ipsilateral or contralateral to the side of infusion (see 
Tables 111.11 and 111.12). As was the case for adenosine and ATP, • 
however, NECA also showed a tendency to increase LCBF in a number of 
the 32 brain regions studied e.g. the visual, auditory and anterior 
cingulate cortices and the genu.
-92-chloroadenosine (2-CADO), at a concentration of 10 moles/min, 
produced significant decreases in LCBF in 3 of the 32 ipsilateral 
brain regions studied: globus pallidus, red nucleus and cerebellum 
nucleus (see Table III.11 and Figs.III.21, III.24 and III.25)./..
III.25). 2-CADO also produced significant decreases in 3 of the 
33 contralateral brain regions studied: sensory-motor cortex, 
cochlear nucleus and cerebellum nucleus (see Table III.12).
2-CADO also showed a tendency to decrease LCBF in the other brain
regions where significant changes were not evident.
6 —10N -cyclohexyladenosine (CHA), at a concentration of 10
moles/min, produced significant decreases in 11 of the 32 ipsi­
lateral brain regions studied: sensory-motor cortex, frontal 
cortex, medial geniculate, lateral geniculate, lateral habenula, 
caudate nucleus, globus pallidus, superior olive, dentate gyrus, 
cerebellum nucleus and cerebellum hemisphere (see Table III.11 and 
Figs.III.15 - III.23, III.25 and IIIw26). CHA also produced 
significant decreases in LCBF in 6 of the 33 contralateral brain 
regions studied: sensory-motor cortex, globus pallidus, vestibular 
nucleus, red nucleus, cerebellum nucleus and cerebellum 
hemisphere (see Table III. 12). The effect of CHA on LCBF can be 
seen to be apparent at a variety of concentrations (see Tables III.13 
and 111.14). The effect of CHA on LCBF can be seen to be apparent 
with particular reference to the ipsilateral cortical structures 
(see Fig.III.27).
4.2.Discussion
Since adenosine and the adenosine analogues have previously been 
shown to be vasodilatators both in vitro and in vivo (Results Section 
1 and 2) one would expect them to produce increases in LCBF. This 
is, in fact, the case with adenosine, ATP and NECA which all show a 
tendency to increase LCBF. These increases in LCBF, however, are not 
significant unlike the changes produced by adenosine and ATP in 
other species. Adenosine and ATP, infused via the carotid artery in/.
in baboons, have been shown to produce significant increases in 
global CBF (Forrester et al.,1979). Adenosine, injected via the 
carotid artery at a variety of concentrations, has been shown to 
increase blood flow in the cerebrum, brain stem and cerebellum 
of the dog (Heistad et al.,1981). The lack of a significant 
effect with 15 minute infusions of adenosine or ATP could be due 
to degradation of the compounds by adenosine deaminase, thus 
limiting the concentration of the compounds reaching the brain.
An explanation still has to be found for the decreases in 
flow produced by 2-CADO and CHA. 2-CADO, along with adenosine 
and NECA, has been shown to increase local cerebral blood flow 
in the rat when infused locally into the brain tissue (van Wylen 
et al.,1987). The results also show that decreases in local cerebral 
blood flow were apparent in areas other than those supplied by 
the internal carotid artery and also in the hemisphere contra­
lateral to the side of infusion. Since both CHA and 2-CADO are 
stable analogues of adenosine and therefore not susceptible to 
degradation by the enzyme adenosine deaminase, these changes 
probably occur as a consequence of sufficient concentrations of 
CHA and 2-CADO circulating round the animal and passing back into 
the brain via the contralateral internal carotid artery, as well 
as via the other arteries (i.e. the basilar artery) supplying both 
the contra- and ipsilateral hemispheres of the brain.
One possible explanation for the observed decreases in flow 
could be that the CHA and 2-CADO are acting on another receptor to 
constrict the vessels rather than the receptor known to mediate 
vasodilatation. One other possible explanation for the observed 
changes in blood flow could be that any vascular actions of CHA and 
2-CADO could be secondary to any metabolic changes that they may/..
Fig.3H.15 LCBF IN THE IPSILATERAL SENSORY MOTOR CORTEX
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Figures in parentheses indicate n value
*  P <  0.05(Students t-test with Bonferroni correction factor)
Fig. HT. 16 LCBF IN THE IPSILATERAL FRONTAL CORTEX
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Figures in parentheses indicate n value
*  P <  0.05(Students t-test with Bonferroni correction factor)
FigJH. 17 LCBF IN THE IPSILATERAL MEDIAL GENICULATE
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Figures in parentheses indicate n value
*  P <  0.05(Students t-test with Bonferroni correction factor)
Fig JH18 LCBF IN THE IPSILATERAL LATERAL GENICULATE
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All bars indicate mean ± standard error of mean .
Figures in parentheses indicate n value
*  P <  0.05(Students t-test with Bonferroni correction factor)
Fig.HEl9 LCBF IN THE IPSILATERAL LATERAL HABENULA
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Figures in parentheses indicate n value
*  P <  0.05(Students t-test with Bonferroni correction factor)
Fig.ffi20 LCBF IN THE 1PS1LATERAL CAUDATE NUCLEUS
LOCAL CEREBRAL BLOOD FLOW (ml 100g~1min 1)
50 100 150 
_I__
200 250 
I__
CONTROL
10 umoles/min 
CHA
10* moles/min 
2-CADO
10 moles/min 
NECA
CONTROL
(6 )
(6)
(5)
w
10*7 moles/min 
ADENOSINE 
3 x10*7moles/min 
ADENOSINE 
10’7moles/min
ATP
SxlO^moles/min
ATP
(5)
(4)
(5)
(4)
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Figures in parentheses indicate n value
*  P <  0.05(Students t-test with Bonferroni correction factor)
Fig.m 21 LCBF IN THE IPSILATERAL GLOBUS PALLIDUS
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All bars indicate mean ±  standard error of mean .
Figures in parentheses indicate n value
*  P <  0.05(Students t-test with Bonferroni correction factor)
Fig.Ill 22 LCBF IN THE IPSILATERAL SUPERIOR OLIVE
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Figures in parentheses indicate n value
P< 0.05(Students t-test with Bonferroni correction factor)
Fig. HI .23 LCBF IN THE IPS1LATERAL DENTATE GYRUS
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Fig. m 24 LCBF IN THE IPSILATERAL RED NUCLEUS
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Figures in parentheses indicate n value
*  P <  0.05(Students t-te s t with Bonferroni correction factor)
Fig.IE 25 LCBF IN THE iPSILATERAL CEREBELLUM NUCLEUS
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Figures in parentheses indicate n value
*  P <  0.05(Students t-te s t with Bonferroni correction factor)
Fig HI 26 LCBF IN THE IPSILATERAL CEREBELLUM HEMISPHERE
LOCAL CEREBRAL BLOOD FLOW (ml 100g~1min 1)
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All bars indicate mean ± standard error of mean .
Figures in parentheses indicate n value
*  P< 0.05(Students t-test with Bonferroni correction factor)
LOCAL CEREBRAL BLOOD FLOW (ml.100gr1 min.- 1 )
ro
o
o
_l_
31
<5‘
m
to''J
o<
XCO
H Cm >xr-
F
&  jH
»  H *
X
A
O
001
8 2 
I 8o> o
-1 3
5’
(Q CO
to «
3 5 
» 5: 
m =■ Q. cj
< 3w EL
C  <6 
<0 ^
i §
O O
°  3 3 o ~  o 
o cr. — o < 3
03 _*
C  J?
CD 2. 
w o
?!□3! >CO —E o- 
® 2
CO o»
co
3 3
■O 9:03 O
m 03 CD <■*
3  CD
ST 3
®  CD 
CO 0) 
CD §
_  H -
I s
0 32. o. 
O 5
3  O-
< S'
03 3  
C O
O,
3”o
CDco
3
3 *
o
X
>
Oi
3 °o
o
CO
3
5
O
X
>
Oi
3o
CD
CO
3
5*
O
X
>
o
0
XH
O
>r~
co
H
X
c
oH
C
X
m
w
xx
o
D
C
om
u
x
-<
<
>x
O
c
CO
o
o
z
o
m
z
H
X
o
z
CO
OX
o
X
1“
o
o
>I”
o
mx
m
xx
>r~
XI-
O
O
D
m
x
>
r~
may produce i.e. CHA and 2-CADO could be vasodilatators but also 
be producing a decrease in local cerebral glucose utilisation and, 
therefore, what we are seeing is a decrease in local cerebral blood 
flow in response to a decreased metabolic demand. It is this 
aspect of the possible reasons for the reductions in blood flow 
which is examined in the next section, Section 5, of the results.
The results show that there is no apparent difference between 
the effects of the analogues on the cortical and non-cortical 
brain regions, since significant changes were apparent in both.
The changes in local cerebral blood flow observed were not only 
apparent in those areas supplied by the internal carotid artery. 
There is no physiological significance to the areas affected by 
by the analogues i.e. the effect appeared to be randomised.
4.3.Summary of the 15 minute infusion results
(i) Adenosine, ATP and NECA
No significant effect on LCBF. All show a tendency to 
increase LCBF.
(ii) CHA
Decreases LCBF. Significant decreases were observed in 
the following regions:
Structures
Cortical
Diencephalic
Hindbrain
Mesencephalic
Telencephalic
Ipsilateral
Sensory-motor cx. 
Frontal
Medial geniculate 
Lateral geniculate 
Lateral habenula 
Caudate nucleus 
Globus pallidus 
Superior olive
Dentate gyrus 
Cerebellum nucleus 
Cerebellum hem.
Contralateral 
Sensory-motor Cx.
Globus pallidus
Red nucleus 
Cerebellum nucleus 
Cerebellum hem.
Fibre tracts
4.3.Summary (continued)
(iii) 2-CADO
Decreases LCBF. Significant decreases were observed in 
the following regions:
Structures Ipsilateral Contralateral
Cortical — —  Sensory-motor ex.
Diencephalic Globus pallidus
Hindbrain
Cochlear nucleus
Mesencephalic Red nucleus ---
Telencephalic Cerebellum nucleus Cerebellum nucleus
Fibre tracts --- ----
145. ['C]-2-DEOXYGLUCOSE AUTORADIOGRAPHY
5.1.Effects of a 15 minute infusion of adenosine, ATP and some
adenosine analogues on local cerebral glucose utilisation (LCGU)
14in the rat as measured by [ C]-2-deoxyglucose (2-DG) auto­
radiography
No significant alterations in local cerebral glucose utilisation 
were observed with any of the analogues used in either the ipsi- or 
contralateral hemispheres (see Tables III.18 and III.19). If any 
changes were apparent, however, they showed a tendency to produce 
increases, and these increases were most marked with CHA. Fig. 111.2 8 
shows how the compounds studied (i.e. adenosine, 2-CADO, CHA and 
NECA) have little effect on local cerebral glucose utilisation in 
four brain areas which showed significant alterations in local 
cerebral blood flow.
The following physiological parameters were monitored throughout 
the course of all the experiments : KX^, PO^, mean arterial blood 
pressure, core body temperature, bicarbonate (HCO^ ) concentration, 
base excess and pH. No significant changes in any of these 
parameters were found with any of the experiments reported in this 
section (see Table III.20).
5.2.Discussion
14The results obtained using [ C]-2-DG autoradiography show that 
none of the four compounds used produced any significant changes 
in LCGU. We have a situation, therefore, whereby 2-CADO and CHA are 
producing significant decreases in local cerebral blood flow and 
having no significant effect on glucose utilisation. The results/..
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results obtained indicate that the vascular effects of CHA and 
2-CADO observed in 'Results Section 4' are not as a result of any 
alterations in metabolic demand.
6. THEOPHYLLINE STUDY (1)
6.1.Effects of an intraperitoneal (i.p.) injection of theophylline 
(30mg/kg) on the changes in local cerebral blood flow (LCBF) 
produced by a 15 minute infusion of the adenosine analogue,
N^-eye1ohexy1adenosine (CHA)
The following parameters were monitored throughout the course 
of all the experiments: PC02, P02, mean arterial blood pressure, 
core body temperature, bicarbonate (HCO^ ) concentration, base 
excess and pH. No significant alterations in any of these parameters 
were evident in any of the experimental groups mentioned (see 
Table III.23).
When administered via the internal carotid artery CHA alone 
-10(at 10 moles/min) (plus saline i.p.) significantly decreased LCBF 
in the sensory motor cortex and caudate nucleus of the ipsilateral 
hemisphere (see Table III.21). CHA also showed a tendency to decrease 
LCBF in a number of other ipsilateral brain regions e.g. frontal 
cortex, ventrolateral thalamus, globus pallidus, internal capsule and 
hippocampus molecular layer (see Table III.21). In the contra­
lateral hemisphere CHA had no significant effect on LCBF, however, it. 
did show a tendency to decrease LCBF in a number of the contralateral 
brain regions e.g. visual and sensory motor cortices, globus 
pallidus (see Table III.22).
When theophylline alone (30mg/kg) was given intraperitoneally 
(with saline via the internal carotid artery) there was a significant 
increase in LCBF in the ipsilateral sensory-motor cortex. Theophylline 
also significantly decreased LCBF in the internal capsule and the 
inferior olive of the ipsilateral hemisphere. Theophylline also 
showed a tendency to increase LCBF in all of the other ipsilateral 
cortical structures except the visual cortex, and a tendency to/..
to decrease LCBF in a number of the other non-cortical ipsilateral 
brain regions e.g. globus pallidus, pons/see Table III.21). 
Theophylline significantly increased the LCBF in the contralateral 
frontal cortex and also showed a tendency to increase I£BF in all 
of the other contralateral cortical areas, except the visual 
cortex. Theophylline also significantly decreased ICBF in the 
contralateral inferior olive and showed a tendency to decrease 
LCBF in a number of the other contralateral non-cortical brain 
regions e.g. superior olive, pons (see Table III.22).
-10
When theophylline (30mg/kg intraperitoneally) and CHA (10 
moles/min via the internal carotid artery) were administered 
in the same animal they significantly decreased ICBF in the 
ipsilateral internal capsule and inferior olive. They also, 
showed a tendency to decrease LCBF in a number of the other ipsi­
lateral brain regions e.g. ventrolateral thalamus, globus 
pallidus (see Table III.21). In all of the ipsilateral cortical 
structures, except the visual and auditory cortices, CHA and 
theophylline together had almost no effect on LCBF (see Table 
III.21). Theophylline and CHA together significantly decreased 
the LCBF in the contralateral inferior olive and showed a tendency 
to decrease LCBF in a number of the other contralateral brain 
regions e.g. globus pallidus, corpus callosum (see Table III.22).
In all of the contralateral cortical areas, except the auditory and 
parietal cortices, CHA and theophylline together had almost no 
effect on IX3BF (see Table III.22).
As was the case with the agonist 15 minute infusion study the 
effects of the compounds are not only observed in those brain 
regions being supplied by the internal carotid artery, nor is/..
is there any physiological significance in the areas affected.
6.2.Discussion
The results obtained in this study appear to show an obvious 
difference between the cortical and non-cortical brain areas. In 
the majority of the cortical structures CHA alone decreases LCBF, 
theophylline alone increases LCBF, and CHA and theophylline 
together have little or no effects. Since CHA alone and 
theophylline alone have opposite effects in the cortical areas it 
can not be determined conclusively whether the minimal effects of 
CHA and theophylline together are due to an antagonism of the CHA 
effect by theophylline or due to the effects of each compound 
cancelling each other out.
In the majority of the non-cortical structures CHA alone 
decreases LCBF, theophylline alone decreases LCBF, and CHA and 
theophylline together decrease LCBF. It appears, therefore, that 
theophylline has no effect on the response to CHA in the non- 
cortical structures.
Since it appears that theophylline can not antagonise the 
effect of CHA, it is unlikely, therefore, that the decreases in LCBF 
are mediated via an A^ or A2 adenosine receptor interaction since 
both are antagonised by theophylline. As stated above, however, 
there may be some evidence to suggest an antagonism by theophylline 
in the cortical areas and if this is the case it would be likely 
that the changes produced by CHA in these areas are mediated via an 
A^ or A2 receptor interaction.
6.3.Summary of theophylline/15 minute CHA results
Ipsilateral hemisphere
Structures
Cortical
Diencephalic
Hindbrain
Mesencephalic
Telencephalic
Fibre Tracts
Effect on local cerebral blood flow
CHA Theophylline
T
1
A
A
A
A
CHA+Theophy11ine
A
A
A
A
A
Contralateral hemisphere
Structures
Cortical
Diencephalic
Hindbrain
Mesencephalic
Telencephalic
Fibre Tracts
Effect on local cerebral blood flow
CHA Theophylline
t
A
A
A
A
A
CHA+Theophy1line
A
I
I
I 
i
-  indicates that the LCBF in the majority of structures is unaffected.
^ indicates that the LCBF in the majority of structures is decreased,
f indicates that the LCBF in the majority of structures is increased.
7. SHORT-TERM INFUSION STUDY
14Since the [ C] -IAP autoradiographic experiemnts only allow the 
LCBF measurement to be made at one time point (15.5 minutes) during 
the infusion, a shorter infusion was used to test if different 
changes were evident earlier in the infusion. Two minutes was the 
minimum time that could be used since it took that length of time 
for the compounds being infused at 50pl/min. to reach the cerebral 
tissue via the length of internal carotid cannula.
7.1.Effects of a 2 minute infusion of adenosine and the adenosine 
6analogue N -cyclohexyladenosine (CHA) on local cerebral blood
14flow (LCBF) in the rat as measured by [ C] -iodoantipyrine 
(IAP) autoradiography
The following physiological parameters were monitored throughout 
the course of all the .experiments: PCO^, PO^, mean arterial blood 
pressure, core body temperature, bicarbonate (HCO^ ) concentration, 
base excess and pH. No significant changes were found in any of 
these parameters with any of the experimental groups (see Table III.26).
-7
Adenosine, at a concentration of 3 x 10 moles/min., produced 
significant increases in LCBF in 5 of the 35 ipsilateral brain 
regions studied: anterior cingulate cortex, ventrolateral 
thalamus, red nucleus, substantia nigra and corpus callosum (see 
Table III.24). Adenosine also showed a tendency to increase LCBF in 
a number of the other ipsilateral brain regions e.g. prefrontal 
cortex, mediodorsal thalamus (see Table III.24).
Adenosine produced significant increases in LCBF in 2 of the 36 
contralateral brain regions studied: anterior cingulate cortex and 
pons (see Table III.25). Adenosine also showed a tendency to/..
to increase LCBF in a number of the other contralateral brain 
regions e.g. mediodorsal thalamus, corpus callosum (see Table 
III.25).
6 *”10N -eyelohexyladenosine (CHA), at a concentration of 10
moles/min., did not produce any significant changes in LCBF either 
ipsilateral or contralateral to the side of infusion (See Tables 
III.24 and III.25). CHA, however, did show a tendency to increase 
LCBF in a number of the ipsilateral brain regions e.g.frontal 
cortex, nucleus accumbens (see Table III.24).
CHA also showed a tendency to increase LCBF in a number of 
the contralateral brain regions e.g. visual cortex, corpus 
callosum (see Table III.25).
7.2.Discussion
As has already been seen in Sections 1 and 2 of the results 
section both adenosine and CHA are potent vasodilatators and one would 
expect them as has been shown in this section to increase LCBF.
Both adenosine, as was the case with the 15 minute infusion of 
adenosine, and CHA, unlike the 15 minute infusion of CHA, either 
significantly increase or at least show a tendency to increase 
LCBF. It appears, therefore, that both adenosine and CHA, when 
infused for a period of two minutes, are able to increase LCBF by 
an action on a receptor mediating vasodilatation e.g. the A2 
adenosine receptor.
As was the case with the 15 minute infusion agonist study 
there is no apparent difference between the effects of the compounds 
on the cortical and non-cortical areas. The effects are not only 
limited to those areas supplied by the internal carotid artery, 
nor is there any physiological significance in the areas affected.
7.3.Summary of the 2 minute infusion results
(i)CHA
No significant effect on LCBF, but showed a tendency to 
increase LCBF.
(ii)Adenosine
Increases LCBF. Significant increases were observed in the 
following regions:
Structures Ipsilateral Contralateral
Cortical Anterior cingulate ex. Anterior cingulate ex.
Diencephalic Ventrolat. thalamus ---
Hindbrain   Pons
Mesencephalic Red nucleus ---
Substantia nigra
Telencephalic --- ---
Fibre Tracts Corpus callosum------------- ---
8. THEOPHYLLINE STUDY (2)
8.1 .Effects of an intraperitonea1 (i.p.) injection of theophylline 
(30mg/kg) on the changes in local cerebral blood flow (LCBF)
produced by a 2 minute infusion of the adenosine analogue 
6N -cyclohexyladenosine (CHA)
The following physiological parameters were monitored throughout 
the course of the experiments: P(X>2 r PO2 ' 106311 arterial blood 
pressure, core body temperature, bicarbonate (HCO^ "") concentration, 
base excess and pH. No significant alterations in any of these 
parameters were evident in any of the experimental groups 
mentioned (see Table III.29).
When administered via the internal carotid artery CHA alone 
“10
(10 moles/min.) (plus saline i.p.) produced no significant 
alterations in LCBF either ipsilateral or contralateral to the 
side of infusion (see Tables III.27 and III.28). CHA did show , 
a tendency to increase LCBF in almost all of the ipsilateral 
and contralateral brain regions e.g.anterior cingulate cortex and 
corpus callosum (see Tables III.27 and III.28).
When theophylline alone (30mg/kg) was given intraperitoneally 
(Plus saline via the internal carotid artery) it produced no 
significant changes in LCBF either ipsilateral or contralateral 
to the side of infusion (see Tables III.27 and III.28). In the 
ipsilateral cortical structures theophylline had little or no 
effect oft LCBF, except on the parietal cortex, sensory motor cortex 
and frontal cortex where it showed a tendency to increase LCBF. 
Theophylline also showed a tendency to decrease LCBF in a number of 
the other ipsilateral non-cortical brain regions e.g. nucleus/..
accumbens, globus pallidus (see Table III.27). In the contra­
lateral cortical structures theophylline had little or no effect 
on LCBF, except in the parietal, sensory motor and frontal 
cortices where it showed a tendency to increase LCBF. Theophylline 
also showed a tendency to decrease LCBF in a number of the other 
contralateral non-cortical brain regions e.g. lateral geniculate,
nucleus accumbens (see Table III.28).
-10When CHA (10 moles/min via the internal carotid) and 
theophylline (30mg/kg intraperitoneally) were administered in the 
same animal they significantly increased LCBF in the ipsilateral 
visual cortex. CHA and theophylline together also showed a 
tendency to increase LCBF in the ipsilateral cortical structures. 
With the exception of the ipsilateral ventrolateral thalamus 
CHA and theophylline together produced very little change in the 
other ipsilateral diencephalic areas. In most of the other 
non-cortical, non-diencephalic, ipsilateral brain regions, CHA and 
theophylline together had very little effect on LCBF (see Table 
III.27).
CHA and theophylline together significantly increased LCBF in 
2 of the 36 contralateral brain regions: sensory motor cortex and 
cochlear nucleus. CHA and theophylline together also showed a 
tendency to increase LCBF in a number of the other contralateral 
brain regions e.g. all the cortical structures, caudate nucleus.
CHA and theophylline together had little or no effect on LCBF in 
a number of other contralateral brain regions e.g. globus 
pallidus, hippocampus molecular alyer (see Table III.28)
8.2.Discussion/.
8 .2 .Discussion
As was the case in Results Section 6 , the results obtained in 
this section appear to show an obvious difference between the 
cortical and non-cortical brain regions. In the majority of the 
cortical structures CHA alone increases LCBF, theophylline alone 
increases LCBF, and CHA and theophylline together produce an even 
greater increase in LCBF. In the cortical areas CHA increases 
LCBF, suggesting an receptor mediated vasodilatation. Since 
theophylline (an A^ /T^ , adenosine receptor antagonist) does not 
antagonise this increase in LCBF this puts doubt on whether the 
CHA effect is indeed A2 receptor mediated.
In a number of the non-cortical areas CHA increases LCBF, 
theophylline alone decreases LCBF, and CHA and theophylline 
together have no effect. This seems to suggest an antagonism of 
the A2 receptor mediated vasodilatation of CHA by the A^/T^ 
receptor antagonist, theophylline. This antagonism is 
particularly evident in the following ipsilateral brain regions: 
medial geniculate, amygdala, internal capsule, substantia nigra, 
superior colliculus, hippocampus molecular layer, dentate gyrus, 
septal nucleus, cerebellum white and corpus callosum.
As was the case in all of the previous LCBF experiments the 
changes in LCBF were not restricted to the brain regions supplied 
by the internal carotid artery, nor was there any physiological 
significance in those areas affected.
8.3.Summary of theophylline/2 minute CHA results
Antagonism evident
(i)Cortical ---
(ii)Diencephalic
(iii)Hindbrain —
(iv)Mesencephalic
(v) Telencephalic
(vi)Fibre Tracts
in the following ipsilateral brain regions
medial geniculate 
amygdala 
internal capsule
substantia nigra
superior colliculus
hippocampus molecular layer
dentate gyrus 
septal nucleus
cerebellum white
corpus callosum
SECTION IV 
GENERAL DISCUSSION
1. PURINERGIC RECEPTOR SUB-TYPES
As previously mentioned in the 'INTRODUCTION' section the effects 
of adenosine and the adenosine analogues are mediated via an action 
on specific extracellularly located receptors. Experiments have shown 
that the binding of adenosine to compounds of high molecular weight 
or glass beads does not affect the vasodilator activity and this 
indicates that the receptors mediating the vasodilation are located on 
the cell surface (Schrader, Nees & Gerlach,1977; Ghai & Mustafa,1983).
The idea of two groups of purinergic receptors was first put 
forward in- 1978 (Bumstock,1978). The two purinergic receptors were the 
P^ receptor, linked to the adenylate cyclase system, and the P2 receptor,
which is not linked to the adenylate cyclase system. The two purinoceptors
can be differentiated by the order of potency of a group of purine- 
related compounds at them i.e.
P^ receptor: aderibsine >, AMP > ADP ^ ATP
?2 receptor: ATP >, ADP > AMP >, adenosine
The P^ group of purinoceptors can be subdivided into two classes: 
the A^ (or R^) receptor, which is coupled to adenylate cyclase in an 
inhibitory manner (van Calker et al.,1979; Londos et al.,1980) and the 
A. (or R ) receptor which is coupled to adenylate cyclase in aA a
stimulatory manner (Bruns, 1980). As was the case with the P^/^ 
purinergic receptors, the a<^ enos^ne receptors can be
differentiated by the rank order of potency of. adenosine and the various 
adenosine analogues i.e.
A^ receptor/...
receptor:
CHA, L-PIA > 2-CADO > adenosine > NECA
A^ receptor:
NECA > 2-CADO, adenosine > L-PIA > CHA
The P1 group of purinoceptor receptors are located on the cell 
surface of the vascular smooth muscle rather than on the vascular 
endothelium. The endothelium-independency of the observed adenosine- 
induced vascular relaxation has been shown in studies involving 
rabbit vascular smooth muscle, which showed that the relaxation 
produced by adenosine was unaffected by removal of the endothelium 
(Furchgott,1983). Although it has been stated that P^ receptors are 
located on the cell surface of the vascular smooth muscle, intra­
cellular sites of action for adenosine have also been located (Londos 
& Wolff,1977; Collis & Brown,1983).
The group of purinoceptors have been subdivided into two 
further groups: an excitatory receptor, / located on the vascular
smooth muscle; and an inhibitory receptor, P , located on the
^Y
the vascular endothelium. These findings came from studies which 
showed that ATP was able to act at P2 receptors at two locations in 
the isolated rat femoral artery: one on the endothelium mediating 
vasodilation and one on the smooth muscle mediating vasoconstriction 
(Kennedy, Delbro & Bumstock,1985). Kennedy et al. (1985) showed 
that in the isolated rat femoral artery preparation low concen­
trations of ATP produced a relaxation of vessels which had their
—6
tone raised with 10 m noradrenaline (NA), whereas in the same prep­
aration with the endothelium removed ATP produced a contraction of
—6vessels which also had their tone raised with 10 M NA, and these/..
contractions were often produced by concentrations of ATP which
had no effect when the endothelium was intact. It was these studies
led to the introduction of the P2 receptor classification of P2x
and P_ .
2y
2. ISOLATED PORCINE VESSEL STUDY
The rank order of potency of adenosine and the adenosine
analogues in this study was as follows:
NECA > 2-CADO, adenosine > L-PIA > CHA
and as stated earlier this order is in keeping with that of the
A2 adenosine receptor sub-type.
No specific efforts were made to either keep the endothelium
intact or remove the endothelium since it has been shown that the
adenosine-induced relaxation of vascular smooth muscle is
endothelium-independent (Furchgott,1983).
The antagonist data, however, shows that the picture is perhaps
not as simple as an A2 receptor-mediated vasodilation. Although the
A^/A2 adenosine receptor antagonist 8-phenyltheophylline
competitively antagonises the vasodilatory effects of NECA it is
unable to block the effects of any of the other agonists. The adenosine
receptor agonists adenosine, 2-CADO, CHA and NECA, in the presence
of 8-phenyltheophylline cause a constriction of the vessels in the 
—9 -6dose range of 10 M to 10 M agonist. A number of possible
explanations can be put forward to explain these results. Firstly,
it could be that the antagonist 8-phenyltheophylline is indeed
blocking both the A^ and A2 adenosine receptors but in the dose 
—9 —6range 10 M to 10 M the agonists are perhaps acting on another 
distinct receptor to mediate the vasoconstriction. A second/..
second possible explanation could be that the 8-phenyltheophylline, 
in this preparation, is a more potent antagonist at the
receptor than at the A^ receptor and, therefore, in the low dose
- 9 - 6  . .range of 10 M to 10 M the agonists are acting on the A^ adenosine
receptor to mediate a vasoconstriction.
It can be determined from these studies involving isolated
porcine vessels that the A£ adenosine receptor is indeed involved
in mediating the vasodilatory effects of the various agonists.
Although certain aspects of the results suggest that the mechanism
of action is perhaps not as straightforward as a simple A^ receptor
interaction, these experiments with the isolated porcine vessels do
not allow us to determine what other receptor(s), if any, is (are)
involved in the action of adenosine and the adenosine analogues on
the cerebrovasculature.
3. IN VIVO FELINE PIAL VESSEL STUDY
These studies show that adenosine and its analogues are indeed
potent vasodilators, thus supporting the results from the in vitro
isolated porcine vessel study. The results in this study also
confirm the results obtained by other workers using the same
-5preparation i.e. 10 M adenosine gives a 22% dilation at a of
30mmHg which compared favourably with the findings of Gregory et
al. (1980) (14% dilation at a of 25mmHg and a 29% dilation at
P of 34mmHg) and Wahl & Kuschinsky (1976) (24% dilation at a 
2
PCQ of 31mmHg).
Since it has already been shown that it is the A^ receptor 
which mediates vasodilation, both in the previous section 
discussing the in vitro isolated vessels and in the experiments/..
experiments carried out by Edvinsson & Fredholm (1983), one can 
propose that the observed dilations in vivo are as a result of an 
A2 adenosine receptor interaction. The A^/A2 adenosine receptor 
antagonist 8-phenyltheophylline is able to block the vasodilatory 
actions of adenosine, CHA and NECA. As was the case with the in 
vitro vessels, however, the agonists, particularly adenosine and 
NECA, cause a constriction of the vessels in the presence of 
8-phenyltheophylline, suggesting once again that when the A^/A2 
adenosine receptors are blocked by 8-phenyltheophylline the 
agonists are perhaps acting on another non A^/A2 receptor to 
mediate a vasoconstriction.
The overall picture to be obtained from the vessel work is 
that adenosine and the adenosine analogues act on the A2 receptor 
to dilate the cerebral vessels and that although other receptor 
mechanisms, which become apparent on blockade of the A^/A2 
receptors, may be involved their identity or existence can not be 
discovered using the aforementioned results.
4. LCBF MEASUREMENT USING LASER-DOPPLER FLOWMETRY
Since it is known that adenosine and the adenosine analogues
dilate the cerebral vessels it would be expected that they would
in turn cause an increase in local cerebral blood flow (LCBF).
When cerebral blood flow measurements are made using laser-Doppler
flowmetry, however, they show that one of the adenosine analogues,
namely CHA, decreases cerebral blood flow.
When laser-Doppler flowmetry is used to monitor the changes in
cerebral blood flow produced during a fifteen minute infusion of CHA 
-10at 10 moles/min. via the right internal carotid artery, it shows CHA 
producing a monophasic decrease in cerebral blood flow throughout the 
course of the infusion.
5. PHARMACOKINETICS OF ADENOSINE AND THE ADENOSINE ANALOGUES
It has been shown that "a blood-brain barrier transport system 
exists in the rat for the following compounds: adenine, adenosine, 
inosine, guanosine and uridine (Comford & Oldendorf, 1975).
These studies show that approximately 9% of the adenosine administered 
intravascularly will cross to .-the cerebral side of the blood-brain 
barrier. There is no evidence for the existence of a carrier for 
ATP in the rat, however it may cross the blood-brain barrier after 
it has been metabolised to adenosine.
We shall now look at two of the compounds infused via the internal 
carotid artery in the autoradiographic experiments (adenosine and CHA) 
and calculate roughly, making a few assumptions, what concentrations 
are reaching the cerebral circulation:
5.1.Adenosine/..
5.1.Adenosine
Blood flow to the rat brain approximately 70ml/100g/min. 
Weight of rat brain approximately 2g.
Therefore, flow to the rat brain is approximately 1.4ml/min.
1/3 of this goes to the brain via the carotid i.e. 0.47ml/min. 
2/3 of this goes to the brain via the basilar i.e. 0.93ml/min.
Dose of adenosine administered via the right internal carotid artery
-7
= 3 x 10 moles/min.
Approximately 9% of this will cross the blood-brain barrier
= 9/100 x 3 x 10"7 
—8=2.7 x 10 moles/min.
—8Therefore, the concentration reaching the brain = 2.7 x 10 moles/min
0.47ml/min
= 5.7 x 10 ^moles/ml
= 5.7 x 10”5M
Therefore, the total concentration of adenosine reaching the brain 
over 15 minutes assuming minimal further metabolism 
=15 x 5.7 x 10“5M 
=8.6 x 10“4M
The actual concentration of adenosine reaching the brain over 
15 minutes will probably be less than this since it is unlikely that 
there will be no further adenosine metabolism once it has crossed to 
the cerebral side of the blood-brain barrier.
Due to its rapid degradation by adenosine deaminase the 
concentration of adenosine recirculating and passing to the left 
hemisphere of the rat brain will probably be almost zero.
5.2.CHA
Dose of CHA administered via the right internal carotid artery 
=10 "^moles/min.
Assume approximately 9% (as was the case with adenosine since
actual CHA figure not known) of this will cross the blood-brain
-10
barrier = 9/100 x 10 moles/min 
-12= 9 x 10 moles/min.
-12Therefore, concentration reaching the brain = 9 x 10 moles/min
0.47ml/min
-12= 19 x 10 moles/min 
= 1.9 x 10“8M.
Therefore, the total concentration of adenosine reaching the 
brain over 15 minutes assuming minimal further metabolism 
= 15 x 1.9 x 10"8M 
= 2.8 x 10“7M. *
Rate of CHA administration = 50|Jl/min
Therefore, total volume of CHA given over 15 minutes = 750pl
= 0.75ml.
Therefore, if the CHA recirculates to the left hemisphere it 
will be dissolved in total rat blood volume of approximately 25ml.
Therefore, the concentration of CHA reaching left carotid 
=0.75/25 x 2.8 x 10”7M 
=•8.4 x 10“9M.
Assume/..
Assume 9% crosses the blood-brain barrier
. concentration of CHA reaching left hemisphere
= 9/100 x 8.4 x 10-9M 
-10= 7.6 x 10 M.
Assumptions made in this calculation are that there is no metabolism 
of the stable analogue CHA during the recirculation, and that the 
CHA is dissolved only in the total animal blood volume 
(approximately 25ml.) rather than in the total body water volume 
(approximately 200-300ml.).
6 . [14C]-IODOANTIPYRINE AUTORADIOGRAPHY - 15 MINUTE INFUSION
14When the LCBF is measured using [ C] -iodoantipyrine autoradio­
graphy 15 minute infusions of CHA (10 "^moles/min.) and 2-CADO 
-9(10 moles/min) significantly decrease LCBF in a number of discrete
.. -7
brain regions, whereas 15 minute infusions of adenosine (10 and
-7 -7 -73 x 10 moles/min.), ATP (10 and 3 x 10 moles/min.) and NECA
-11(10 moles/min.) show a tendency to increase LCBF. Although the 
compounds are administered via the right internal carotid artery 
the significant decreases in LCBF produced by CHA and 2-CADO are 
not only observed in those regions supplied by the right internal 
carotid artery, namely, the cortical areas, caudate nucleus, 
hippocampus molecular layer, dentate gyrus, globus pallidus, 
nucleus accumbens, subthalamic nucleus, red nucleus and substantia 
nigra of the right hemisphere (Yamori et al.,1976). One
possible reason for changes being seen in areas other than those 
supplied by the right internal carotid artery could be that the 
compounds are circulating round the body and passing into the/..
the brain via other arteries supplying the brain i.e. the left 
internal carotid artery and the right and left basilar arteries.
Although 15 minute infusions of adenosine, ATP and NECA all 
show a tendency to increase LCBF, as expected of known dilators, 
none of them is able to produce a significant increase in LCBF. 
Adenosine has already been shown to produce significant increases 
in cerebral blood flow in the dog (Kozniewska et al.,1975;
Heistad et al.,1981) and the baboon (Forrester et al.,1979).
A number of reasons can be put forward to explain this lack
of a significant effect. In the case of NECA it could be that at
-11the low concentration used (10 moles/min.) there is an 
insufficient amount of NECA reaching the site of action to produce 
a significant effect. As stated earlier, however, higher 
concentrations of NECA can not be used due to their hypotensive 
effects. The lack of a significant effect with adenosine and ATP 
could be attributed to the fact that they are degraded by various 
enzymes, including adenosine deaminase, therefore the concentration 
of both of these compounds reaching the site of action are not 
sufficient to elicit a significant alteration in LCBF.
Previous studies in other species such as the young rat (Hoffman 
et al.,1984) and the dog (Boarini et al.,1984) have shown infusions 
of adenosine to have no effect on cerebral blood flow. Boarini et 
al. (1984) proposed that it is the route of administration of 
adenosine that determines the effect i.e. the intravascular route 
of administration of the compounds used in their study produces no 
cerebrovascular effects.
A reason still has to be found for the vasoconstrictive effect of 
CHA and 2-CADO resulting in the significant decreases in LCBF observed. 
Adenosine has been seen to produce vasoconstriction in a number of /..
of previous studies, however, in these studies the observed effects
have been attributed to the secondary release of serotonin (5-HT) in
rat femoral vascular bed and tail artery (Sakai,1978; Brown &
Collis,1981) and to a relationship between adenosine and angiotensin
II in the kidney. It has been found that the adenosine-induced
constriction in the kidney is blocked by angiotensin antagonists
(Spielman & Oswald,1979), suggesting that either angiotensin
formation is increased or that there is enhanced vascular reactivity
to angiotensin. The exact mechanism, however^ by which adenosine
acts to unmask the vasoconstrictive effect of angiotensin remains
to be elucidated. It could be possible that CHA and 2-CADO are
acting through similar mechanisms in the brain to produce the
observed constrictions e.g. the effects of CHA and 2-CADO on LCBF
could be monitored in the presence of some 5-HT antagonists, such as
methysergide or cyproheptadine, to determine whether or not the
secondary release of 5-HT is involved in producing the constrictions
observed. Decreases in flow have been observed when adenosine was
injected into rabbit hypothalamus ( Livemore & Mitchell, 1983). In this
-4 -3study injections of 10 M and 10 M adenosine produced the increases
—6in flow expected of a vasodilator, however, an injection of 10 M 
adenosine produced a significant 25% decrease in hypothalamic blood 
flow. This vasoconstriction of the hypothalamic blood vessels was a 
consequence of the direct action of adenosine on adenosine receptors 
on the vessels, since neither adrenergic blockade nor the inhibition 
of neuronal activity were able to block the effect. The identity of 
receptor in the hypothalamus was not determined in this study by 
Livemore & Mitchell,1983), however, it may be possible that 2-CADO 
and CHA are acting through similar receptors in the rat to produce 
the significant decreases in LCBF obtained in my own study/..
study.
One possible reason for the observed decreases in flow could be 
that the vascular effects observed with 2-CADO and CHA are secondary 
to their metabolic actions i.e. although the compounds are vaso­
dilators they also have the effect of decreasing the metabolic 
demand and this, in turn, leads to the observed decrease in local 
cerebral blood flow. This explanation for the decreases in LCBF, 
however, is not a possibility since studies carried out to monitor
the effects of 15 minute infusions of adenosine, CHA, 2-CADO and
14NECA on local cerebral glucose utilisation, using [ C]-2-deoxy- 
glucose (2-DG) autoradiography, showed that they have no 
significant effect on LCGU.
A second possible reason to explain the vascular effects of CHA 
and 2-CADO could be the involvement of receptors other than the A2 
receptor known to mediate vasodilation. Possible receptors involved 
could be the A^ adenosine receptor, a recently identified third 
(A^ ) adenosine receptor or eVen a completely different receptor type.
7. A THIRD (AJ ADENOSINE RECEPTOR
The idea of a third (A^ ) adenosine receptor, not coupled to 
adenylate cyclase system but possibly linked to calcium channels, 
was propsed by Ribeiro & Sebastiao (1986). The order of potency of 
adenosine analogues at this receptor site is: L-PIA,CHA,NECA>2-CAD0. 
Two speculative hypotheses have been put forward to explain the 
identity of this A^ receptor. Firstly, it could be a voltege dependent 
calcium channel which changes its conformation after bimding adenosine 
Secondly it could be that activation of the A^ adenosine receptor 
induces a conformational change in the membrane in such a way that the 
calcium receptor sitr becomes altered. This A^ receptor, like the A^/.
and A2 receptors, is also xanthine sensitive. A third adenosine 
receptor associated with calcium channels has also been proposed 
by Chin & DeLorenzo (1986) with a rank order of potency for the 
adenosine analogues of: 2-CAD0>NECA>L-PIA. Since the orders of 
potency for the analogues are different it seems likely that the 
A^ receptor of Ribeiro & Sebastiao and the A^ receptor of Chin & 
DeLorenzo are not the same receptor. These proposals for a third 
adenosine receptor are in continuity with previous suggestions 
(Phillis & Wu,1981; Stone,1985) concerning the need for a third 
adenosine receptor mediating the electrophysiological effects of 
adenosine on the central nervous system.
8 . [14C] -IODOANTIPYRINE AUTORADIOGRAPHY - 2 MINUTE INFUSIONS
When adenosine and the analogue CHA were infused for
2 minutes via the right internal carotid artery at concentrations of
3 x 10 7moles/min. and 10 lOmoles/min., respectively, they both 
increased local cerebral blood flow. The changes in local cerebral 
blood flow produced by adenosine are significant in a number of 
brain regions e.g. anterior cingulate cortex, ventrolateral 
thalamus, red nucleus, substantia nigra, corpus callosum. Although 
CHA did not produce any significant changes in local cerebral blood 
flow it did show a tendency to increase flow in a number of brain 
regions e.g. frontal and anterior cingulate cortices, nucleus 
accumbens, substantia nigra, cerebellum white, corpus callosum. Since 
it is know that the A2 receptor mediates dilation and that a vaso­
dilation would result in an increase in local cerebral blood flow it 
could be proposed that the increases observed in flow produced by CHA 
and adenosine are mediated via an A2 receptor mechanism.
9. DIFFERENCES/..
9. DIFFERENCES BETWEEN TWO AND FIFTEEN MINUTE INFUSIONS
The decreases in local cerebral blood flow produced by CHA and 
2-CADO are not what one would expect with known vasodilators, 
however it still seems likely that these changes are real and not 
due to some experimental artefact, which can be ruled out for two 
reasons. Firstly, it would be unlikely that any artefact would only 
be evident in the 15 minute infusion experiments and even then only 
in the experiments involving CHA and 2-CADO. Secondly, the 
unexpected results obtained with CHA and 2-CADO are not due to 
damage as a result of the route of administration i.e. injecting 
compounds via the internal carotid artery resulting in thrombi or 
emboli leaving the cannula tip and damaging the brain. Experiments 
carried out using FAM fixation and pathological examination showed 
no evidence of damage to the cerebral tissue caused by air emboli 
or thrombi (see Appendix).
Unlike the increases in LCBF produced by a 15 minute infusion 
of adenosine, the increases produced by a 2 minute adenosine infusion 
are significant increases. One possible reason which may explain this 
difference in the response could be linked to adenosine metabolism. 
After a 2 minute infusion of adenosine there would be an amount of the 
adenosine metabolite, inosine, present in addition to the adenosine. 
After a 15 minute infusion, however, there would be a much larger 
concentration of the metabolite inosine present, but the adenosine 
concentration would not be that much greater. In studies involving 
vasal (dog), cardiac (frog), intestinal (rat) and uterine musculature 
inosine has been shown to be inactive by itself, but is able to 
increase tha activity of adenosine (Rossi et al.,1982), and this 
could explain why the 2 minute adenosine infusion gives significant 
changes in blood flow i.e. the inosine present.enhances the /..
the adenosine action in a 2 minute infusion but in a 15 minute 
infusion too much of the inactive inosine is present in relation 
to the adenosine levels.
10. AUTORADIOGRAPHIC STUDIES INVOLVING THE ADENOSINE RECEPTOR
ANTAGONIST THEOPHYLLINE
Studies were carried out involving the intraperitoneal 
administration of the A^/A2 adenosine receptor antagonist, theophylline, 
in animals receiving 15 minute infusions of the adenosine analogue,
CHA, via the right internal carotid artery. These studies seem to 
show no evidence of an antagonism of the decreases in local cerebral 
blood flow produced by the 15 minute infusion of CHA, therefore it 
seems unlikely that the decreases in flow are mediated by an A^ or 
A2 receptor interaction. The A^ receptor proposed by Ribeiro &
Sebastiao (1986) is also xanthine sensitive, therefore it is unlikely 
that the decreases are caused by an A^ receptor interaction.
When the A^/A2 adenosine receptor antagonist, theophylline was 
given in animals receiving a 2 minute infusion of CHA there appeared 
to be an antagonism of the increases in local cerebral blood flow 
produced by CHA in a number of the non-cortical brain regions studied 
e.g. amygdala, caudate nucleus, internal capsule, substantia nigra, 
hippocampus molecular layer, dentate gyrus, septal nucleus and corpus 
callosum. In the cortical brain areas, however, there appears to be a 
degree of synergism i.e. the increase in local cerebral blood flow 
produced by CHA and theophylline together is greater than the sum 
of the increases produced by CHA alone and theophylline alone.
In all of the autoradiographic experiments theophylline increases 
local cerebral blood flow in the cortical areas but decreases local 
cerebral blood flow in the other non-cortical brain areas. When the 
theophylline is given to animals receiving a 2 minute infusion of 
CHA the synergistic effect in the cortical areas could be due to the 
theophylline blocking the A^ receptor, which CHA would act on to/..
to constrict the vessels, thus allowing the receptor mediated 
vasodilatory effect of CHA to become more noticeable.
11. CONCLUSION
The significant decreases in local cerebral blood flow produced
by a 15 minute infusion of CHA do not appear to occur either as a
result of decreases in metabolic demand, since CHA has no effect on
14local cerebral glucose utilisation as measured by [ C]-2-deoxy- 
glucose autoradiography, or as a result of an interaction with any 
of the known xanthine sensitive adenosine (A^,A£,A^)receptors, 
since the xanthine derivative, theophylline, was not able to 
block the observed decreases in local cerebral blood flow. 
Theophylline exerts some of its pharmacological effects via , among 
others, the inhibition of cyclic AMP phosphodiesterase and also via 
the release of catecholamines from neurones, however, it is 
unlikely that after a dose of 30mg/kg i.p. theophylline (as used 
in this study) has any effect on either phosphodiesterase activity or 
catecholamine release (Winn et al.,1985). It could be possible that 
the decreases in LCBF occur as a result of an interaction with 
another, as yet unknown, receptor type, however, the results obtained 
in this study do not allow us to identify what this receptor may be. 
One factor that can not be used to explain the observed decreases in 
is that of cerebral damage since FAM fixation pathological studies 
showed no evidence of embolic or thrombic damage following the 
administration of solutions via the internal carotid artery. As 
discussed earlier adenosine has produced vasoconstrictions in the rat 
femoral vascular bed and rat tail artery (Salai,1978; Brown & 
Collis,1981) which have been attributed to the secondary release of/..
of serotonin and it could be that CHA and 2-CADO are producing their 
constrictions via a similar mechanism. Adenosine has been shown to 
produce a vasoconstriction of the hypothalamic blood vessels 
Livemore & Mitchell,1983) to cause a 25% decrease in blood flow, 
and it was proposed that the effect was due to a direct action on 
adensosine receptors on the blood vessels, however the exact identity 
of the receptor was not proposed.
It is known that the A2 receptor mediates vasodilation 
(Edvinsson & Fredholm,1983), which results in increased blood flow, 
and that the same receptor is blocked by xanthine derivatives, of 
which theophylline is one,(Daly,1982), therefore it seems likely 
that the increases in LCBF produced by a 2 minute infusion of CHA, 
which are blocked by theophylline (30mg/kg i.p.), are mediated via 
an A2 receptor interaction.
Although the isolated porcine vessel experiments support the 
role of adenosine and the adenosine analogues as cerebral vaso­
dilators, the unmasking of a* vasoconstrictive action in the agonist 
-9 -6dose range of 10 to 10 M following the application of the A^/^ 
receptor blocker 8-phenyltheophylline ( a xanthine derivative), 
suggests that receptors other than the classical adenosine
receptors may be involved in producing the observed responses in 
vitro.
In summary, the isolated porcine vessel and cat pial vessel 
studies confirm the vasidilatory properties of adenosine and the 
adenosine analogues and the LCBF autoradiographic experiments 
involving 2 minute infusions of adensoine and CHA and 15 minute 
infusions of adenosine, ATP and NECA show the increases in LCBF 
expected of known vasodilators. The decreases in LCBFproduced by 
15 minute infusions of the known vasodilators CHA and 2-CADO ,/
2-CADO, however, are without doubt the most interesting and
original findings within the thesis. Studies carried out using 
14[ C]-2-deoxyglucose autoradiography, FAM fixation and the 
adenosine antagonist theophylline showed that the decreases in LCBF 
were not a consequence of either changes in metabolic demand, 
damage to the cerebral tissue during the infusion or an interaction 
with one of the known, xanthine-sensitive adenosine (A^, 2^ 'A3 ) 
receptors, respectively. The range of techniques available to me, 
however, did not allow me to identify what factors were involved in 
producing the vasoconstrictions observed with the vasodilators CHA 
and 2-CADO.
12. FURTHER STUDIES
There are a number of other studies which could be carried out 
to help clarify the picture of what is happening. Although the lack 
of antagonism by theophylline of the decreases in LCBF produced by 
CHA suggest that none of the adenosine receptors is involved in the 
mechanism of action, one could test specific A^ and A^ receptor 
antagonists to monitor the involvement of each adenosine receptor 
independently e.g. the specific A^ receptor antagonist 
8 -eye lopenty 1 -3,7-dihydro-l, 3 -dipropyl-lH-purine-2,6-dione 
(PD,116,948)(Haleen,Steffen & Hamilton,1987) or the specific A^ 
receptor antagonist N- [2- (dimethylamin) ethyl ] -N-methyl-4- (2,3,6 ,7- 
tetrahydro-2,6-dioxo-l, 3-dipropyl-lH-purin-8-y 1) benzenesulfonamide 
(PD,115,199)(Bruns et al.,1987).
The A^ adenosine receptor is thought to be linked in some way to 
a calcium channel, therefore, perhaps the use of a calcium channel 
blocker, such as nifedipine or nimodipine, would help to determine/.
determine if the receptor was involved in any way.
The concentrations of adenosine and the adenosine analogues 
used were chosen, as stated earlier, since they were the highest 
that could be used without producing hypotensive effects. Higher 
concentrations could be tested, however, however, to see how 
they would differ from those already used if the peripheral 
vascular effects of adenosine could be antagonised without 
affecting the central actions. The adenosine receptor antagonist 
8-p-sulfophenyltheophylline (8-SPT) is a polar analogue of 
theophylline and as such does not gain access to the central 
nervous system across the blood brain barrier (Evoniuk, von 
Borstel SWurtman, 1987). 8-SPT is able, therefore, to block the 
peripheral hypotensive effects of adenosine and the adenosine 
analogues without affecting their central effects, thus allowing 
higher concentrations of adenosine and the adenosine analogues 
to be used.
SECTION V 
A P P E N D I X
1. EFFECT OF CHANGES IN MEAN ARTERIAL BLOOD PRESSURE (MABP) ON
RAT LOCAL CEREBRAL BLOOD FLOW (LCBF)
1.1.Experimental Protocol
All the rats used in this experimental group received 15
minute infusions of 0.9% saline via the right internal carotid
artery in order to replicate the conditions under which the
earlier autoradiographic experiments were carried out. The MABP
of the animals was reduced by haemorrhage and maintained for
14approximately 15-20 minutes at this new level before the [ C]-IAP 
experiments were carried out to determine the LCBF.
1 .2.Results
Comparing the LCBF of each MABP range with that of the upper 
MABP range of 90-109 mmHg (for each of the 36 discrete brain regions 
studied), no significant alterations in LCBF were evident at any 
of the MABP ranges, either contralateral or ipsilateral to the side 
of saline infusion (see Tables V.l. and V.2.).
If we express the change in LCBF at each MABP range from the 
ICBF of the 90-109 mmHg range as a percentage (for each of the 36 
discrete brain regions) and then calculate the mean percent change 
from all of the cortical and non-cortical regions, we can plot the 
graphs of "% change in LCBF against MABP range" shown in Figs. V.l. 
and V.2. Figures V.l and V.2 show that in both the ipsilateral and 
contralateral hemispheres and for both the cortical and non-cortical 
areas there is no significant alteration in LCBF when the MABP is 
taken down below 90mmHg, even when it is taken as low as 40mmHg.
With the obvious exception of the MABP there were no significant 
alterations in any of the physiological parameters monitored from/..
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from range to range of blood pressure (see Table V.3).
1.3.Discussion
One possible problem that can be experienced with lowering the 
animal's blood pressure is that the flow rate of the blood flowing 
from the femoral cannula can be so low that it results in a false 
calculation of blood flow. This problem was overcome by using a 
small screw clamp which was tightened round the femoral cannula at 
higher blood pressures and loosened as the blood pressure was 
reduced, thus ensuring a similar flow rate through the femoral 
cannula at all the blood pressure ranges.
The results obtained in this study show that there is no 
significant alteration in LCBF in the range 40-109mmHg. No 
alterations in LCBF were evident due to autoregulation i.e. when 
the MABP is reduced the blood flow also decreases, therefore 
the vessels dilate to counteract this and increase flow. The lower 
the MABP is taken the greater the vasodilatation of vessels 
required to compensate for the decrease. Since vasodilatatory 
compounds are being tested one does not want the vessels to be 
dilated too much initially or the effect of the compound may not 
be observed. Although the MABP can be taken as low as 40mmHg 
and still not affect the LCBF, the higher it is kept the better 
the preparation is to show a vasodilatatory effect, therefore, 
in all of the autoradiographic experiments no animal was used if 
the MABP fell below 70mmHg.
2. PATHOLOGICAL EXAMINATION OF THE RAT BRAIN USING FAM FIXATION
2.1.Results and Discussion/..
2.1.Results and Discussion
As stated in the Material and Methods section all of the animals 
used in this experimental group received a 15 minute infusion of 
saline via the right internal carotid artery in order to replicate . 
the conditions under which the earlier autoradiographic experiments 
were carried out. Four hours after the end of the 15 minute infusion 
the rats underwent FAM (formaldehyde/acetic acid/ methanol) fixation. 
The brains of all the rats used in this study then underwent 
pathological examination and in all cases there was no evidence of 
embolic or thrombic damage to the cerebral tissue. The results 
obtained in this section show that the changes observed in the earlier 
autoradiographic experiments are not as a result of damage to the 
brain caused by the administration of the compounds.
SECTION VI 
TABLES
Table III.l D- VALUES AS DETERMINED FROM THE AGONIST
P 2______________________________________
DOSE RESPONSE CURVES
Agonist n
Relative Emax 
(mean ± s.e.m.)
Relative ECcn
DU
(mean).
NECA
Adenosine 
2-CADO 
L- PIA 
CHA
13
8
9
9
8
88.1 ±9.1 
145.1 ± 14.4 
159.6 ± 20.8 
99.3 ± 10.9 
89.5 ± 8.6
9.1xl0~?M 
3.9x 10_6M 
4.5x 10“6M 
1.1x 10“5M 
2.0x 10”5M
Relative
6.15
5.40
5.35
4.95
4.90
Table III.2 D, VALDES AS DETERMINED FROM THE HILL PLOT
___________ P 2 ____________________________________
Agonist
NECA
2-CADO
Adenosine
L-PIA
CHA
p° 2 (mean i s.e.m.)
6.00 ± 0.47 
5.43 ± 0.15 
5.36 ± 0.19 
5.31 ± 0.80 
4.85 ± 0.25
Slope of Hill Plot 
(Hill co-efficient)
0.55
1.16
0.89
0.45
1.24
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Table III.? EFFECT OF CHA ON CEREBRAL BLOOD FLOW AS
MEASURED BY LASER DOPPLER FLOWMETRY
% change in CBF from baseline level
—10Time (minutes) 0.9% saline 10 moles[min CHA
1 -2.8±6.5(6) -3.515.9(6)
2 0.118.6(6) -2.816.0(6)
3 1.6±11.4(6) -5.8111.4(6)
4 6 .2111.2 (6) -5.411?.0(6)
5 4.21?.4(6) -9.91?.4(6) *
10 ?.2i?.8 (6) -18.8114.4(6)*
15 10.31?.5(6) -20.0116.0(5)*
15.5 10.61?.3(6) -1?.6112.9(5)*
All values are expressed as meanistandard deviation 
Figures in parentheses, indicate n value 
* P<0.05 (Student's t-test comparing CHA value to the 
corresponding saline control value at each time point)
Table 111.8 PHYSIOLOGICAL PARAMETERS MONITORED IN
LASER - DOPPLER EXPERIMENTS
Parameter
PC02 (mmHg)
P02 (mmHg)
MABP (mmHg)
Temp. (°C)
[HCO3-](mmol/1)
Base excess (mmol/1) 
EH
Pre-saline infusion
44.614.4 
129.111?.9 
10511?
36.610.9
24.412.8
-1.114.1
Pre-CHA infusion
43.116.9
134.0115.4
87119
36.110.8
24.512.4
-0.913.6
7.37510.0877.36010.078
All values are expressed as meanlstandara deviation, 
n = 6 in all cases.
No significant differences in any of the parameters between 
CHA and saline control.
Table I I I . 9 M L M L  HEMLSfflEFE: OffNEES 3N KEF REDUCED By ACED6ISE AND ATP
_J2 _7 _J2 _7
0.9% Saline 10 moles/min 3x10 m/m 10 moles/min 3x10 m/m 
SMJCIUFE CCNIECL ACEKBINE ACHSC61NE JEP________ AEP
Cortical 'Areas
Visual Cortex 140±4 (4) 154132(4) 14?+16(5) 152142(4) 220153(5)
Auditory Cortex l?8+?2(5) 185156(4) 181134(5) 2?0ill2(4) 186156(5)
Earietal Cortex 15?131(5) 2451156(4) 165166(5) 18?160(4) 143120(5)
SaBory Motor Cfcartex; l?8+65(5) 164162(4) 14212?(5) 269194(4) 1?4123 (5)
Ercntal Cortex 150159(5) 150154(4) 184129(5) 18914?(4) 199146(5)
Prefrmtal Cortex 166+5(3) 20214?(4) 1?5123(5) 20816?(3) 230149(4)
Anterior Crngulate 
Cortex 196164(5) 253+55(4) 165126(4) 2961123(4) 200180(5)
Cdox^halic Areas
Madial Gatijculabe 159145(5) 188150(4) 165114(5) 222186(3) 1881102(5)
lateral GaiicuLafe 120140(5) 169+49(4) 182±?8 (5) 198168(4) 159+43(5)
Ibalamjs, Madio- 
dorsal 148+56(5) 185185(4) 154133(4) 19?+58(4) 182160(5)
Thalsrrus, Venfcro- 
lateral 125+42(5) 134154(4) 139+49(5) 158i?L(4) 129136(5)
Hypothalarrus 121144(5) 138165(4) 113138(5) 1?41128 (4) 109124(5)
Lateral ffibanla 154125(5) 189153(4) 204193(5) 208+78(4) 1?6162(5)
Anygdala 99131(5) ‘ 138+1(2) 114141(3) 92135(2) 102118(3)
CSndate Nucleus 2331?! (5) 1?6158 (4) 156129(5) 208166(4) 190+43(5)
Nucleus AcmrbaTS 164191(5) 185169(4) 1?4160 (5) 164112(4) 154121(5)
Gldous Eallidus 104134(5) 120+85(4) 91+18(5) 1611120(4) 126+42(5)
Internal Cbpsule 90+35(4) 106112(2) 94148(3) 6?B(2) 92123(2)
SubtiBlanrio Nucleus 145134(5) 140138(4) 160118(4) 1??169 (4) 188+48(5)
ncfarain Areas
f^estribular Nucleus 193149(4) 20918(3) 192145(4) 256168(3) 2631112(3)
Superior Olive 22?H21(5) 196154(4) 204+42(5) 233H00 (3) 203149(3)
Inferior Olive 205162(5) 210122(2) 13013?(2) 4261181(2) 286120(3*
Rns 135144(5) 101+13(4) 89114(5) 90132(2) l?6ill3(5)
Icble III.9 (ccntimed)
SMJCIUFE
0.9% Saline 
CTNIRX
10 nDles/min 
ACENDSINE '
-?
3x10 m/m 
AEHSCSINE
-7
10 mcles/min 
ATP
_?
3x10 m/m 
AEP
Nksaxqdialic Areas
Red Nucleus 1471*28(5) 1?0149(4) 14?H1(4) 152148(3) 1?1134(5)
Substantia Nigra 103±26 (5) 122138(4) 101115(5) 134131(3) 12412? (5)
Superior Cblliculus : 156±21(5) 1961102(4) 161+36(5) 202148(3) 203+46(5)
Inferior Cbllioulus 204+4?(5) 2461118(4) 229138(5) 251160(3) 282198(4)
Ttelexj^ dialuc Areas
Hippccanpus, 
Melecular layer 139+5?(5) 116113(4) 13311? (5) 140118(4) l?8il?(5)
Dentate C^ rus 143±50(5) 122141(4) 134116(5) 164150(4) 156151(5)
Sgptal Nucleus 163+6?(5) 108125(4) 110123(5) 122+49(4) 140158(5)
Cerebellum Nucleus 169119(5) 19?110(3) 1?3153(4) 212138(3) 193121(5)
Oerdellun IfenL- 
sfhare 93+18(5) 85130(3) 115131(4) 104119(3) 124+43(5)
Fibre Tracts
Qsndellun White 55115(5) 53112(3) 66129(4) 8411? (3) ?0129(5)
Gan 69132(5) ; 6?il5(4) ?6136(5) 86130(4) 64111(5)
-1 -i
All values fear local corral blood flew (ml.lOOg .mm .) are expressed 
as mean ± standard deviation.
Table I I I .  10 CCNIRALAIIERAL HEMTSfflEFE: CHANGES IN  ICEF iOTUCED Eg ACENG6INE A1SD AIP
_J2 _a _J2 _^ Z
0.9% Saline 10 nDles/mm 3x10 m/m 10 moles/min 3x10 m/m 
snraxiFE  cc n irX j aeetcsine acensbine; atp atp
Cortical Structures
Visual Cbrtex 156±50(5) 145132(4) 13311? (5) 138+41(4) 155194(5)
Auditory Cbrtex 150+4?(5) l?0+60(4) 152133(5) 23?1124(4) 150+42(5)
Ebrietal Cbrtex 15?+24(5) 160129(4) 162*78(5): 146142(4) 137130(5)
SoTsacy mctcar Cbrtex 16?+45 (5) 139125(4) 133115(5) 164159(4) 160+48(5)
Eicntal Cbrtex ■134+66(5) 142132(4) 132119(5) 164142(4) 143+48(5)
EteErcntal Cbrtex 1591? (3) 1?3±42 (4) 14?i41(5) 183+43(3) 180+40(4)
Anterior CLngulate 
Cbrtex 189156(5) 2441?8(4) 160119(4) 275+121 (4) 1801?4(5)
Edor^halie Areas
tfedial Gaiiculate 164146(5) 1?8156(4) 183142(5) 159l?8 (3) 181162(5)
lateral Gaiiculate 124±34(5) 142123(4) 173+81(5) 192182(4) 164i?0(5)
Ihalanus, Nfedio-
dorsal 152+5? (5) 156+46(4) 12?110(4) 184*7L(4) 159135(5)
Uialarrus, Veitro-
lateral 121 +3?.(5) 126+4? (3) 128138(5) 1631121(4) 140150(5)
HypottHlsmjs 10?±19(5) ; 103130(4) 104+45(5) 160112? (4) 105123(5)
lateral Habaula 154±24(5) 166136(4) 180i?0(5) 212110?(4) 163+40(5)
Arygdala 106±28(5) 10913(2) 73+4 (3) 80122(2) 9116(3)
Caudate Nucleus 234+?0 (5) 138122(4) 1351? (5)* 1891101(4) 187180(5)
Nucleus Accunbaas 1?4±88 (5) 154156(4) 128116(5) 162135(4) 14811? (5)
Glcbus Ibllldus 106±41(5) 80126(4) 82122(5) 1821338(4) 1291?9(5)
Internal Capsule 96131(4) 8618(2) 62111(3) 80129(2) 8214(2)
Subthalamic Nucleus 148135(5) 123130(4) 159111(4) 156+6? (4): 185150(5)
Hindbrain Areas
Vestibular Nucleus 186140(4) 193115(3) 189+44(4) 233184(3) 1291?9 (4)
Superior Olive 2351142(5) 204152(4) 216+46(5) 222i?6(3) 206136(4)
Inferior Olive 194155(3) 216112(2) 124112(2) 2461100(2) 264130(3)
Rns 129+40(5) 96115(4) 94H4 (5) 83128(2) 152+110(5)
Tcble I I I . 10 (acntirudd)
0.9% Saline
-3 _3
10 moles/min 3x10 m/m 10 moles/min
_3
3x10 n^m
SMJC1UFE CQSHRCL AEEN36INE AEBSCSTSE ATP ATP
Nfesax^halic Area
fed Nucleus 146±26(5) 146138(4) 141+13(4) 148152(3) 19*3126(5)
Substantia Nigra 102121(5) 99110(4) 93110(5) 123138(3) 113133(5)
Superior OolliohLus 158123(5) 19*6+69*(4) 153114(5) 155*151(3) 183128(5)
Inferior Oolliculus 202149(5) 199150(4) 235160(5) 192132(3) 2361106(5)
Ttelax^halic Areas
Hifpocsnpus, 
Molecular layer 124115(5) 118116(4) 140114(5) 121+32(4) 146120(5)
Dartale G^ rus 120126(5) 116111(4) 13118(5) 125134(4) 126131(5)
Sqptal Nucleus 156154(5) 105*121(4) 100113(5) 116138(4) 129*159(5)
CfefefeLlum Nucleus 166135(4) 18019(3) 160135(4) 209155(3) 200135(5)
Cerebellum HariL- 
^here 92114(5) 8118(3) 116131(4) 101124(3) 110131(5)
Fibre Tracts
Cfer^ Dellum Phite 55120(5) 4415(3) 60118(4) 63114(3) 72124(5)
Gan 69131(5) 62115(4) 50111(5) 82122(4) 56119* (5)
-1 . -i
All values fear local cerebral blood flow (ml.lOOg . m m  .) are expressed 
as mean ± standard deviation.
Figures in paraitheses indicate n value
*P<0.05 (Studait's t-test, incxzpczating Bcnferrcni cracnactim factor corparing each 
corpourd to cmtrol).
liable I I I .  11 SSHATERAL HEM3SEHETE: CHASCES IN  KEF HCDGCED E5T CHA, 2GAD0 and NECA
0.9% Saline 10 Proles/mm 10*"^ moles/min 10 ^moles/min 
SMETOFE (XNHCL CHA 2-CADO NECA______
Cbrtiml Structures
Visual Cbartex 126+34(8) 94117(6) 114125(6) 190194(5)
Auditcay Gcartex 128127(8) 89+37(6) 122138(6) 180+88(5)
Ibriefcal Cbrtex 151152(8) 95130(6) 124124 (6)> 147143(5)
SaTscsry Motor Cbrtex 165132(8) 93118(6)* 136136(6) 159135(5)
Frcntal Cbrtex 144117(8) 108116(6)* 126126(6) 168140(5)
Erefrmfcal Cbrtex 148148(6) 122130(4) 132+49(4) 186152(3)
Anterior Cingulate 151148(8) 110130(6) 131130(6) 196185(5)
Diecgdialic Areas
Madial Gaticulate 131136(8) 86116(6)* 115139(6) 141137(5)
lateral GarLculate 106136(8) 68111(6)* 113116(6) 109+44(5)
Ibalarrus, Nbdicdorsal 145172(8) 99125(6) 98+43(5) 150154(5)
Hialanus, \fe±rolaferal 145172(8) 82117(6) 101+49(5) 106135(5)
Hypothalamus 86127(8) 76122(6) 68112(6) 94132(5)
lateral ffibanla 133134(7) 91118(6)* 118131(6) 137150(5)
Caudate Nucleus 153129(8) 99134(6)* 128128(6) 129126(5)
Nucleus Aocunbans 120125(8) 93128(6) 113+49(6) 141152(5)
Glcbus Ballidus 109126(8) 77110(6)* 67118(6)* 94135(5)
Sufottelamic Nucleus 153126(8) 122+18(6) 128118(6) 157149 (5)
irdorain Areas
\festibular Nucleus 169+40(8) 122+28(6) 140114(3) 176137(4)
Superior Olive 174138(8) 13116(6)* 139120(6) 163+47(5)
Inferior Olive 158+46(8) 127123(5) 119124(5) 160+48(3)
Res 102129(8) 76112(6) 78H0 (6) 86118.(4)
Tbble III. 11 (ccnfcinued.)
—10 —9 —*ii
0.9% Saline 10 noles/min 10 noles/nun 10 nDles/min
S3HCT3FE
Nfesax^halic Areas 
fed Nucleus 
Substantia Nigra 
Superior Cblliculus 
Inferior Cblliculus
(XNIKL
146129(8) 
109122(8) 
143134(8) 
196163(8)
CHA 2-CADO NECA
111+17(6)
86113(6)
106113(6)
136125(6)
110+8(6)*
82115(6)
13786(6)
132117(6)
138141(5)
113144(5)
142146(5)
196159(4)
Teleic^balic Areas 
Hippocanpus,
Mclecular layer 322129(8)
Eaibate Gyrus 115124(8)
Septal Nucleus 91118(8)
Cerebellum Nucleus 175H7(7)
Ganduellum feni^here 86117(8)
87126(6)
83114(6)*
71+10(6)
131+25(6)*
6219(6)*
105132(6)
107+39(6)
70126(6)
U7±33(5)*
6917(5)
104130(5)
104130(5)
98130(5)
136133(5)
82128(4)
Fibre Tracts 
Oanduellum Write 
Gau
50121(8)
50121(8)
38112(6)
34+8(6)
4617(4)
4719(6)
52117(5)
61+15(5)
-1 . -1All values fear local cerdural blood flow (ml.lOOg . imn ) are eqatessad as rrean 1 
standard dadatim.
Figures in parmtbeses indicate n value.
*P<0.05 (Student’s fr-best, iirraporating Bcnferrmi cnrrectim fectrar,ccnparing 
each caipourd to cmtrol.)
Table III. 12 aJflEALAJERAL HEMISfflEFE: OEN3ES IN KEF HOXJCH) W  CHA, 2-CADO and NECA.
-10 -9 -110.9% Saline 10 noles/min 10 noles/min 10 itDles/min
SMJCTORE CENIKIj CHA. 2-CADO NECA_____
Chrtdcal Structures
Visual Cbrtex 142±44(8) 103124(6) 92135(6) 159197(5)
Auditory Cbrtex 126±32(8) 105129(6) 95150(6) 151178(5)
Ibrietal Cbrtex 149144(8) 103119(6) 99124(6) 148191(5)
Smsary Mater Cbrtex 194149(8) 108110(6)* 105130(6)* 136164(5)
Frcntal Cbrtex 151140(8) 120111(6) 108129(6) 149158(5)
Erefrmtal Cbrtex 148146(6) 128116(4) 120124(4) 195139(3)
Anterior CLngulate Cbrtex
0088 119128(6) 101146(6) 218192(5)
niHr^balic Areas
Madial GatiouLate 131141(8) 9219(6) 103153(6) 144+45(5)
lateral Gariculate 121+38(8) 81118(6) 106136(6) 126152(5)
Ibalanus, Madiadcrsal 15:l£5(8) 103125(6) 101152(5) 139155(5)
Ihalsnus, ^ ±rolateral 128139(8) 84H1(6) 86124(5) 105+45(3)
Hypotbalanus 89120(8) 65116(6) 62110(6) 95138(5)
lateral Ifebaula 129128(9) 93123(6) 113136(6) 139+48(5)
Caudate Nucleus 148153(8) 10919(5) 105122(6) 112+48(5)
Mcleus Axunfoens 120138(8) 106131(6) 101124(6) 138160(5)
Glcbus Ibliidus 112+30(8) 66119(6)* 99112(6) 91134(5)
Subthalamic Nucleus 154139(8) 134115(6) 120120(6) 162168(5)
Lrdarain Areas
Vestibular Nucleus 169139(8) 119125(6) 133123(3) 182148(4)
Cbchlear Nucleus 148+16(6) 134+11 (2) 10014(2)* 166132(2)
Superior Olive 199+43(8) 135114(6) 131129(6) 155160(5)
Inferior Olive 162139(8) 129121(5) 115130(5) 159146(3)
Ebns 102+26(8) 76114(6) 9918(6) 89129(4)
Tcble III.12 (oanfcinued)
S I R n H i F E
>fesenc^ ±alic Areas 
Rad Ntcleus 
Substantia Nigra 
Superior Cblliculus 
Inferior Oollioulus
0.9% Saline 
CCNIKXj___
138+26(8) 
100119(8) 
144131(8) 
205+?? (8)
—10 —9 -11
10 rroles/rrrLn 10 noles/rnin 10 noles/min
C H A 2-CADO
105H3(6)*
89111(6)
10819(6)
142125(6)
NECA
108111(6)
99111(6)
118119(6)
139126(6)
139+42(5)
114139(5)
140+49(5)
193159(4)
Iblax^halio Areas
Hifpocsnpus, Malecmlar
l£§er 123+42(8) 90125(6) 97131(6) 109+48(5)
Dentate Gyrus 114131(8) 91119(6) 99136(6) 111146(5)
Septal Nucleus 93H5(8) 94112(6) ^129(6) 9=9t36(5)
OEsebellum Nucleus 166115(8) 133128(6)* 116133(5)* 128138(5)
OsrteDellum Iferdsftere 85119(8) 6415(6)* 90+9(5) 82128(5)
Fibre Tracts 
Cerebellum Vtoite 
Gem
51122(8)
53112(8)
38+4(6)
42111(6)
52113(4)
4518(6)
51116(5)
62125(5)
-1 -1All values fear local aentoral blood flow (ml.lOOg .iron ) are expressed as 
neanistandard deviation.
Figures in parentheses indicated n value
*P<0.05 (Student's t-test, iirorpcmtirg Bcnfemni ocazecticn factor, corparing 
each cnrpound to control).
Table III.13 SSHAIEKAL HEMISfflHFE: CHSNSS IN KEF HEDCJCED E£ VARIOUS COCENIMIlCaE
CF cm
-10 -11 -120.9% Saline 10 noles/min 10 noles/min 10 noles/min
SMJCTUFE dNffd CHA. CHA CHA
Cbrfcioal Structures
Visual Cbrtex 126+34(8) 94±1?(6) 101135(5) 97134(4)
Auditory Cbrtex 128+2? (8) 89±3?(6) 111145(5) 100133(4)
Ibriefcal Cbrtex 151±52(8) 95130(6) 100153(5) 99+43(4)
SaiscaY Mctrar Cbrtex 165+32(8) 93±18 (6) * 126159(5) 126156(4)
Ercntal Cbrtex 144+1?(8) 108116 (6)* 119153(5) 118+45(4)
Erefrcnfcal Qxtex 148±48(6) 122130(4) 130169(4) 115130(4)
Anterior Cingulate Cbrtex 151+48(8) 110130(6) 134+49(5) 142155(4)
Djaxqftalic Areas
jyfeclial Geniculate 131136(8) 86116(6)* 118+42(5) 86126(4)
lateral Geniculate 106136(8) 68111(6)* 79143(5) 75121(4)
Unalarrus, Jfeciiocbrsal 145i?2(8) 99125(6) 104128(5) 109137(4)
Ohalanus, ^ fentrolateral 145+72(8) 82+1? (6) ‘ 85134(5) 75125(4)
I^ pothalanus 8612?(8) 76122(6) 61119(5) 56124(4)
Lateral ffibanla 133134 (?) 91+18(6)* 105134(5) 120+45(4)
Anygdala 85128(6) 60121(2) 59122(5) 47+16(3)
Ctedate Mncleus 153129(8) 99134(6)* 128159(5) 139165(4)
Nucleus Axuibans 120125(8) 9312?(6) 9312? (5) 94130(4)
Glcbus Ibllidus 109126(8) ??110(6)* 7611?(5) 89132(4)
Interral Capsule 65112(6) 51123(2) 42116(5) 42113(3)
SubttBlamic Nucleus 153126(8) 122+18(6) 126154(5) 148137(4)
incbrain Areas
f^esribular Nucleus 169+40(8) 122+28(6) 142147(5) 135138(4)
Superior Olive 1?4138(8) 13116(6)* 152137(5) 164+48(4)
Inferior Olive 158+46(8) 127123(5) 136119(5) 144116(4)
Bans 102129(8) 76112(6) 85118(5) 76116(4)
TSble III.13 (cmtimed)
—10 —11 —12
0.9% Saline 10 noles/min 10 noles/min 10 noles/min
SMJCTUFE CCNMXi
Mssancgiialic Areas 
Rad Nucleus 146+29(8)
Substantia Nigra 109122 (8)
Superior COlldoulus ; 143134(8)
Inferior Cblliculus 196163 (8)
CHA CHA CHA
111117(6)
86113(6)
106113(6)
136125(6)
125143(5)
8919(5)
120122(5)
142+41(5)
116137(4)
86124(4)
125119(4)
136144(4)
Talarqdialic Areas
Hippocanpus, Molecular
layer 122129(8) 87+26(6) 96130(5) 95125(4)
Dentate Gyrus 115124(8) 83114(6)* 90128(5) 86127(4)
Septal Nucleus 91118(8) 71+10(6) 79128(5) 81133(4)
Cerebellum Nteleue 175+17(7) 131125(6)* 134153(5) 148+45(4)
Cfer^ ellun Hatii^ here 86117(8) 6219(6)* 67118(5) 68119(4)
Fibre Tracts 
Gardnelluin fthibe 
Gsrn
50121(8)
50121(8)
38112(6)
34+8(6)
44114(5)
39114(5)
34110(4)
45115(4)
-1 -1All values fear local oerdaral blood flew (mL.lOOg .non ) are expressed as 
rrean 1 standard deviation.
Figures in parentheses indicate n value.
*EK0.05 (Student's t-test, inocrpcmting Bcnferrcni correction factor, enrparing 
each ompound to ocntrol.
Table I I I .  14 aNERLATEmL HEMISffiEFE: OEN3ES IN  KEF HCDUCED E£ VPELOJS OKENIEftTIQSS
cf cm
-10 -11 -120.9% Saline 10 riDles/min 10 noles/min 10 rrDles/rnin
smjciufe ccnikXj cm cm cm____
Oartdcal Structures
Visual Cfcctex 142144(8) 103124(6) 116136(5) 106143(4)
Auditory Oarbex 126132(8) 105129(6) 128158(5) 109138(4)
ferietal Oartex 149144(8) 10311^ ; (6) 114149(5) 119154(4)
Saisay Wbta: Cbrtex 194+49(8) 108110(6) 141166(5) 140168(4)
Ercntal Qarbex 151140(8) 120111(6) 131162(5) 140143(4)
Prefrcntal Oxtex 148146(6) 128116(4) 142184(4) 126140(4)
Anterior Cirgulate 
Gartex 145143(8) 11?128(6) 143152(5) 148155(4)
Edax^halic Areas
Msdial Gaiiculate 131141(8) 9219(6) 109128(5) 89128(4)
lateral Gaticulate 121+38(8) 81118(6) 82146(5) 98128(4)
Ihalarus, Nfediodarsal 15Ht5(8) 103125(6) 104129(5) 114+44(4)
Tialanus, \fe±rolateral 128139(8) 84111(6) 96139(5) 90135(4)
P^potolarus 89120(8) 65116(6) 62119(5) 65124(4)
lateral Ekbaula 129128(9) 92123(6) 110136(5) 130158(4)
Amygdala 86125(6) 65116(2) 92129(5) 59123(3)
Caudate Nucleus 148153(6) 10919(5) 145+45(5) 142169(4)
Nucleus Aruteis 120138(8) 106131(6) 102122(5) 104123(4)
Glcbus lallidus 112130(8) 66119(6) 98129(5) 96134(4)
Internal C&psule 66112(6) 55119(2) 50116(5) 49119(3)
Subttelanrio Nucleus 154+39/(8) 134115(6) 166132(5) 148+46(4)
iirtarain Areas
Vestibular Nucleus 169139(8) 119125(6)* 145152(5) 134132(4)
Cbchlear Nucleus 148116(6) 134+11 (2) 142151(3) 151+51(4)
Superior Olive 199143(8) 135114(6) 161120(5) 183159(4)
Inferior Olive 162139(8) 129121(5) 129119(5) 144136(4)
Res 102126(8) 76114(6) 83116(5) 85120(4)
Tbble 111.14 (ant±ued)
-10 -110.9% Saline 10 noles/min 10 nDles/min
SMJC1UFE CDSDKXj
IVfeggx^ halic Areas 
Ited Nucleus 138126 (8)
Substantia Nigra 100119 (8)
Superior Galliculus ; 144131(8)
Inferior Oalliculus 205199(8)
CHA CHA
105113(6)*
89111(6)
10819(6)
142125(6)
116133(5)
90110(5)
133129(5):
149152(5)
Ttelax^halic Areas
Hippocanpus, Malecular
Ia^er 123142 (8)
Deitate Gyrus 114131(8)
S^tal Nucleus 93H5 (8)
Gsndoellum Nucleus 166115 (8)
Cerebellum ffemi^ here 85119(8)
90125(6)
91119(6)
94112(6)
133128(6)*
6415(6)*
102134(5)
94125(5)
84128(5)
133+92(5)
68121(5)
Fibre Tracts 
Qandrellim Write 
Gan
51122(8)
53112(8)
38+4(6)
42111(6)
45115(5)
41116(5)
-I . -IAll values fear local cerebral blood flow (ml.lOOg .mm ) are expressed as
nean 1 standard deviation.
figures in parentheses indicate n value
*P<0.05 (Sfaufent's t-best, inoarpcaating Bcnferrcni ocsrrecticn iacfcar, 
ocnparing each cnrpound to ocntrol).
-1210 nDles/min
cm
118134(4)
99125(4)
136139(4)
150+48(4)
104126(4)
92130(4)
85135(4)
146+45(4)
91+19(4)
3419(4)
44114(4)
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liable I I I . 18 nSHMERSL HEMISfflEFE: CHANGES IN  ICGU HOXEED EZ ACBLB3NE,
2-cado, cm akd m
_2Z _ n  _1A _ T 1
0.9% Saline 3x10 noles/min 10 mcles/m 10 moles/m 10 males/m 
SMJCIUFE (XNIKL AEENDSUSE 2-CADO CHA NECA______.
tortical Areas 
Visual Gcrtex 108115 (5) 110120(5) 140134(5) 132+25(4) 130119(5)
Auditory Cbrtex 112+14(5) 111+19(5) 138130(5) 150122(4) 128115(5)
Parietal ttrtex • 101±26(5) 98118(5) 115122(5) 120120(5) 120128(5)
SaTscay Nbtor (Mex 101121(5) 101120(5) 106116(5) 10515(5) 116130(5)
Frcnbal Cortex 101122(5) 102113(5) 109116(5) 116110(5) 119123(5)
Etefrcnfcal Cortex 119+20(5) 133121(5) 122128(5) 143121(5) 136114(5)
Anterior Cingulato •
CtdEX 130135(5) 128128(5) 142114(5) 145125(5) 140121(5)
ter^halic Areas
Madial (Maculate 84116(5) 95112(5) 99133(5) 98135(5) 89111(5)
Lateral Gaiiculate 95123(5) 98116(5) 89122(5) 99116(5) 88124(5)
Tbalarrus, Nfedio-
cbrsal 96119(5) 96125(5) 101119(5) 103121(5) 110+12 (5)
Ihalarrus, Vaitro-
lateral 82110(5) 85124(5) 82116(5) 85+8(5) 92119(5)
H^ pothalamas 64112(5) 62119(5) 98135(5) 90135(5) 69115(5)
lateral Haaanla 98129(5) 106131(5) 101118(5) 119118(5) 110120(5)
Anygdala 53135(5) 54135(4) 66111(4) 6016(5) 65113(5)
Caudate Nucleus 126122(5) 332132(5) 129116(5) 14219(5) 135132(5)
Ktocleus Axunbais 109132(5) 96125(5) 103111 (5): 119124(5) 116124(5)
Glcbus Fallidus 64111(5) 90119(5) 94114(5) 9616(5) 81+23(5)
Internal capsule 40116(5) 44111(4) 36117(4) 53135(5) 46110(5)
Subthalamic Nucleus 91115(5) 103126(5) 101114(5) 109118(5) 119+25(5)
lincbrain Areas
\festibular Nucleus 109121(5) 112+20(5) 119133(5) 331112(5) 121+12(5)
Superior Olive 95126(5) 92112(5) 93H5(5) 313118(5) 112+14(5)
Inferior Olive 103121(5) 98118(5) 108135(5) HOHO (5) 106122(5)
Rus 64112(5) 92114(5) 85110(5) 82114(4) 92113(5)
Icfole III.18 (cmtinusd)
—9 -9 —in —11
0.9% Saline 3x10 nDles/min 10 moles/m 10 moles/m 10 moles/m
SIRETUFE CCNHCL ACENDSINE 2-CADO CHA NECA______
Mssax%fralic Areas
Red Nucleus 84+22 (5) 89112(4) 104130(4) 9515(4) 91119(5)
Substantia Nigra 
Cfcnpacta 86119(5) 94115(5) 114138(5) 101128(4) 91118(5)
Substantia Nigra 
Iteticulata 90118(5) 94116(5) 84128(5) 81+12(4) 80123(5)
Superior Cblliculus 98113(5) 106118(5) 110124(5) 12019(5) 109122(5)
Inferior Cblliculus 104123(5) 111+23(5) 128131(5) 131122(4) 132115(5)
telergdalic Areas
Hippocanpus 
Mclecular layer 129116(5) 128114(5) 145129(5) 138115(4) 124121(5)
Deitabe G^ rus 109121(5) 106110(5) 111+29(5) 113110(4) 109119(5)
Sqstal Nucleus 90110(5) 83118(5) 89114(5) 88114(5) 88112(5)
Cerebellum Nucleus 103128(5) 114119(5) 133128(5) 129111(5) 122128(5)
Cenriellum .Ifeni- 
d^iere
63114(5) 63113(5) 99110(5) 6618(5) 90110(5)
ibre Tracts
Cerebellum Write 46113(5) 44113(5) 53110(5) 4219(5) 44112(5)
Ctarpus Callcsum 48112(3) ! 54122(4) 60122(5) 4619(3) 60110(5)
Gan 49+16(5) 58121(5) 69110(5) 69115(5) 68117(5)
-1 -1All values fear local asntoral glucose utilisatim (urol.lOOg .min ) are stressed as 
meanlsfcanckrd deriatim.
Figures in pargitheses indicate n value
Table I I I . 19 CCNIKALADERALj HEMCSfflERE: CHANGES IN  KGUIRXUDED BY- AESSCSINE,
2-CADO, CHA AND NECA
—9 -9 —10 —11
0.9% Saline 3x10 noles/min 10 noles/m 10 noles/m 10 nDles/min
SMJCIUFE CCNIKXj AEHSCSIISE 2-CADO CHA NECA
Ccrtical Areas
Visual Oartex 109125(5) 111+25(5) 339+43(5) 120123(4) 122+19(5)
Auditory Cbrtex 108120(5) 106118(5) 129138(5) 13218(4) 122+16(5)
ferietal Qxtex 104132(5) 106120;© 109125(5) 114125(5) 123129(5)
Sensory Motor Cortex 89129(5) 98115(5) 103113(5) 95+6(5) 110121(5)
Etental Cortex 96123(5) 90113(5) 101121(5) 102111(5) 116123(5)
Erefrcntal Cortex 101118(2) 114124(4) 115123(5) 139119(5) 136112(4)
Anterior Cingulate 
Cortex 126133(5) 323128(5) 338124(5) 142125(5) 14119(5)
Ddox^balic Areas
Madial Gaticulate 99119(5) 92113(5) 102129(5) 9619(4) 90112(5)
lateral Geniculate 99128(5) 81120(5) 94116(5) 96123(5) 81119(5)
Thalamus, tfedio- 
dxsal 95118(5) 93119(5) 102120(5) 100122(5) 113111(5)
Thalamus, Vantro- 
lateral 8219(5) 81+28(5) 85136(5) 85114(5) 89120(5)
Hypothalamus 63111(5) .63116(5) 80119(5) 91+11(5) 90116(5)
lateral Habemula 94131(5) i04125(5) 104114(5) 119119(5) 108122(5)
Arrygdala 53118(5) 59114(4) 66+6(4) 60+8(5) 63116(5)
Caudate Nucleus 116110(5) 323122(5) 119122(5) 139119(5) 134126(5)
Nucleus Axurbans 101123(5) 100125(5) 105+19(5) 110135(5) 113123(5)
Glduus I^ llldus 55128(5) 69120(5) 9618(5) 9315(5) 85124(5)
Internal capsule 39116(5). 36122(4) 4416(4) 51112(5) 4419(5)
Subthalamic Nucleus 96133(5) 101129(5) 105135(5) 104118(5) ■ 116124(5)
Lrrbrain Areas
fetdbular Nucleus 106116(5) 109115(5) 122+21(5) 131110(5) 121+12(5)
Superior Olive 92123(5) 90110(5) 96+15(5) 118121(5) 112+14(5)
Inferior Olive 114114(3) 99119(5) 108123(5) 11619(5) 106122(5)
Rns 66114(5) 68115(5) 85112(5) 98133(4) 92113(5)
Table I I I . 19 (cxntirijed)
_9 -g _io -21
0.9% Saline 3x10 nDles/min 10 noles/m 10 noles/m 10 noles/min 
SMTIUFE aZNIKL AEESDSINE 2-CADO CHA NECA _____
ffesanogdnalic Areas
R3d Nucleus 84+23(5) 89114(4) 105132(4) 9918(4) 92122(5)
Substantia Nigra 
Cfcnpacta 88135(5) 93119(5) 113138(5) 105128(4) 91+22(5)
Substantia Nigra 
Reticulate 91+16(5) 68116(5) 99128(5) 81118(5) 81129(5)
Superior Cblliculus 99135(5) 104114(5) 114128(5) 121+10(5) 109119(5)
Inferior Cblliculus 104121(5) 113130(5) 128130(5) 126116(4) 330119(5)
elanc^balic Areas
Hippocanpus 
JVblecular layer 122+23(5) 114119(5) 119129(5) 133122(5) 122118(5)
Dentate Qrus 110120(5) 99116(5) 107124(5) 115115(5) 103119(5)
Sgptal Nucleus 69112(5) 84119(5) 83118(5) 84113(5) 88116(5)
Cerebellum Nucleus 101129(5) 100H4 (5) 138129(5) 133H6 (5) 325134(5)
Osndnellum Hemi.- 
qdnere 60112(5) 63110(5) 83+12(5) 92110(5) 69111(5)
Fibre Tracts
Cerebellum Write 43111(5) 41+13(5) 59+13(5) 43±20(5) 42±13(5)
Oarpus 'Callosum 48±16(5) 55121 (4) 62120(5) 52132(3) 5918(4)
Gan 45112(5) 51+20(5) 6619(5) 6015(5) 65118(5)
-1 -1All values fear local cerferal glucose uti lisatim (prol.lOOg . min ) are expressed 
as maan 1 standard deviation.
Figures in parentheses indicate n value.
All 
values 
are 
expressed 
as 
meanistandard 
deviation. 
*P<0.01 
(Student's 
t-test 
incorporating 
Bonferroni 
correction
factor 
comparing 
drug 
treated 
value 
with 
control 
value.
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Table I I I . 21 THE EFFECT CF TOECHMT.TNE CN IHE CHANGES IN  KEF HOECED Ef
A 15 MMHE INEUSICN CF CHA (IPS3IA1EPAL HEMTSfflEFE
-m . -10
0 . 9 %  S a l i n e  1 0  n D l e s / m i n  C H A  0 . 9 %  S a l i n e  1 0  n o l e s / m m  C H A
1.c*5ml/kg i.c.+5ml/kg i.c.+3Cftg/kg. i.c.+30ng/kg
Structure saline i.p. saline i.p. tiecpbylline ttecphylline
 _____        i.p. i.p.________
Qxtical Areas
Visual cortex 126±32(16) 106123(12) 122120(9) 139163(9)
Auditory cortex 13012? (16) 111+39(12) 149139(9) 159156 (9)0
larietal cortex 140±40(16) 11?136(12) 165140(9)d 139149(9)
SaTScry-nota:
cortex 156+35(16) 114131 (12)a 19813?(9)d 154145 (9)0
Frcntal cortex 149+22(16) 119122(12) 169130(9)d 146+48(9)0
EreErcntal cortex 143±3? (14) 123133(9) 160116(9) 141134(8)
Anterior cdngulate 
cortex 143142(16) 130139(12) 190138(9) 138133(9)
Edanc^balic Area
Madial geniculate
001 101125(12) 119131(9) 130+45(9)
lateral geniculate: 98130(16) 80120(12) 92123(9) 93122(9)
Halcnus, Madio- 
dorsal 129155(16) ' 114136(12) 119128(9) 104119(9)
Unalamjs, vmtro- 
dorsal 122159(16) 88120(12) 106125(9) 92118(9)
IfypoEbalarrus 99122(16) 96119(12) 93119(9) 68116(9)
lateral babaula 120132(15) 104121(12) 113129(9) 105118(9)
Anygdala 82124(14) 64111(9) 72113(8) 65111(8)
Caudate nucleus 152133(16) 114130 (12)a 133124(9) 125+41(9)
Nucleus accunbans 119141(16) 102128(12) 116134(9) 94129(9)
Glcbus pallidus 103125(16) 81116(12) 88118(9) 81126(9)
Internal capsule 66115(14) 5219(7) 54111(8)b 49ill(8)C
Subthalamic
nucleus 152123(16) 134129(12) 142149(9) 121+31(9)
incbrain Areas
Vestibular nucleus 163137(16) 139131(12) 141132(9) 194139(9)
Qxhlear nucleus 154130(9) 128+49(5) 136129(8) 151149(9)
Superior olive 166135(16) 136H?(12) 135131(8) 140150(8)
Inferior olive 150136(16) 134122(12) 114121 (9)b 118122(8)°
Rns 96124(16) 82113(12) 99+13(9) 92149(9)
Tcible I I I . 21 (cm tirued)
Strucbure
0.9% saline
1.c.+5mL/kg 
saline i.p.
.-10 -1 010 nDles/min CHA.10 nDles/min CHA 0.9% saline
i.c.+5ml/kg i.p.430rrg/kg i.c.+3Qmg/kg
saline i.p.  thecf±ylline i.p. thscrfoyllline i.p
lYfesaegdelic Areas
Ited Nucleus 134129 (16) 122123(12) 114126(9) 131181(9)
Substantia nigra 98±21(16) 89116(12) 82120(9) 82125(9)
1l
136132(16) 118122(12) 11512? (9) 136165(9)
Infericr colliculus 17515?(16) 151126(12) 159136(9) 2021104(9)
Ifelaxephalic Areas
Hippocanpus, 
MDlecular layer 117132(16) 95126(12) 106125(9) 108152(9)
Dentate gyrus 10812?(16) 9211? (12) 98122(9) 101142(9)
Sgptal nucleus 88118(16) 85121(12) 84120(9) 80125(9)
Gen&ellum nucleus 163132(15) 141136(12) 158133(9) 163158(9)
Cerebellum hari- 
sjdiere 78116(16) 69113(12) ?9il?(9) 80132(9)
Fibre Tracts
CferdDellum vbite 47116(16) 42111(12) 43112(9) 41+14(9)
Cbrpus callosum 50114(16) 56125(12) 60127(9) 4118(9)
Gem 47116(16) 39119(12) 4619(9) 4219(9)
All values are for local central blood flew (mi.lOQg ^.rrrin
-1
) expressed as mean ±
standard deviation.
Figures in parentheses indicate n value.
i.e. indicates that the corpound was administered via tie right internal carotid artery.
i.p. indicates tint tie oenpound vas adninistered inlxaperitrneally.
a, b and c-indicates significant differsre frcm saline i.c./saline i.p. groups;
d and e - significant difference frcm CHA i.c./saline i.p. group;and
f - significant difference frcm saline i.c./tiecpiyllire i.p. group
(PC0.05 - ere way analysis of variance with IfeJTarrffeubnultiple range test)
Table I I I . 22 THE EFFECT CF THECEHYIT.TNE CN THE OffiNGES IN  KEF HCDUCED E£
A 15 MMJIE INFIEICN CF CHA (QZMTALMEFAL HEMISEHEKE)
0.9% saline 10 ^ Sroles/iran CHA 0.9% saline 10 ^ noles/mm CHA
1.c.+5ml/kg i.c.+5ml/kg i.c.+30ng/kg i.c.+3ftrg/kg
S1KJC1U.KE saline i.p. saline i.p. tbecphyllins i.p. ttecphylline i.p.
Qxtical Areas
Visual cnrtex 133+40(16) 113+28(12) 132423(9) 140177(9)
Auditory axtex 126426(16) 128438(12) 154440(9) 163459(8)
ferietal cortex 138438(16) 123426(12) ' 175441 (9)d 152452(9)
SaBary-motar axtex 163±41(16) 128426(12) 191444(9)d 162441(9)0
Ercntal axtex 147437(16) 128417(12) 184439 (9*P'd 151443 (9)^
Erefrcntal axtex 141437(14) 136423(12) 175420(7) 144434 (8)f
Anterior cdngulate 
cortex 140+42(16) 140444(12) 171441(9) 137431(9)
Dier^halic Areas
Nfedial gauiculate 114436(16) 113431(12) 116439(9) 132455(9)
lateral geniculate 104435(16) 91420(12) 96+25(9) 94421(9)
Thalamus, IVfedio- 
dxsal 128459(16) 116435(12) 116432(9) 101417(9)
Thalamus, vaitro- 
lateral 110438(16) 95420(12) 100428(9) 91416(9)
Hypothalamus 79420(16) 76423(12) 76418(9) 67412(9)
lateral habaula 118427(16) 103420(12) 119437(9) 106417(9)
Aiygdala 86424(14) 76412(8) 79416(8) 70412(8)
Cboudate nucleus 151440(16) 128422(12) 135428(9) 124426(9)
Nucleus aacunbans 116439(16) 113430(12) 112+25(9) 100429(9)
Glcbus pallidus 106426(16) 90418(9) 90418(9) 85427(9)
Internal capsule 67414(14) 6048(7) 62411(8) 5249(8)
Subthalamic nucleus 154434(16) 138428(12) 138441(9) 125431(9)
indxain Areas
\festibular nucleus 156436(16) 138431(12) 146437(9) 170479(9)
Cochlear nucleus 161432(12) 153430(7) 147441(9) 151447(5)
Superior olive 184441(16) 145423(12) 148425(9) 154451(8)
Inferior olive 156433(16) 139426(12) 11942? (9)b 120427(8)*
Rns 94422(16) 84416(12) 79413(9) 91+50(9)
Icfole III.22 (cmtirued)
0.9% saline 10 nDles/min CHA. 0.9% saline 10 moles/min CHA
1.c.+5ml/kg i.c.+5mL/kg i.c.+30ng/kg i.c.+3ftrg/kg
3MJU1UHE saline i.p. saline i.p.______ thec£hylline i.p. ttecphyiline i.p.
Nfesax^ tealic Areas
Rad nucleus 131±26(16) 120126(12) 108122(9) 129173(9)
Substantia nigra 95±19(16) 94113(12) 79116(9) 78125(9)
|I
134131 (16) 124125(12) 116127(9) 135173 (9)
Inferior oolliculus 184+66(16) 162130(12)' 168135(9) 198198(9)
aler^halic Areas
Hippocanpus, 
Mblecular layer 115136(16) 98128(12) 109124(9) 115152(9)
Dentate Gyrus 108127(16) 101122(12) :9912519) 107150(9)
Septal nucleus 89117(16) 89121(12) 88118(9) 82124(9)
Cerebellum nucleus 163130(16) 145142(12) 160143(9) 163149(9)
Cerebellum bent- 
qteere 80114(16) 70112(12) 80118(9) 79128(9)
ibre Tracts
Cerebellum vbite 50117(16) 4019(12) 40110(9) 45112(9)
Cbrpus callosum 66132(16) ; 60127(12) 56123(9) 4118(9)
Gan 50110(16) 45110(12) 46112(9) 43110(9)
-1 . -1)All values are for local cen±ral blood flow (ml.lOOg .mm ©pressed as 
msan 1 standard deviation.
Figures in pareitheses indioats n value.
i.e. indicates that tee corpound vas administered via tee right interal carotid artery.
i.p. indicates teat tee oarpourd vas adninistered intraperiteneally.
b and c - indicates a significant difference from saline i.c./saline i.p. group;
d and e - significant difference from CHA i.c./saline i.p.? and
f significant difference frcm saline i.c./teeqdylline i.p. group
(PC0.05 - ere vay analysis of variance wlte Ngwran-Keuls nultiple range test).
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Table 
III.23 
PHYSIOLOGICAL 
PARAMETERS 
MONITORED 
DURING 
THE 
THEOPHYLLINE/15 MINUTE 
CHA. 
INFUSION 
STUDY
Table I I I . 24 H5HA3EEAL HEMSfflERE CHANGES IN  ICEF FRUDCED Ef
2 MINUIE5 INEIBIOSS CF AEEMKDSE M 3  CHA.
_3 -in
3x10 nDles/miii 10 nDles/min
SMJOIHE 0.9% Salim: AEE1C63NE: CHA._____
Cortical Aceas
Visual axtex 133120(6) 13?114(4) 143151 (?)
Auditory axtex 329131(6) 156126(4) 160145 (?)
Parietal axtex 121+21(6) 150130(4) 15815? (?)
Sausaynotnr axtex 122123(6) 143120(4) 162151 (?)
Fractal axtex 122120(6) 146124(4) 163+64 (?)
Etefrcntel axtex 142150(6) 189126(4) 1?4166(?)
Anterior cdngulate axtex 138128(6) 260+80(4)* 2551184 (?)
Edm^halic Areas 
Nbdial geniculate 109±32(6)
lateral gaciculate 85±16 (6)
Uialanus, nedicdorsal 102+52(6)
Thalanus, vootrolateral ?6+20 (6)
Hypothalamus 69+20 (6)
lateral babemla 101136 (6)
Anygdala 65113(6)
Cardate nucleus 123124 (6)
Nucleus accunbacs 106132(6)*
Glcfaus pallidus 98120(6)
Internal capsule 551? (6)
Subthalamic nucleus 146+45 (6)
335121(4)
109114(4)
145112(4)
109112(4)*
8419(4)
136128(4)
81118(4)
164121(4)
132115(4)
102116(4)
64113(4)
186113(4)
140+40 (?) 
102130 (?) 
116148 (?) 
95125 (?) 
?5+21(?) 
10?136 (?) 
8412? (?) 
160150 (?) 
146+62 (?) 
103+41(?) 
6411? (?) 
18316? (?)
Hindbrain Areas 
\fesdhilar nucleus 
Cbchlear nucleus 
Superior olive 
Inferior olive 
Etns
132113(6)
142120(4)
153111(6)
128133(6)
80110(6)
155139(4)
1?1±4?(4)
132122(4)
99112(4)
15?+35(?) 
l?l+46 (3) 
182132 (?) 
158+40 (?) 
96124 (?)
/
Icble III.24(ocntinu9d)
SMJCIUFE
jyfesahc^ dialic Areas 
Red nucleus 
Substantia nigra 
Superior colliculus 
Inferior colliculus
0.9% Saline
111114(6) 
?9115(6) 
122122(6) 
144H8 (6)
-? -103x10 nDles/min 10 noles/min
ADENDSINE
148115(4)* 
10811?(4)* 
158135(4) 
180135(4)
CHA
13515 (?) 
10?i40 (?) 
149139 (?) 
159135 (?)
Tblgogdialic Areas
Hippxanpus, rrDlecular 
layer
Doctate gyrus 
Sgptal nucleus 
Geiteuellum nucleus 
Osrricellum henisphare
9611?(6) 
92110(6) 
82H9 (6) 
148121(6) 
6?112(6)
121115(4)
10819(4)
102128(4)
156120(4)
?6il2(4)
122141 (?) 
112128 (?) 
10613? (?) 
163123 (?) 
?8114(?)
Fibre Tracts 
Osrriuellum vbite 
Cbrpus callosum 
Gan
35110(6) 
441? (6) 
4118(6)
44114(4)
66116(4)*
54111(4)
4?122 (?) 
62123 (?) 
50121 (?)
< —1 —1All values fcr local oer^xal blood flew (ml.lOOg .rrrin ) are sqxessed
as rrean 1 standard dsviatim.
FLgrues in parmLheses indicate n value.
* K0.05 (Studait's t-test inaxpxating Bcnferrcni correctim factor)
Table I I I . 25 OMRALATHRAL HEMISPHERE: CHANGES IN  KEF HCDUCED
m  2 mmhe infusiosb cf aeengsine aind cha
-10SxlO-Ttoles/min 10 noles/iran 
SMTUTRE 0.9% Satire ACEN26INE CHA
CJxtkal Areas
Visual cortex 109±20(6) 130112(4) 140+42 (?)
Audibxy cortex 128128(6) 336123(4) 159152 (?)
ferietal axtex 11?+14(6) 134+23(4) 154164 (?)
Sauscay-fiotor cortex 123119(6) 135133(4) 148+42 (?)
Ercntal cortex 119120(6) 136122(4) 149156 (?)
Erefrcntal axtex 151169(6) l??+29(4) l?6i?4 (?)
Anterior dngulate cortex 146186(6) 255160(4)* 2281149 (?)
ima^dialic Areas
Madial geniculate 109136(6) 135119(4) 134142 (?)
lateral geniculate 8?+20(6) 100124(4) 99128 (?)
Tnalamus, madiccbrsal 106149(6) 150119(4) 124+62 (?)
Thalanus, ventrolateral 80126(6) 105112(4) 9?136(?)
Hypothalamus 6611?(6) 86H5 (4) ?0120(?)
lateral tabeiula 101130(6) 129126(4) 108141 (?)
Anygdala 6016(6) ?0110(4) ?6+26(?)
Ccoudate nucleus 125130(6) 149126(4) 149154 (?)
Nucleus accunbaus 110136(6) 129118(4) 132155 (?)
Glcbus pall idis 95H9 (6) 96110(4) 98133 (?)
Internal capsule 54115(6) 62112(4) 5911?(?).
Subthalamic nucleus 152132(6) l?3+20(4) 162+48 (?)
inbrain Areas
vestibular nucleus 134+11 (6) 158129(4) 160133 (?)
Oxhlear nucleus 14?+16(5) 15?±43 (4) 141+22(6)
Superior olive 141110(6) 150138(4) 1?H36 (?)
Inferior olive 134+18(6) 133124(4) 162142 (?)
Rrs ?8110(6) 10119(4)* 94128 (?)
Tcfole 111.25 (cmtimed)
SMCT3FE
flfesaicgdnalic Areas 
Ited nucleus 
Substantia nigra 
Superior colliculus 
Inferior colliculus
Talanc^ dnalic Areas
Hippocaripus, rrolecular 
layer
Dsitabe gyrus 
Sqptal nucleus 
Osrduellum nucleus 
Cerebellum ham^tere
Fibre Tracts 
Genduellum vhite 
Qxpus callosum 
Gam
0.9% Saline
116±24(6)
92122(6)
120126(6)
13519(6)
100125(6) 
97120(6) 
81118(6) 
145116(6) 
661? (6)
3815(6)
4419(6)
44110(6)
3x10 riDles/min 
AEHSDSTSE
147112 (4) 
101119(4) 
149120(4) 
162132(4)
108118(4) 
99115(4) 
102126(4) 
149118(4) 
9116 (4)
44112(4)
62117(4)
5718(4)
-1010 noles/min 
CHA
139148 (?) 
104142 (?) 
147142 (?) 
156144(7)
113125(7) 
102125 (?) 
102128 (?) 
160134(7) 
76114 (?)
44116 (?) 
63126 (?) 
50120(7)
-1 -1All values for local aerrixal blood flow (ml.lOOg *min ) are expressed as 
nean 1 standard deviatim.
Figures in parentheses indicate n value.
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Table 
III.26 
PHYSIOLOGICAL 
PARAMETERS 
MONITORED 
DURING 
EXPERIMENTS 
WITH 
A
Table I I I . 2? THE EFFECT CF THECEHYTT.TNE CN OHE OENGES IN  KEF EK3XCED B£
A 2 MMJIE INEIEICN CF CHA. (KSILAIHELi HEMISfflEFE)
0.9% saline 10 ^ nDles/min CHA 0.9% saline 10 ^ SrDles/mLnCHA
1.c.+5ml/kg i.c.+5mL/kg i.c.+3Qmg/kg i.c.+30rrg/kg
SHmUHE saline i.p. saline i.p.______tfrecphylline i.p. •tbeqAylline i.p.
Qxtdcal Areas
Visual cortex 113120 (6) 143151(9) 114117(4) 145163(4)
Auditory cortex 129131(6) 160145(9) 324148(4) 181152(4)
Parietal cortex 121121(6) 158159(9) 134138(4) 189161(4)
SaiscayMiDbca: cxxtex 122±23 (6) 162151(7) 148144(4) 2331104 (4)a
Frcntal cxxtex 122120(6) 163164(9) 149145(4) 209192(4)
Erefixntal cortex 142150(6) 194166(9) 146154(4) 198144(4)
Anterior cdngulate 
cortex 138128(6) 2551184(9) 141146(4) 2691182(4)
iax^iialio Areas
Nfedial gaiioulate 109132(6) 140140(9) 95126(4) 118121(4)
Lateral goiioulate 85116(6) 102130(9) 96122(4) 90116(4)
Thalanus, Madio- 
dxsal 102152(6) 116148(9) 92138(4) 112148(4)
Thalarrus, Vantro- 
lateral 77120(6) 95128(9) 94135(4) 103129(4)
H^ potbalarrus 69120(6) ; 95121(9) 62124(4) 96122(4)
lateral babaula 101136(6) 109136(9) 93135(4) 109129(4)
Arygdala 65113(6) 84129(9) 59114(4) 90113(4)
Caudate nucleus 123124(6) 160150(9) 125126(4) 139143 (4)
Nucleus aoxnbans 106132(6) 146162(9) 83121(4) 116130(4)
Glcbus pallidus 98120(6) 103141(9) 99119(4) 90112(4)
literal capsule 5519(6) 64119(9) 55118(4) 53115(4)
Siictielaraic nucleus 146145(6) 183169(9) 116134(4) 129130(4)
Lrrforaln Areas
Vestibular nucleus 132133(6) 159135(9) 130133(4) 149131(4)
Gcchlear nucleus 142120(4) 191146(5) 111+11(2) 133120(3)
Superior olive 153111(6) 182132(9) 125128 (4)b 138128 (4)C
Inferior olive 128113(6) 158140 (?) 120128(4) 150129(4)
Rxrs 80H0 (6) 96124(9) 93118 (4) 89129(4)
Tcfole I I I . 2? (cmtinuad)
-10 -10
0.9% saline 10 noles/mm CHA 0.9% saline 10 noles/mm CHA.
1.c.+5ml/kg i.c.+5mL/kg i.c.+30rig/kg i.c.+30rrg/kg
SlHnJEFE saline i.p. saline i.p. feeqteylline i.p. teecrhylline i.p.
Nfesenogtealic Areas
fed nucleus 111+14(6) 135+50 (?) 9613?(4) 102116(4)
Substantia nigra ?9115(6) 10?+40 (?) "^ 4121(4) ?819 (4)
1I
122±22(6) 149+39 (?) 103121(4) 109110(4)
Inferior colliculus 144118 (6) 159±35 (?) 142132(4) 164154(4)
alanc^ tealic Areas
Hippocanpus, 
Molecular layeri 96+1?(6) 122+41 (?) 90126(4) 9811? (4)
Dentate gyrus 92110(6) 11?+?8(?) 88132(4) 90+14(4)
Septal nucleus 82±19(6) 106+3? (?) ?5122(4) 84120(4)
Osrteellun nucleus 148+21(6) 163123 (?) 125128(4) 151126(4)
Cerebellum heri- 
gteere 6?+12(6) ?8+14 (?) 69120(4) ?6116(4)
ibre Tracts
Cferebellum vhite 35±10(6) 4?±23(?) 36113(4) 4211? (4)
Cbrpus callosum 441? (6) ; 62123 (?) 44111(4) 4511?(4)
(fern 41+8(6) 50121(?) 5011?(4) 56121(4)
-1 . -1All values fca: local cetearal blood flow (ml.lOOg .mm ) are stressed as mean ± 
standard deriatdm.
Figures in parentheses indicate n value.
i.e. indicates -that the coipound vas administered via tee right internal carotid artery,
i.p. indicates teat tee oenpounds vbs administered intraperitcneally. 
a - indicates a significant difference frcm saline i.c./saline i.p. group? and 
b and c - significant difference frcm CHA i.c./saline i.p. group.
(K0.05 - ere vay analysis of variance wife Ifewran-Keuls rrultiple range test.)
Table III.28 H E  EFFECT CF H H H M U N E  CN H E  CHASGES IN.ICEF HCDUCED
B y  A  2  M M J 3 E  I N E U S I C N  C F  C H A  ( O d S T R A L A I E R A L  H E M ISEHEHE)
0 . 9 %  s a l i n e  1 0  ^roles/min C H A  0 . 9 %  saline 1 0  ^nDles/min C H A
1.c.+5mil/kg i . c . + 5 m l / k g  i . c . ± 3 Q m g / k g  i.c.+3Qrng/kg
S M T U I F E  S A L I N E  i.p. s a l i n e  i.p. t h e o p h y l l i n e  i . p . t h e o p h y l l i n e  i.p.
Q xtical Areas
Visual cortex 109120(6) 140+42 (?) 11?135(4) 152159(4)
Auditory cortex 128128(6) 159152 (?) 126+45(4) 187156(4)
ferietal cortex 11?+14(6) 154164 (?) 130+41(4) 182163(4)
Sescay^ -nDtar cortex 123+19 (6) 148+42 (?) 14414?(4) 2321106(4)'
Frontal ocatex 119120(6) 14?i56(?) 151148(4) 2201105(4)
Etefrcntal cortex 151169(6) 1?61?4 (?) 140153(4) 196151(4)
Anterior cdngulate 
cotex 146+861(6) 2281149 (?) 134133(4) 238112?(4)
Dieogdnalic Areas
Ifedial geniculate 109136(6) 134+42 (?) 98126(4) 12?136 (4)
lateral geniculate 8?120(6) 99128 (?) ?3il?(4) 95113(4)
Thalamus, Madio- 
dorsal 106+49(6) 124162 (?) 95135(4) 118150(4)
Hnalarrus, Ventro­
lateral 80126(6) 9?136 (?) 95+40(4) 113134(4)
Hypothalamus 6611?(6) ! ?0120 (?) 66122(4) ??123(4)
lateral habaola 101130(6) 108141 (?) 93134(4) 124126(4)
Anygdala 6016(6) 76126 (?) 62121(4) ?2114 (4)
Chudate nucleus 125130(6) 149154 (?) 110125(4) 15?t?0( 4)
Nucleus aconbens 110i36(6) 1321551;?) 82114(4) 120131(4)
Gldcus pallidus 95119(6) 98133 (?) ?4126 (4) 93118(4)
Internal capsule 5415(6) 5911? (?) 54119(4) 58114(4)
Sibfchalamric nucleus 152132(6) 162148 (?) 119130(4) 130135(4)
tindnrain Areas
Vestibular rucleus 134+11(6) 160133 (?) 138131(4) 160139(4)
Occhlear nucleus 14?116(6) 141122(6) 131+34(4) 202±?3(4)S
Superior olive 141110(6) l?l+36 (?) 12?132(4) 135126(4)
Inferior olive 134118(6) 162142 (?) 122+35(4) 14613?(4)
Etns ?8110(6) 94128 (?) ?6+21(4) 90129(4)
Table I I I . 28 (acntimed)
SMJCUHE
,-10 -1010 nDles/min CHA0.9% saline 10 tenroles/niin CHA 0.9% saline
1 . c . + 5 m l / k g  i . c . + 5 m l / k g  i.c.+3Qtg/lg' i . c . + 3 0 m g / k g
s a l i n e  i.p .  s a l i n e  i.p. t h e c p h y l l i n e  i.p .  t h e c y h y l l i n e  i . p
tfesanc^ dnalic Areas 
Bed nucleus 116+24(6)
Substantia nigra 92±22(6)
Superior colliculus 120±26 (6) 
Inferior colliculus 135+9 (6)
139148 (?) 
104+42 (?) 
14?142 (?) 
156144 (?)
102132(4) 
?5123(4) 
9912?(4) 
144128(4)
108125(4) 
81116(4) 
11011? (4) 
156158(4)
felencgdnalic Areas 
Hippocarrpus,
Nblecular layer 100125(6)
Dentate gyrus 9?+20 (6)
Sgctal nucleus 81118 (6)
Cerebellum nucleus 145116 (6)
Cterebellum h a n i -
sjdnere 661?(6)
113125 (?) 
102125 (?) 
102128 (?) 
160134 (?)
?6il4(?)
9012?(4) 
82129(4) 
?3123(4) 
141149(4)
?0+22(4)
104134(4)
96128(4)
88121(4)
140128(4)
?6116(4)
Fibre Tracts 
Oefeellum vhite 3815 (6)
Ocrpus callosum 4419 (6)
Gam 44+10(6)
44116 (?) 
63126 (?) 
50120 (?)
46113(4) 
46111(4) 
5011?(4)
42112(4)
44+L?(4)
56120(4)
-1
All values for local cendcral blood flow (ml.lOOg ) are expressed as nean 1 
standard deviation.
Figures in parentheses indicate n value.
i.e. indicates that tine coipound vas administered via the right internal carotid artery,
i.p. indicates that the cmpcund vas administered intraperiirneally. 
a - indicates a significant difference from saline i.c./saline i.p.; 
c - significant difference from CHA i.c./saline i.p. group; and d - significant 
difference frcm saline i.c./thecpiylline i.p. group.
(PC0.05; cue vey analysis of variance wLth tfewran-Kauls multiple range test).
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Table V .l EEEECT CF CHANGES IN MEAN AKEEFIAL B U D  H^ ESSURE (MABP)
CNIOCAL CEREBRAL HOCD ELCW (ICEF) - IESIEAM^L HEMISEHEFE
SMTUTRE MAH5 I^ ABP NRBP MABP MffiP
_______  40-59mrHg 60-69nnHg 7fr79rtnH? 8Q-89miHg 90-lQ9rmHg
Oartkal Areas
Visual ccrtex 117±53(8) 116i?4(4) 145164(4) 123139(4) 13618(5)
Auditory cortex 132±66 (8) 13016? (4) 1411?8(4) 121+1? (4) 164169(6)
Parietal cortex 118149(8) 112141(4) 143166(4) 145151(4) 1?6134(6)
SaTsary-fiDtor cortex 130±44 (?) 128150(4) 153154(4) 162122(4) 199146(6)
Ercntal cortex 127+51(7) 96138(4) 14?158 (4) 14?117 (4) 141+25(5)
Erefrcntal cortex 155182 (?) 148192(3) 155169(3) 13316(3) 176+40(5)
Anterior dngulate 
cortex 1631100(8) 170+122 (4) 1?0±4?(4) 149153(4) 190+68(5)
Edm^balie Areas
Madial gmiculate 130155(8) 104145(4) 154152(4) 120128(4) 150+41(6)
lateral geniculate 9?134(8) 91142(4) 118+46(4) 92122(4) 119+40(6)
Unalamns, lyfedio- 
dnrey?1 123158(8) 108154(4) 125136(4) 122+56(4) 165177(6)
lhalamjs, ■ventro­
lateral 9612?(8) 88+32(4) 124+45(4) 110131(4) 134+41(6)
Hffiothalarrus 6?±35(8) . ?0128 (4) • 85129(4) 84133(4) 104119(6)
lateral habanla 119138(8) 104148(4) 137131(4) 136+48(5) 150129(5)
Amygdala ?0129(8) 5811?(4) 81122(4) 80121(4) 107132(5)
caudate rucleus . 13?153 (?) 13016? (4) 181137(4) 14118(4) 222170(6)
Nucleus acoirbans 132163 (?) 109159(4) 128139(4) 114113(4) 167180(6)
Glctaus pallidus 94131(?) ?6135(4) 115134(4) 113123(4) 102130(6)
Interml capsule 62125(8) 45116(4) 69118(4) 67112(4) 89135(4)
Subthalamic nucleus 166+81(8) 14415?(4) 1681100(4) 170121(4) 149129(6)
Lndbrain Areas
f^estibular rucleus 162173(8) 160156(4) 201174(4) 174154(4) 176125(5)
Cochlear rucleus 157+43 (?) 130+4(4) 206188(4) - 1941110(2)
Superior olive 193180(8) 172149(4) 2821147(4) 168132(4) 185157(6)
Inferior olive 158166(8) 147+48(4) 180155(4) 180157(4) 181164(6)
Rns 115158(8) 98138(4) 118138(4) 99136(4) 129+43(6)
Tcble V .l (cxnt±XEd.)
snraiERE MABP
40-59rmHq-
MABP
60-69rmHg
NKEP
?0-79nmHg
MABP
80-89rmHg
MABP
90-109miB
f^esanoqphalic Areas
Bsd rucleus 151£59(8) 142156(4) 153144(4) 148129(4) 141+25(6)
SLbsfcanba nigra 120155 (8) 95132(4) 116140(4) 110118(4) 9911?(6)1I
148182(8) 132149(4) 139151(4) 138129(4) 160125(6)11
19%35(8) 158180(4) 201162(4) l?6i52 (4) 21615?(6)
Talaxqdialic Areas
Hippocarpus, 
lyblecular la^ er 114155(8) 102146(4) 13414?(4) 118136(4) 144+48(6)
Dartate gyrus 10614? (8) 9?t42 (4) 132142(4) 114133(4) 142143(6)
Sgpfcal nucleus 96139 (?) 86144(4) 111+24(4) 8419(4) 15016? (6)
fet^ cellun nucleus 180188(8) 154130(4) 217182(4) 159116(4) l?6+22(5)
OaD±ellun haru.- 
^tere 92141(8) 8111? (4) 100133(4) 90123(4) 86H 8 (6)
Fibre Tracts
ferebelluri vbite 46118(8) 42+15(4) 55116(4) 51130(4) 48116(6)
Cbrpus callosum 55128(8) 4211? (4) ?6+34(4) 6911? (4) 125154(6)
fen 45116 (?) 42120(4) 52114(4) 4816(4) ?2128(6)
-1 . -i)
All values fear local cerebral blood flew (rriL.lOOg .mm are expressed as 
nean ± standard deviation.
Figures in parartbeses indicate n value.
Table V.2 EFFECT CF CHAN5ES IN MEAN AKDEFIAL BLGCD IKESSUEE (TW)
CN IOCAL CEFEBFiAL BLOCD ELOV (KEF) - CCNERALAEEFAL HEM35EHERE
SIRCTURE MABP MABP MABP MABP WEP
 _____  40-59rmHg 60-69nnH? 70-79rmHg 80-89nnB? 90-109rcnBg
Ctartioal Areas
VisiEl cortex 123159(8) 120173(4) 135150(4) 132143(4) 165+45(6)
Auditory cortex: 144+73(8) 130164(4) 150158(4) 122+40(4) 146145(6)
Parietal cortex: 129156(8) 125+49(4) 151162(4) 142136(4) 167138(6)
SaTsaryHTotar cortex 142+43 (?) 143153(4) 160+38(4) 181145(4) 180152(6)
Frcnbal cortex 135+42(7) 128+49(4) 170+62(4) 148152(3) 153+42(5)
PreErcntal cortex 156172 (?) 156180(3) 147152(3) 12713(3) 173138(5)
Antericr cdrguLate 
cortex 1651113(8) 1741130(4) 169142(4) 141143(4) 186161(6)
Edax^balic Areas
Nfedial garioulate 145173 (8) 125152(4) 143+46(4) 119133(4) 153+44(6)
lateral gaiioulate 98136(8) 104162(4) 126154(4) 108123(4) 129137(6)
Thalamus, Madio- 
dorsal 120158(8) 111+52(4) 137*34(4) 127*58(4) 171182(6)
Thalamus, vorfcro- 
lateral 99129(8) 94138(4) 123+46(4) 120136(4) 128+45(6)
Hypothalamus 73+40(8) 66126(4) 92130(4) 85125(4) 103118(6)
lateral haboula 124+49(8) . 104139(4) 138128(4) 131+38(4) 150126(5)
Anygdala 80+48(8) 70123(4) 86127(4) 96125(4) 98131(5)
rai idate nucleus 156155(7) 145170(4) 183+49(4) 136112(4) 225+80(6)
Nucleus aconbais 133160(7) 117155(4) 138130(4) 10615(4) 174186(6)
Glcbus pallidas 97136(7) 84137(4) 127*34(4) 108128(4) 105137(6)
Interml capsule 60129(8) 60126(4) 78128(4) 7219(4) 83132(4)
SubttalarnLc nucleus 174183(8) 147*64(4) 157*78(4) 152124(4) 165142(6)
Hiifbrain Areas
f^estibular nucleus 166+78(8) 155+56(4) 202+82(4) 172±49(4) 177±35(5)
Qcdhlear nucleus 119±11(3) 145133(4) 2451153(3) 144H6(4) 178156(4)
Superior olive 193171(8) 168132(4) 2831169(4) 183139(4) 182155(6)
Inferior olive 157159(8) 134+44(4) 176152(4) 177*45 (4) 178+49(6)
Kxe 113155(8) 98139(4) 121+40(4) '96127(4) 122+38(6)
1cbleV.2 (ocntirued)
SMJCOTE MABP
40-59nnB}
MABP
60-69mrffcj
MABP
70-79rmHg
MABP
80-89mrHg
MABP
90-109nnB
flfesanoginalic Areas
Red rucleus 145±75(8) 137152(4) 145144(4) 136121(4) 139121(6)
Srtetantia nigra 114±55(8) 91138(4) 118140(4) 98112(4) 97114(6)1I
143±73(8) 142159(4) 148151(4) 138126(4) 159124(6)
Inferior collirulus 183177(8) 183166(4) 221+58(4) 172160(4) 206+45(6)
Telencqdnalic: Areas
Hippocanpus, 
Molecular layer 124±56(8) 116158(4) 128136(4) 128153(4) 125124(6)
Dentate gyrus 123159 (8) 109143(4) 124136(4) 121+41 (4) 120125(6)
Sgctal rucleus 96134(7) 87139(4) 112+17(4) 84+8(4) 146154(6)
Osndellun rucleus 199195(7) 176156(4) 216171(4) 159116(4) 162122(5)
Cerebellum hsnL- 
gdnere 90139(7) 78115(4) 96136(4) 92122(4) 86114(6)
Fibre Tracts
Gandcellum vhite 48116(8) * 45112(4) 61112(4) 52126(4) 52116(6)
Cbrpus callosum 52125(8) 43120(4) 87146(4) 68116(4) 126152(6)
Gem 50120(7) 47123(4) 58119(4) 4919(4) 71+27(6)
-1 ~1All values fear local aarenral blood flow (ml.lOOg .mm ) are expressed as 
mean ± standard deviation.
Figures in parentheses indicate n value.
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